Virginia Commonwealth University

VCU Scholars Compass
Theses and Dissertations

Graduate School

2011

Anaplasma phagocytophilum remodels its host cell-derived
vacuole into a protective niche by redecorating the vacuolar
membrane with select Rab GTPases and bacterial proteins
Bernice Huang
Virginia Commonwealth University

Follow this and additional works at: https://scholarscompass.vcu.edu/etd
Part of the Medicine and Health Sciences Commons
© The Author

Downloaded from
https://scholarscompass.vcu.edu/etd/280

This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It
has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars
Compass. For more information, please contact libcompass@vcu.edu.

© Bernice

Huang 2011
All Rights Reserved

ANAPLASMA PHAGOCYTOPHILUM REMODELS ITS HOST
CELL-DERIVED VACUOLE INTO A PROTECTIVE NICHE BY
REDECORATING THE VACUOLAR MEMBRANE WITH SELECT
RAB GTPASES AND BACTERIAL PROTEINS
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.

by
B ERNICE H UANG
Bachelor of Science, University of Richmond, 2005
Director: Jason A. Carlyon, Ph.D.
Assistant Professor, Department of Microbiology and Immunology

Virginia Commonwealth University
Richmond, Virginia
December 2011

Acknowledgment
First and foremost, I would like to thank Dr. Jason Carlyon for his mentorship. His guidance,
contagious passion for science, and consistent encouragement enabled my development
as a scientist. I also extend thanks to my graduate committee: Drs. Richard Marconi,
Todd Kitten, Dennis Ohman, and Ghislaine Mayer for their scientific input and expertise
throughout this project. In addition, I want to thank Dr. Francine Marciano-Cabral for her
valued advice and friendship.
I wish to thank past and present members of the Carlyon lab for their intellectual input,
technical assistance and benchside banter. In particular, Dr. Nore Ojogun for her willingness
to walk to lab through treacherous storms and Dr. Matt Troese for his understated humor.
Current lab members I would also like to thank are Hilary Truchan, Dr. Amandeep Kahlon,
Stephanie Ragland, Lauren VieBrock and Dr. Andrea Beyer.
I would like to thank my friends for their encouragement and fun times throughout my
graduate career. Specifically, Erica Longenbach for her unwavering support and entertainment, Melissa Jamerson for her friendship throughout graduate school, and Aaron Wolen
for always making me laugh and making sure my axes were labeled.
Last but not least, I would like to express my heartfelt gratitude to my parents for their
unconditional love and support throughout my life, without which I would never be where I
am today. Thank you for always encouraging me to pursue my interests and accepting 28
years of homemade gifts.

ii

Table of Contents
List of figures

vi

List of tables

viii

List of abbreviations

ix

Abstract
1

2

xiv

Introduction

1

1.1

Anaplasma phagocytophilum . . . . . . . . . . . . . . . . . . . . . . . . .

1

1.2

Ecology and epidemiology . . . . . . . . . . . . . . . . . . . . . . . . . .

2

1.3

Human granulocytic anaplasmosis . . . . . . . . . . . . . . . . . . . . . .

5

1.4

The A. phagocytophilum genome . . . . . . . . . . . . . . . . . . . . . . .

6

1.5

A. phagocytophilum intracellular development . . . . . . . . . . . . . . . .

9

1.6

Subversion of host antimicrobial defenses . . . . . . . . . . . . . . . . . . 10

1.7

Pathogenesis and immune responses . . . . . . . . . . . . . . . . . . . . . 13

1.8

Establishing an intracellular niche . . . . . . . . . . . . . . . . . . . . . . 15

1.9

Research objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16

Materials and Methods

18

iii

3

The A. phagocytophilum-occupied vacuole (ApV) selectively recruits Rab-GTPases
that are predominantly associated with recycling endosomes

37

3.1

Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37

3.2

Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
3.2.1

Fluorescent protein-tagged Rab1, Rab4A, Rab10, Rab11A, Rab14,
Rab22A and Rab35 localize to the ApV. . . . . . . . . . . . . . . . 41

3.2.2

The ApV recruits Rabs upon formation and continues to do so
throughout infection. . . . . . . . . . . . . . . . . . . . . . . . . . 45

3.2.3

Endogenous Rab14 localizes to the ApV. . . . . . . . . . . . . . . 46

3.2.4

GFP-Rab10 and GFP-Rab14 localization to the ApV is not dependent on an intact Golgi apparatus. . . . . . . . . . . . . . . . . . . 49

3.2.5

GFP-Rab1, GFP-Rab4A, GFP-Rab11A, GFP-Rab14 and GFP-Rab35
associate with the ApV in a guanine nucleotide-dependent manner, but GFP-Rab10 localizes to the ApV in a guanine nucleotideindependent manner. . . . . . . . . . . . . . . . . . . . . . . . . . 49

3.2.6

Selective recruitment of GFP- or RFP-Rab GTPases to the ApV is
dependent on A. phagocytophilum protein synthesis. . . . . . . . . 55

3.3
4

Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58

A. phagocytophilum APH_1387 is expressed throughout bacterial intracellular development and localizes to the pathogen-occupied vacuolar membrane (PVM)

67

4.1

Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67

4.2

Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
4.2.1

APH_1387 has limited homology to any previously described protein. 68

4.2.2

APH_1387 is more abundant in A. phagocytophilum RC organisms
than in DC organisms. . . . . . . . . . . . . . . . . . . . . . . . . 70
iv

4.2.3

APH_1387 is induced following bacterial entry into host cells and
localizes to the AVM. . . . . . . . . . . . . . . . . . . . . . . . . . 72

4.2.4

APH_1387 localizes to the AVM during A. phagocytophilum infection of human myeloid and endothelial cell lines and tick embryonic
cell lines. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75

4.2.5

APH_1387 is expressed and localizes to the AVM throughout A.
phagocytophilum intracellular development in HL-60 cells. . . . . . 75

4.2.6
4.3
5

APH_1387 is expressed and localizes to the AVM in vivo. . . . . . 81

Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81

A. phagocytophilum APH_0032 is expressed late during infection and localizes to
the pathogen-occupied vacuolar membrane

85

5.1

Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85

5.2

Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
5.2.1

APH_0032 displays limited similarity to other known proteins but
exhibits predicted secondary structural characteristics that are suggestive of AVM localization. . . . . . . . . . . . . . . . . . . . . . 86

5.2.2

APH_0032 is present in higher abundance in A. phagocytophilum
RC organisms than in DC organisms. . . . . . . . . . . . . . . . . 88

5.2.3

APH_0032 is not detected until 24 h post infection and localizes to
the AVM. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90

5.2.4

APH_0032 localizes to the AVM during A. phagocytophilum infection of human myeloid and endothelial cell lines and tick embryonic
cell lines. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90

5.2.5

APH_0032 is not amply expressed by A. phagocytophilum and does
not localize to the AVM until 24 h post infection of HL-60 cells. . . 93
v

5.2.6

APH_0032 is expressed and localizes to the AVM during in vivo
A. phagocytophilum infection and aph_0032 and aph_1387 are
transcribed during A. phagocytophilum residence in tick salivary
glands. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97

5.3
6

Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

A. phagocytophilum proteins APH_1387 and APH_0032 are expressed on the cytoplasmic face of the AVM and are critical for ApV development.

102

6.1

Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102

6.2

Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
6.2.1

GFP tagged APH_1387 and APH_0032 constructs used in this study.103

6.2.2

A. phagocytophilum AnkA, but not APH_0032 or APH_1387 can
be heterologously secreted by the L. pneumophila Dot/Icm T4SS
secretion system. . . . . . . . . . . . . . . . . . . . . . . . . . . . 106

6.2.3

The N-terminal non-repeat regions of APH_0032 and APH_1387
possess domains that facilitate association with host cell membranes.108

6.2.4

APH_1387 and APH_0032 are exposed on the cytoplasmic face of
the AVM. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111

6.2.5

Ectopic expression of GFP-tagged APH_1387 and APH_0032 interferes with A. phagocytophilum development in RF/6A cells. . . . . 117

6.3
7

Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122

Monoubiquitinated proteins decorate the A. phagocytophilum-occupied vacuolar
membrane (AVM)

127

7.1

Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127

7.2

Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
7.2.1

Ubiquitinated proteins accumulate on the AVM. . . . . . . . . . . . 129
vi

7.2.2

The AVM accumulates ubiquitinated proteins over the course of A.
phagocytophilum infection in HL-60 cells. . . . . . . . . . . . . . 132

7.2.3

The AVM is monoubiquitinated. . . . . . . . . . . . . . . . . . . . 137

7.2.4

de novo bacterial protein synthesis is important for continued association of ubiquitinated proteins at the AVM. . . . . . . . . . . . . 137

7.3
8

Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138

Conclusions

142

Bibliography

147

Copyrighted license material

168

Vita

170

vii

List of Figures
1

A. phagocytophilum infected cells. . . . . . . . . . . . . . . . . . . . . . .

3

2

Lifecycle of Ixodes spp. ticks. . . . . . . . . . . . . . . . . . . . . . . . .

4

3

Biphasic development of A. phagocytophilum in HL-60 cells. . . . . . . . . 11

4

Selective GFP- or RFP-Rab GTPase localization to the A. phagocytophilumoccupied vacuole (ApV). . . . . . . . . . . . . . . . . . . . . . . . . . . . 42

5

Percentages of ApVs exhibiting GFP- or RFP-Rab GTPase localization. . . 44

6

Time-course analyses of GFP- or RFP-Rab GTPase recruitment to the ApV.

7

Endogenous Rab14 localizes to the ApV. . . . . . . . . . . . . . . . . . . . 48

8

GFP-Rab10 and GFP-Rab14 localization to the ApV is insensitive to BFA. . 50

9

Localization of GFP-Rab1, GFP-Rab4A, GFP-Rab11A, GFP-Rab14 and

47

GFP-Rab35 to the ApV is guanine nucleotide-dependent, while GFP-Rab10
association with the ApV is guanine nucleotide-independent. . . . . . . . . 53
10

Selective recruitment of GFP- or RFP-Rab GTPases to the ApV is dependent
on bacterial protein synthesis. . . . . . . . . . . . . . . . . . . . . . . . . . 56

11

Model indicating the Rab GTPases and host cell membrane traffic pathways
that are hijacked by the ApV. . . . . . . . . . . . . . . . . . . . . . . . . . 59

12

Schematic diagram of A. phagocytophilum APH_1387 and its secondary
structure. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69

viii

13

Screening of A. phagocytophilum-infected HL-60 cells and host cell-free
bacterial populations with anti-APH_1387. . . . . . . . . . . . . . . . . . 71

14

A. phagocytophilum APH_1387 is detectable on the surfaces of intravacuolar
bacteria and localizes to the AVM in infected host cells.

15

. . . . . . . . . . 73

Kinetics of APH_1387 expression and AVM localization in A. phagocytophilum-infected cells. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76

16

Assessment of A. phagocytophilum APH_1387 expression and localization
to the AVM by immunoelectron microscopy. . . . . . . . . . . . . . . . . . 79

17

A. phagocytophilum APH_1387 is expressed and associates with the AVM
during in vivo infection. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82

18

Schematic representation of A. phagocytophilum APH_0032, sequence, and
secondary structure analyses. . . . . . . . . . . . . . . . . . . . . . . . . . 87

19

APH_0032 is present in greater abundance in lysates of A. phagocytophilum
RC organisms compared to DC organisms. . . . . . . . . . . . . . . . . . . 89

20

A. phagocytophilum APH_0032 is detectable on the surfaces of intravacuolar
bacteria and localizes to the AVM in infected host cells. . . . . . . . . . . . 91

21

Kinetics of APH_0032 expression and AVM localization in A. phagocytophilum-infected HL-60 cells. . . . . . . . . . . . . . . . . . . . . . . . . 94

22

Assessment of A. phagocytophilum APH_0032 expression and localization
to the AVM by immunoelectron microscopy. . . . . . . . . . . . . . . . . . 95

23

A. phagocytophilum APH_0032 is expressed and modifies the AVM during
in vivo infection. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98

24

Schematic representation of APH_0032 gene constructs used in this study. . 104

25

Schematic representation of APH_1387 gene constructs used in this study. . 105

ix

26

A. phagocytophilum AnkA, but not APH_0032 or APH_1387 can be secreted by the Legionella pneumophila Dot/Icm secretion system. . . . . . . 107

27

Deletion analysis of APH_0032 reveals a N-terminal domain necessary for
host cell membrane association. . . . . . . . . . . . . . . . . . . . . . . . 109

28

Deletion analysis of APH_1387 identifies a N-terminal domain, residues
101-112, necessary for host cell membrane association. . . . . . . . . . . . 112

29

APH_1387 and APH_0032 contain portions exposed on the cytoplasmic
face of the AVM. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115

30

Ectopically expressed GFP-1387 interferes with ApV development at 24 h
post infection. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118

31

Ectopically expressed GFP-APH_1387 and GFP-APH_0032 competitively
inhibit ApV development at 48 h post infection. . . . . . . . . . . . . . . . 120

32

Monoubiquitinated proteins decorate the AVM in HL-60 cells. . . . . . . . 130

33

Ubiquitinated proteins localize to the AVM in infected host cells. . . . . . . 131

34

Ubiquitinated proteins are detectable on the AVM following A. phagocytophilum entry into nascent vacuoles and continue to accumulate on the
AVM throughout infection. . . . . . . . . . . . . . . . . . . . . . . . . . . 133

35

Percentages of AVMs exhibiting ubiquitinated protein association over the
course of A. phagocytophilum infection of HL-60 cells. . . . . . . . . . . . 136

36

Ubiquitin association with the AVM is dependent on bacterial protein synthesis.139

37

The A. phagocytophilum-occupied vacuole interacts with a broad repertoire
of host pathways to facilitate its intracellular survival strategy in host cells. . 143

x

List of Tables
1

Oligonucleotides used to amplify select Rab GTPases. . . . . . . . . . . . 20

2

Oligonucleotides used to generate GFP-APH_1387 and -APH_0032 fusion
constructs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22

3

Oligonucleotides used to generate CyaA fusion constructs . . . . . . . . . 25

4

Rab GTPases examined in this study . . . . . . . . . . . . . . . . . . . . . 39

xi

List of Abbreviations
C

degrees Celsius

A. phagocytophilum

Anaplasma phagocytophilum

g

relative centrifugal force (RCF), or g-force

µg

microgram

µl

microliter

Ab

antibody

ApV

A. phagocytophilum-occupied vacuole

AVM

A. phagocytophilum-occupied vacuolar membrane

BFA

Brefeldin A

BLAST

basic local alignment search tool

BME

b -mercaptoethanol

BMMC

Bone marrow derived mast cell

BSA

bovine serum albumin

cAMP

adenosine 3’,5’-monophosphate

CDC

Centers for Disease Control

CO2

carbon dioxide

CyaA

adenylate cyclase

CYE

charcoal yeast extract

DAPI

4’-6-diamidino-2-phenylindole

DC

dense-cored cell form of A. phagocytophilum

DMEM

Dulbecco’s Modified Eagle’s Medium
xii

DNA

deoxyribonucleic acid

DTT

dithiothreitol

EDTA

ethylenediaminetetraacetic acid

EE

early endosome

ER

endoplasmic reticulum

ERC

endocytic recycling center

FBS

fetal bovine serum

GAP

GTPase-activating protein

GDF

GDI displacement factor

GDI

guanine nucleotide dissociation inhibitor

GEF

guanine nucleotide exchange factor

GFP

green fluorescent protein

GTP

guanosine triphosphate

h

hour

HCl

hydrochloric acid

HGA

human granulocytic anaplasmosis

HGE

human granulocytic ehrlichiosis

HRP

horseradish peroxidase

IC

pre-Golgi intermediate compartment

IFA

indirect immunofluorescence analysis

IFN-g

interferon-g (gamma)

IL

interleukin

IMDM

Iscove’s Modified Dulbecco’s Medium

Inc

chlamydial inclusion membrane protein

IPTG

isopropyl-b -D-thiogalactopyranoside
xiii

kDa

kilodalton

KOH

potassium hydroxide

LAMP-1

Lysosomal-associated membrane protein-1

LB

Luria-Bertani

LCV

Legionella-containing vacuole

LCVM

Legionella-containing vacuolar membrane

LE

late endosome

LPS

lipopolysaccharide

mAb

monoclonal antibody

Mb

megabases

MBP

maltose binding protein

MEM

Minimum Essential Medium

Mg(CH3 COO)2

magnesium hydroxide

MgCl2

magnesium chloride

MHC

major histocompatibility complex

min

minute

ml

milliliter

mM

millimolar

MPR

mannose-6-phosphate receptor

MPV

Mycobacteria-pathogen vacuole

Msp2 (P44)

major surface protein 2 (44-kDa protein)

NaC2 H3 O2

sodium acetate

NaCl

sodium chloride

NADPH

nicotinamide adenine dinucleotide phosphate-oxidase

NaHCO3

sodium bicarbonate
xiv

NaOH

sodium hydroxide

ng

nanogram

nM

nanometer

O2 –

superoxide

PAGE

polyacrylamide gel electrophoresis

PAMPs

pathogen-associated molecular patterns

PBS

phosphate buffered saline

PCR

Polymerase chain reaction

PFA

paraformaldehyde

PM

plasma membrane

PMA

phorbol 12-myristate 13-acetate

PSGL-1

Platelet selectin glycoprotein ligand-1

PV

pathogen-occupied vacuole

PVM

pathogen-occupied vacuolar membrane

RC

reticulate cell form of A. phagocytophilum

RE

recycling endosome

RFP

red fluorescent protein

ROS

reactive oxygen species

rpm

revolutions per minute

RPMI

Rosewell Park Memorial Institute

RT-PCR

reverse transcriptase polymerase chain reaction

s

second

SCID

severe combined immunodeficiency

SCV

Salmonella-containing vacuole

SDS

sodium dodecyl sulfate
xv

SG

secretory granule

sLex

siayl Lewis x

SV

synaptic vesicle

T1SS

type I secretion system

T4SS

type IV secretion system

TBS-t (0.5)

tris-buffered saline with 5% tween-20

TFR

transferrin receptor

TGN

trans-Golgi network

TIGR

the institute for genomic research

TMD

transmembrane domain

TNF-a

tumor necrosis factor-a

TRP

tandem repeat protein

xvi

Abstract
ANAPLASMA PHAGOCYTOPHILUM REMODELS ITS HOST CELL-DERIVED
VACUOLE INTO A PROTECTIVE NICHE BY REDECORATING THE VACUOLAR
MEMBRANE WITH SELECT RAB GTPASES AND BACTERIAL PROTEINS
By Bernice Huang, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2011
Major Director: Jason A. Carlyon, Ph.D.
Assistant Professor, Department of Microbiology and Immunology

Anaplasma phagocytophilum is an obligate intracellular bacterium that infects neutrophils to cause the emerging tick-transmitted disease, human granulocytic anaplasmosis
(HGA). Following entry, the pathogen replicates within a host cell-derived vacuole that fails
to mature along the endocytic pathway, does not acidify, and does not fuse with lysosomes.
Selective fusogenicity is prototypical of many vacuole-adapted pathogens and has been
attributed, at least in part, to pathogen modification of the vacuolar inclusion membrane
and/or to selective recruitment or exclusion of host trafficking regulators. As a result, the A.
phagocytophilum-occupied vacuolar membrane (AVM) provides a unique interface to study
the host-pathogen interactions critical to A. phagocytophilum intracellular survival.
Diverse vacuole-adapted pathogens – including Chlamydia, Legionella, and Salmonella
spp. – selectively recruit host Rab GTPases to their vacuolar membranes to establish
replicative permissive niches within their host cells. Rab GTPases coordinate many aspects

of endocytic and exocytic cargo delivery. We determined that the A. phagocytophilumoccupied vacuole (ApV) selectively recruits a subset of fluorescently-tagged Rabs that
are predominantly associated with recycling endosomes. Another emerging theme among
vacuole-adapted pathogens is the ability to hijack ubiquitin machinery to modulate host
cellular processes. Mono- and polyubiquitination differentially dictate the subcellular localization, activity, and fate of protein substrates. Monoubiquitination directs membrane traffic
from the plasma membrane to the endosome and has been shown to promote autophagy. We
show that monoubiquitinated proteins decorate the AVM during infection of promyelocytic
HL-60 cells, endothelial RF/6A cells, and to a lesser extent, embryonic tick ISE6 cells.
Importantly, tetracycline treatment concomitantly promotes loss of the recycling endosomeassociated GFP-Rabs and ubiquitinated proteins and acquisition of the late endosomal
marker, Rab7, and lysosomal marker, LAMP-1, implicating bacterial-derived proteins in the
ApV’s altered fusogenicity. Therefore, we rationalized that A. phagocytophilum-encoded
proteins that associate with the AVM may establish interactions with the host cell that
are important for intracellular survival. By focusing on A. phagocytophilum proteins that
are induced during host infection, we identified the first two bacterial-encoded proteins –
APH_1387 and APH_0032 – that modify the AVM. Although functional studies are hindered by the lack of a system to genetically manipulate Anaplasma, the pathobiological
roles of APH_1387 and APH_0032 are likely unique, as both proteins exhibit very little
or no homology with any previously described protein. APH_1387 and APH_0032 are
present at the cytoplasmic face of the AVM, therefore they likely interact with host proteins.
We demonstrate that ectopic expression of APH_1387 and APH_0032 inhibits the ApV
development in A. phagocytophilum infected cells. The results presented in this dissertation
contribute to our understanding of how A. phagocytophilum modifies the vacuolar membrane
in which it resides to establish a safe haven and evade lysosomal degradation.
xviii

Introduction
1.1

Anaplasma phagocytophilum

Anaplasma phagocytophilum is a Gram-negative bacterium in the family Anaplasmataceae,
in the order Rickettsiales and the class a-Proteobacteria (53). All members of this family are
obligate intracellular bacteria that replicate exclusively in membrane-bound compartments
within their respective host cells and are the causative agents of animal and human diseases
(162). To date, five species are known to infect humans, A. phagocytophilum, Ehrlichia
chaffeensis, Ehrlichia ewingii, Ehrlichia canis and Neorickettsia sennetsu. Collectively,
infections caused by members of this family are referred to as ehrlichioses. A. phagocytophilum was first identified as a veterinary pathogen in 1932 and was originally classified
as two separate Ehrlichia species. The first human infection was documented in 1994
and was referred to as human granulocytic ehrlichiosis (HGE) (35). In 2001, taxonomic
reclassification based on improved genetic analyses of 16S rRNA gene and groESL operon
sequence results and surface protein genes grouped the three former species, Ehrlichia equi,
Ehrlichia phagocytophila and the HGE agent into the single species, A. phagocytophilum
(53). Following the revised nomenclature, A. phagocytophilum infection is now referred to
as human granulocytic anaplasmosis (HGA) (53).
A. phagocytophilum is a small (0.2-2 µm diameter) pleomorphic coccobacillary bacterium that replicates within a host cell derived vacuole to form microcolonies (35). Microcolonies are typically 2-7 µm in diameter and can be visualized by Giemsa staining (Figure
1

1) (13, 35). The hallmark feature of A. phagocytophilum is its unique tropism for replicating
inside neutrophils. The human promyelocytic leukaemia cell line, HL-60, is used for standard in vitro cultivation studies (72). In addition, A. phagocytophilum infects endothelial
cells in vivo and in vitro and mast cells and megakaryocytes in vitro (75, 82, 133, 143).

1.2

Ecology and epidemiology

In its natural environment, A. phagocytophilum cycles between its Ixodes tick vector and
small mammalian hosts, the primary of which is the white-footed mouse, Peromyscus
leucopus (Figure 2). Humans are accidental hosts. In the United States, the vector includes
Ixodes scapularis in the northeast and upper midwest, and I. pacificus and I. spinipalis in
the Pacific coast and mountain regions, respectively (195). It is estimated that 10-50% of
I. scapularis ticks in the United States are infected with A. phagocytophilum (121, 147).
Within Europe and Asia, the vectors are I. ricinus and I. persulcatus, respectively (26, 146).
In addition to A. phagocytophilum, Ixodes spp. are the vectors for Borrelia burgdorferi (25)
and Babesia microti (185), the causative agents of Lyme disease and babesiosis, respectively.
Coinfection of Ixodes spp. ticks with one or more of the aforementioned pathogens has been
confirmed (194, 200). The lifecycle of Ixodes spp. ticks span 2 to 3 years and includes three
developmental stages, larva, nymph, and adult (Figure 2). Each developmental stage feeds
only once (9, 12, 194). Tick acquisition of A. phagocytophilum occurs during a blood meal
of an infected mammalian host, but since there is no transovarial transmission, once an adult
tick has laid eggs, the A. phagocytophilum infection cycle is interrupted. Within the tick, A.
phagocytophilum replicates inside cells of the midgut and salivary glands.
Geography is an important factor in the epidemiology of anaplasmosis. The areas with
high incidence rates of A. phagocytophilum infection correspond to the distribution of Ixodes
spp. HGA was first identified in 1994 in patients from Wisconsin and Minnesota and it
2

Figure 1. A. phagocytophilum infected cells.
Giemsa stained A. phagocytophilum infected (A) peripheral blood neutrophils and (B)
human HL-60 promyelocytic cells in tissue culture. Microcolonies appear as circular blue
inclusions in the cytoplasm of the host cells, denoted by the arrows. Image from: Dumler
JS, Madigan JE, Pusterla N, Bakken JS. Ehrlichioses in humans: epidemiology, clinical
presentation, diagnosis, and treatment. Clin Infect Dis 2007;45 Suppl 1:S45-51.
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Figure 2. Lifecycle of Ixodes spp. ticks.
Ticks acquire A. phagocytophilum from infected mammals through a blood meal. The
bacterium is transmitted to a susceptible mammal during the ticks next blood meal. Since
there is no transovarial transmission, once an adult tick has laid eggs, the A. phagocytophilum
infection cycle is disrupted. Humans are accidental hosts and are not part of the normal tick
life cycle. Image from: Nicholson, W.L, K.E. Allen, J.H. McQuiston, E.B. Breitschwerdt
and S.E. Little. 2010. The increasing recognition of rickettsial pathogens in dogs and people.
Trends in Parasitology 26(4):205-212.
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became a nationally notifiable disease in 1999 (11, 35). Since 1999, the number of reported
cases has steadily increased, with 1,761 cases of A. phagocytophilum infection documented
in 2010 (33). However, the numbers likely underrepresent the true incidence and prevalence
as many cases of HGA follow a mild course or go unrecognized. Seroepidemiological data
estimate that in regions where the disease is endemic 15-36% of the populations have been
infected (2, 13).

1.3

Human granulocytic anaplasmosis

Clinical manifestations and treatment. The onset of HGA typically occurs 5-21 days
after a bite from an infected tick (195). Clinical presentations of the disease range in severity
from asymptomatic to severe febrile illness and in rare cases death. Commonly associated
symptoms include headache, malaise, fever, chills and myalgia (55). Laboratory findings
can include leukopenia, thrombocytopenia, and elevated levels of serum hepatic enzymes
(43, 55). While the disease is often self-limiting, severe infections and poor outcomes have
been linked to patients with underlying medical conditions, preexisting immune dysfunction,
or when antibiotic therapy was not provided in a timely manner (55, 164). Up to 17% of
patients with severe HGA require intensive care hospitalization (12). In the United States,
the case fatality rate is 0.7% and is largely associated with opportunistic infections. Most
patients respond to doxycycline, which is the preferred treatment (195). Currently there is
no vaccine available.
Diagnosis. The most rapid approach for diagnosis is examination of a Giemsa-stained
peripheral blood smear for intravacuolar bacterial colonies within the cytosol of granulocytes,
which appear dark blue (Figure 1A). This test is most useful during the first week of
infection because sensitivity of the assay is 25-75% for A. phagocytophilum infection.
Polymerase chain reaction (PCR) amplification of A. phagocytophilum-specific DNA can
5

also confirm diagnosis during acute infection with assay sensitivity reported to range between
67-90% (55). However, the most frequently used method for diagnostic confirmation is the
serological detection of antibodies in patient serum by indirect immunofluorescence analysis
(IFA). This method is most sensitive 2-4 weeks following disease onset because it requires
that the patient has had sufficient time to develop an antibody response. Once a patient
is seropositive, antibodies may persist for years in the absence of clinical infection (12).
Therefore, a serologic reaction in the absence of clinical presentation should not definitively
be interpreted as an active, persistent or even chronic infection (55).

1.4

The A. phagocytophilum genome

The genome of A. phagocytophilum strain HZ was annotated in 2006 and consists of a
single circular chromosome of 1,471,282 base pairs with 41.6% G-C content (57). It is
about one quarter the size of the Escherichia coli genome (57). The notably small genome
size is common among obligate intracellular pathogens such as Chlamydia trachomatis
(genome 1.04 Mb), Rickettsia prowazekii (genome 1.11 Mb) and Coxiella burnetii (genome
2 Mb) (10, 178, 189). It is thought to be a pathoadaptive evolutionary process where the
bacteria compensate their gene loss with a greater ability to acquire nutrients from the
host cell. Analysis of the genome has revealed unique and important insights into the
obligate intracellular lifestyle of A. phagocytophilum. Among these is the notable absence
of genes involved in lipopolysaccharide (LPS) and peptidoglycan biosynthesis (112). This is
supported by electron micrographs of A. phagocytophilum that show an unusual morphology
characterized by a pleomorphic and thin outer membrane that is atypical of Gram-negative
bacteria (57, 112). These observations are consistent with the role of LPS and peptidoglycan
in the maintenance of outer membrane integrity. The loss of these genes allow the bacteria
to be tightly packed while replicating in the limited intravacuolar space within their host cell
6

(112). To compensate for the fragility of their cell wall, A. phagocytophilum incorporates
cholesterol into its membrane (112). Further analysis revealed the genome encodes genes
for the biosynthesis of most cofactors and vitamins and all necessary nucleotides (57).
This suggests the bacterium does not need to compete with the host cell for these essential
metabolites. Furthermore, it implicates the enzymes in these biosynthetic pathways are
important for intracellular survival. However, A. phagocytophilum has a reduced capacity
for amino acid biosynthesis, and can only make glycine, glutamine, glutamate, and aspartate;
therefore it must acquire the remaining amino acids from the host (57).
Major surface protein 2 (Msp2 [P44]). The A. phagocytophilum genome has numerous
repeats (12.7% of the genome), exemplified by over 100 copies of the msp2 (p44) genes
encoding outer membrane Msp2 (P44) proteins (57). The msp2 (p44) genes are defined by a
central hypervariable region of about 280 bp that is flanked by conserved sequences (57).
Diverse msp2 (p44) paralogs are expressed in each developmental stage of I. scapularis
ticks, in patients, and in animal models of infection (16, 59, 114, 208, 216, 217). Expansion
of the Msp2 (P44) family is thought to provide a diverse antigenic population to aid in
the establishment of new infections. Msp2 (P44) is the immunodominant, constitutively
expressed, major outer membrane protein of A. phagocytophilum. It is the most abundant
and most studied surface protein. Through RecF-dependent gene conversion at a single msp2
(p44) expression locus, A. phagocytophilum can presumably evade immune recognition
and adapt to changing host environments (113). Msp2 (P44) has been shown to have
pore-forming activity and there is some evidence that suggests it is an adhesin (88).
Protein secretion systems. A virulence strategy used by many intracellular pathogens
is the manipulation of host processes by secreted bacterial effectors. Bacteria use at least
six distinct protein secretion systems, termed type I to type VI secretion systems (148).
Homologs of type I secretion system (T1SS) and type IV secretion system (T4SS) components are encoded by the A. phagocytophilum genome (57). A. phagocytophilum lacks
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genes for type II and type III secretion systems (57). Analysis based on conserved domains showed A. phagocytophilum encodes a T4SS homologous to the VirB/D system of
Agrobacterium tumefaciens (140, 142). Exemplifying the repetitive nature of the genome,
A. phagocytophilum carries up to eight nonidentical copies of these genes (57). T4SSs
are broadly defined as macromolecular transporters with components ancestrally related to
the conjugation system of Gram-negative bacteria. In pathogenic bacteria, many of these
T4SSs are recognized as transporters of virulence proteins that manipulate eukaryotic cell
processes. To date, only two A. phagocytophilum T4SS effectors have been identified,
ankrin repeat protein A (AnkA) and Anaplasma translocated substrate 1 (Ats-1) (111, 139).
AnkA was initially identified from a genomic DNA expression library screened with A.
phagocytophilum infected dog sera (190) and Ats-1 was discovered by yeast two-hybrid
using A. phagocytophilum VirD4 as bait against an A. phagocytophilum genomic prey library
(139). Both AnkA and Ats-1 have basic C-terminal domains similar to T4SS effectors of A.
tumefaciens (201). Binding of A. phagocytophilum to host cells promotes AnkA delivery
into the host cytoplasm where it interacts with a host adaptor protein that recruits Abl-1
tyrosine kinase for AnkA phosphorylation (95, 111, 161). AnkA activation of the Abl-1 signalling pathway is crucial for bacterial infection. Subsequently, phosphorylated AnkA binds
tyrosine phosphatase SHP1, conceivably to block host signaling pathways (95). Studies
have shown that a large proportion of AnkA localizes to the nucleus (32, 66, 150). Within
the nucleus, AnkA interacts with a range of targets, including ATC-rich sequences and
transcriptional regulatory regions of the CYBB locus, to suppress innate immune activation
(32, 66, 150). Ats-1 localizes to host cell mitochondria and delays apoptosis (139).
The overall genetic intractability of obligate intracellular bacteria has limited the use
of molecular techniques in understanding the genetic basis of their pathogenesis. However,
the Himar1 transposase system has allowed for the random insertion of constructs encoding
spectinomycin resistance and fluorescent proteins into the A. phagocytophilum chromosomes
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(60). The resulting transgenic bacteria have been useful in host-pathogen interaction studies.
This system has been successful for other obligate intracellular bacteria such as C. burnetti
and R. prowazekii (18, 102, 118). The continued development of genetic tools should
soon enable methods for site-specific gene inactivation and complementation and advance
our understanding of virulence factors involved in the pathogenesis of these intracellular
organisms. The most recent breakthrough has been the development of a medium that
supports axenic growth of C. burnetti (144, 145). Significantly, this has allowed axenically
grown organisms to be electroporated and plated for colony formation. As a result, it is
easier to generate isogenic knock-out mutants for use in functional studies.

1.5

A. phagocytophilum intracellular development

Adhesion to sLex -modified PSGL-1. Siayl Lewis x (sLex )-modified platelet selectin
glycoprotein ligand-1 (PSGL-1) is the only known receptor used by A. phagocytophilum
to bind and invade human neutrophils, bone marrow derived progenitors, and myeloid cell
lines (73). Specifically, A. phagocytophilum cooperatively recognizes a-2,3-sialic acid and
a-1,3-fucose of sLex and amino acid determinants in the PSGL-1 N-terminus (73). PSGL1 is present on granulocytes and monocytes and facilitates tethering to endothelial cells.
Binding of A. phagocytophilum activates the PSGL-1 signaling pathway, which results in
Syk mediated tyrosine phosphorylation of ROCK1 (161, 184, 196). ROCK1 mediates actin
cytoskeleton reorganization and is important for bacterial invasion. Inhibiting either Syk or
ROCK1 using siRNA significantly impairs A. phagocytophilum infection (196). The human
promyelocytic cell line HL-60 expresses PSGL-1 and is used for standard in vitro cultivation
of A. phagocytophilum (72). An enriched subpopulation of A. phagocytophilum, termed
NCH-1A2, binds HL-60 cells in a sLex and PSGL-1 independent manner, suggesting the
use of alternative receptor(s) for infection (160, 173). Support for this premise is the ability
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of A. phagocytophilum to bind and infect endothelial cells in vivo and in vitro, which do not
express PSGL-1 (133). Further support is A. phagocytophilum binding to murine neutrophils
requires a-1,3-fucosylated ligands, but not PSGL-1 (29). The alternative host receptors as
well as the A. phagocytophilum adhesin(s) that mediates attachment are unknown.
Developmental cycle. Within the host cell A. phagocytophilum undergoes a biphasic
developmental cycle that consists of two distinct morphological forms, a larger pleomorphic
reticulate cell (RC) form and a smaller dense-cored cell (DC) form (Figure 3A) (199).
By electron microscopy, DCs are distinguished by a dense nucleoid and a ruffled outer
membrane, whereas RCs have dispersed nucleoids and are pleomorphic in form (Figure
3B and C) (199). The DC binds to the cell surface and mediates entry into neutrophils
or human myeloid cells, while the RC does not. Similar results have been observed for A.
phagocytophilum binding to ISE6 tick embryonic cells (132). It takes approximately 4 h
to detect individual DCs within nascent vacuoles (20, 28, 96, 199). At 12 h, most of the A.
phagocytophilum-occupied vacuoles (ApV) contain a few RCs, indicating DC organisms
have converted to metabolically active RCs and have initiated replication by binary fission
(110, 199). By 24 h, multiple RCs are observed within each ApV (Figure 3A). The loss
of LPS and peptidoglycan from the cell wall presumably affords the bacteria structural
flexibility so they can be tightly packed within the inclusion (112). Also by 24 h, some
RCs begin to condense into DCs and are subsequently released from the cell to initiate new
infections. Reinfection occurs between 24 and 32 h (199).

1.6

Subversion of host antimicrobial defenses

Neutrophils are the first line of defense against invading pathogens. Therefore to establish a
safe haven in such an inhospitable host, A. phagocytophilum has evolved mechanisms to
subvert an array of powerful antimicrobial defenses. The strategies used are complex and
10

Figure 3. Biphasic development of A. phagocytophilum in HL-60 cells.
(A) Transmission electron micrograph of an A. phagocytophilum infected HL-60 cell at
24 h post infection. A. phagocytophilum undergoes a biphasic developmental cycle that
consists of two morphologically distinct forms – (B) a dense-cored cell (DC) and a (C)
pleomorphic reticulate cell (RC). The insets demarcated by solid boxes in B and C, are
representative images of a DC and a RC, respectively. The DC binds to host cells and
induces its internalization into a nascent vacuole where it converts to the RC form. The RC
begins to replicate and by 24 h post infection multiple bacteria can be seen in an inclusion.
In addition, at 24 h the RC begin to revert back to the DC form to prepare for reinfection.
Scale bar equals 1 µm. Image from: Troese MJ, Carlyon JA. Anaplasma phagocytophilum
dense-cored organisms mediate cellular adherence through recognition of human P-selectin
glycoprotein ligand 1. Infect Immun 2009;77(9):4018-4027.
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multifactorial.
Inhibition of O–2 production. Upon exposure to pathogens, a primary means used by
neutrophils to destroy bacteria is the generation of toxic oxygen intermediates derived from
superoxide (O–2 ). Collectively, the influx of O–2 into the phagosome that is reduced to H2 O2
and HOCl, and the potassium-dependent release of proteases destroys engulfed bacteria
(158, 169). In activated neutrophils, the nicotinamide adenine dinucleotide phosphateoxidase (NADPH) complex is rapidly assembled at the phagosome and/or plasma membrane.
In resting neutrophils, the components are dispersed and segregated into membranes of
secretory vesicles and specific granules. To combat oxygen-dependent killing, A. phagocytophilum blocks the assembly of a functional NADPH oxidase in the ApV membrane
and inhibits transcription of components necessary for generating O–2 (28, 31, 96, 130). In
addition, A. phagocytophilum detoxifies O–2 triggered by exogenous stimuli, such as LPS,
or E. coli (28). These inhibitory effects are consistent with in vivo observations of reduced
NADPH oxidase activity in neutrophils from A. phagocytophilum infected mice (29, 207).
Inhibition of neutrophil apoptosis. Although abundant, neutrophils have a very short
half-life in circulation (8-20 h) (3). Peripheral blood neutrophils are naturally programmed
for spontaneous apoptosis. However, in response to infection induced apoptosis is readily
and rapidly initiated (39). As a survival strategy, A. phagocytophilum prolongs the life span
of their naturally short-lived host cell by delaying neutrophil apoptosis (67, 68, 214). This
affords the bacterium sufficient time to replicate. In vitro, A. phagocytophilum infected
neutrophils remain non-apoptotic for up to 96 h, with similar results observed in A. phagocytophilum infected ovine neutrophils ex vivo (68, 214). Reactive oxygen species (ROS)
initiate neutrophil apoptosis by activating the death receptor pathway. Furthermore, there
is a reduced rate of apoptosis observed in NADPH oxidase deficient neutrophils (89, 174).
Therefore the ability of A. phagocytophilum to delay apoptosis is coupled to its active
interference of ROS production. Spontaneous apoptosis can also be initiated by Fas receptor
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clustering on the cell surface. Studies have shown A. phagocytophilum prevents clustering
of Fas and consequently blocks apoptosis (67). Neutrophil apoptosis is also initiated by the
translocation and insertion of the proapoptotic protein Bax into the mitochondrial membrane.
The A. phagocytophilum T4SS effector Ats-1 contains a cleavable N-terminal targeting
sequence that localizes it to the mitochondrial matrix and prevents Bax translocation (139).
As a result, apoptosis is blocked. Microarray studies have reported increased transcription of
the antiapoptotic bcl-2 family during A. phagocytophilum infection of neutrophils (20, 109).
Collectively, A. phagocytophilum has evolved multiple mechanisms to target and delay host
apoptosis.

1.7

Pathogenesis and immune responses

Neutrophils express receptors that recognize pathogen-associated molecular patterns (PAMPs)
on the surface of microorganisms, such as LPS and peptidoglycan. Such recognition triggers
a robust innate immune response. Efficient clearance of microbial infections depend upon a
productive cytokine response but may also contribute to disease severity and tissue damage.
Evidence from murine models and human studies of A. phagocytophilum infection highlight
a discrepancy between bacterial burden and histopathology, suggesting the innate immune
response contributes more to disease pathology than pathogen load (13, 54, 56). In human
A. phagocytophilum infection, the most prominent cytokine, gamma interferon (IFN-g), is
thought to be the critical contributor to histopathologic severity (23, 52, 123, 124). Support
for this is IFN-g deficient mice infected with A. phagocytophilum show a prominent increase
in pathogen load yet exhibit complete loss of histopathologic lesions (4). However, when
IL-10 (a cytokine that suppresses IFN-g) is depleted, mice develop severe tissue lesions
with no change in pathogen load (124). Together these studies establish a link between
immune response and histopathologic injury that is independent of bacterial load. A recent
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study extends these findings to a horse model, showing disease severity is dampened with
attenuated immune response to A. phagocytophilum infection (45). The advantage of the
horse model is that horses develop a very similar disease with the underlying histopathology
to that observed in human disease.
The proinflammatory cytokines tumor necrosis factor a (TNF-a), IL-1b , IL-4, and
IL-6 are not elevated in sera from HGA patients or infected mice (4, 56). In contrast,
another study reported elevated transcription of IL-1b , TNF-a, and IL-6 in peripheral
blood leukocytes and monocytes in response to A. phagocytophilum (100), suggesting a
role for monocytes in the production of proinflammatory cytokines. The involvement of
monocytes is supported by the activation of p38 MAPK and NF-kB in human monocytes,
but not in human neutrophils, in response to A. phagocytophilum. It is unclear whether the
lack of neutrophil activation is a result of active suppression by A. phagocytophilum. In
addition, A. phagocytophilum inhibits mast cell activation, demonstrated by the failure of
A. phagocytophilum-infected bone marrow derived mast cells (BMMCs) to secrete TNF-a,
IL-6, and IL-13 upon IgE stimulation. Electron micrographs corroborate this by showing
BMMCs containing A. phagocytophilum organisms do not degranulate (143).
A. phagocytophilum infection induces several chemokines, including IL-8, monocyte
chemotactic protein 1, and macrophage inflammatory proteins 1a and 1b (5, 103). IL8 is a chemokine that recruits neutrophils to sites of infection as a host defense against
invading microbes. It has been demonstrated that A. phagocytophilum infected neutrophils
secrete increased levels of IL-8 and upregulate expression of the IL-8 receptor (CXCR2)
(5, 191). Thus, A. phagocytophilum may exploit host IL-8 response to effectively recruit
naive neutrophils and promote bacterial dissemination (5). Overall, evidence indicates A.
phagocytophilum manipulates signaling pathways involved in host phagocyte activation but
the exact mechanisms are yet to be fully understood.
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1.8

Establishing an intracellular niche

Bacteria that adapt to an intracellular lifestyle are protected from cytosolic immune surveillance and the subsequent signaling cascades they activate. However, within an infected cell,
the pathogen must overcome powerful host antimicrobial defenses that can trigger fusion
with lysosomes, autophagy, and/or apoptosis. In addition the integrity and stability of the
pathogen-occupied vacuole (PV) must be carefully maintained to evade detection by host
immune surveillance. Although some intracellular pathogens escape from the PV and reside
in the cytoplasm, many remain exclusively in membrane-bound compartments. Initially
upon entry, the PV shares molecular features of early endosomes. But soon thereafter,
pathogen-derived proteins and lipids modify the PVs and consequently their fusogenicity
with host vesicular pathways is altered. As a result, PVs become unique compartments with
features tailored to the survival strategy of the specific pathogen.
The A. phagocytophilum-occupied vacuole. A. phagocytophilum resides and replicates
exclusively within a host-cell derived vacuole that exhibits an altered fusogenicity. It does
not resemble early endosomes as it lacks transferrin receptor (TFR), early endosomal antigen
I, Rab5, and annexins I, II, IV and VI (129, 209). It lacks endosomal markers a-adaptin
and clathrin heavy chain. It does not acidify, does not acquire the late endosomal/lysosomal
markers myeloperoxidase, CD63, Lysosomal-associated membrane protein 1 (LAMP-1)
and vacuolar-type H+ ATPase and avoids lysosomal fusion. The ApV excludes fusion
with secretory vesicles and specific granules harboring NADPH oxidase and proteolytic
enzymes (28, 96, 130). Furthermore, it fails to acquire Golgi vesicular markers b -coat
protein (COP) or C6-NBD-ceramide, and bacterial growth is unhindered by the Golgi
apparatus destabilizing agent, Brefeldin A (BFA) (129).
While the ApV stains negative for most endosomal, lysosomal and Golgi markers, it
is not an inert compartment that is completely sequestered from membrane traffic. The
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ApV acquires endocytosed bovine serum albumin (BSA)-gold (209), which indicates that it
intercepts some arm of endocytic traffic. Moreover, mannose-6-phosphate receptor (MPR),
which is found on late endosomes, pre-lysosomes and trans-Golgi vesicles (69), and major
histocompatibility complex (MHC) class I and class II molecules, which traffic from the
Golgi to recycling endosomes and the plasma membrane (8, 136), are found on the ApV
(129). Also, the AVM has been shown to accumulate early autophagosomal markers,
caveolae markers, and cholesterol, each of which is important for bacterial survival, as
well as multiple signaling molecules (112, 141). How the ApV interfaces with desired
vesicular trafficking pathways while excluding those that facilitate microbial killing is
poorly understood.

1.9

Research objectives

Vacuole-adapted pathogens have evolved complex functional interfaces involving specific
bacterial-encoded proteins to modulate host cellular functions and establish a replicative
permissive niche. Therefore, the pathogen-occupied vacuolar membrane (PVM) is a crucial
interface to study host-pathogen interactions and elucidate the pathways the bacteria exploit.
A. phagocytophilum modifies the vacuole in which it resides to evade lysosomal degradation
and subvert antimicrobial defenses. However, the mechanism by which this occurs is poorly
understood. We reasoned that because bacterial protein synthesis is required for successful
establishment of a protective niche, A. phagocytophilum encoded proteins that modify the
ApV are likely candidates for manipulating host cellular processes (70). The work presented
here focuses on the intracellular trafficking of the ApV and describes the contribution of
bacterial encoded proteins. This work is divided into two research goals; the first is to assess
whether the altered fusogenicity of the ApV is attributable to the selective acquisition of
host membrane traffic regulators, specifically Rab GTPases, and the second is to identify
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and characterize A. phagocytophilum-encoded proteins that modify the ApV. These analyses
provide insight into A. phagocytophilum’s ability to target conserved host pathways and
contribute to our understanding of how bacterial pathogens control their intracellular fate.
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Materials and Methods
Cell lines and in vitro cultivation of A. phagocytophilum.
The human promyelocytic cell lines HL-60 (American Type Culture Collection [ATCC]
CCL-240; Manassas, VA) and THP-1 (ATCC TIB-202) and A. phagocytophilum strain
NCH-1-infected HL-60 and THP-1 cells were cultivated in Iscove’s Modified Dulbecco’s
Medium (IMDM-10; Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum
(FBS; Gemini Bio-Products, Sacramento, CA). The human microvascular endothelial cell
line HMEC-1 (1) was obtained from the Centers for Disease Control (CDC) and Prevention
(Atlanta, GA). Uninfected and A. phagocytophilum-infected HMEC-1 cells were propagated
in MCDB 131 (Mediatech, Herndon, VA) supplemented with 10 ng ml
factor (Becton Dickinson, Franklin Lakes, NJ), 1.0 µg ml

1

1

epidermal growth

hydrocortisone (Sigma, St.

Louis, MO), and 10% FBS. RF/6A monkey choroidal endothelial cells (ATCC CRL-1780)
were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; Invitrogen) supplemented
with 10% FBS (Gemini Bio-Products), 2 mM L-glutamine, 1x Minimum Essential Medium
(MEM) non-essential amino acids (Invitrogen), and 15 mM HEPES. HeLa 229 epithelial
cells (ATCC CCL-1.2) were grown in Roswell Park Memorial Institute 1640 medium (RPMI;
Invitrogen) supplemented with 10% FBS. All cell lines described above were maintained
at 37 C in 5% CO2 . ISE6 cells, which were derived from I. scapularis embryos (132),
were a kind gift from Dr. Ulrike Munderloh and Curt Nelson (University of Minnesota,
Minneapolis, MN). Uninfected and A. phagocytophilum infected ISE6 cells were maintained
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in L15B300 medium supplemented with 5% FBS, 0.1% bovine lipoprotein concentrate,
pH 7.2 at 34 C in closed flasks (132). L15B300 medium for A. phagocytophilum infected
cultures was buffered with 25 mM HEPES and 0.25% NaHCO3 and the pH was adjusted to
7.5-7.7 with NaOH.
Generation of fluorescent protein-tagged Rab GTPases.
Constructs encoding green fluorescent protein (GFP)-tagged Rab5 and GFP-Rab7 were
kindly provided by Anthony Nicola (Virginia Commonwealth University). Constructs
encoding human GFP-Rab1, GFP-Rab4A, GFP-Rab6A, GFP-Rab10, and GFP-Rab11A
have been previously described (171). pEGFP-Rab2A, pEGFP-Rab3A, pEGFP-Rab8A,
pEGFP-Rab14 and pEGFP-Rab18 were constructed by cloning the coding regions of the respective human gene contained on BamHI/XhoI fragments (Missouri S&T cDNA Resource
Center) into the BglII and SalI sites of pEGFPC1 (Clontech, Palo Alto, CA). pEGFPRab33A was constructed by cloning the coding region of human Rab33A contained within
an EcoRI/XhoI fragment on pCDNA3.1-Rab33A (Missouri S&T cDNA Resource Center) into the EcoRI and SalI sites of pEGFPC2. pEGFP-Rab35 was constructed by PCR
amplification using a gene-specific primer designed with a 50 EcoRI site and a 30 genespecific primer with a XhoI site (Table 1). The PCR product was digested with EcoRI
and XhoI and cloned into the EcoRI and SalI sites of pEGFPC2. PCR amplifications
were performed using HiFidelity Platinum Taq polymerase (Invitrogen), and the fusion
construct was confirmed by DNA sequencing (BioResource Center, Cornell University,
Ithaca, NY). Human Rab13, Rab20, Rab22A, Rab23, and Rab27A coding sequences
were PCR amplified from cDNA templates purchased from Open Biosystems (Thermo
Scientific, Huntsville, AL). Mouse Rab9A coding sequence was PCR amplified from a
construct encoding GST-tagged Rab9A. Primers used for amplifying the Rab9A, Rab13,
Rab20, Rab22A, Rab23, and Rab27 coding sequences are listed in Table 1. PCR products
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30 )

AGGGATCCTCAACAGCAAGATGGAGTTTG
CGAAAAAGGACGCAGTTCTTCCCCACTCCGG
GTGAAATCGCTCCAGGCCTGCTGTATCC
GTCCATATCACACTTGATTCCTAGTAACATTCTTTC
CGAGACAGGAGATTATTCTTTCCAACACC
AGGGATCCTCAGCCCAGGGAGCACTTGT
AGGGATCCTCAGGCACAACACCCAGATC
AGGGATCCTCAGCAGCAGCTCCGCTTTG
TCCCCCGGGTTAGGGTATGCTACAGCTGC
AGGGATCCTCAACAGCCACATGCCCCCTT
CTCGAGd TTAGCAGCAGCGTTT

C-terminal Primer (50

Underlined nucleotides correspond to restriction sites. a. BamHI site. b. SmaI site. c. EcoRI site. d. XhoI site.

GTGGATCCa ATGGCAGGAAAATCGTCTCT
CCGGAGTGGGGAAGAACTGCGTCCTTTTTC
GGATACAGCAGGCCTGGAGCGATTTCAC
GAAAGAATGTTACTAGGAATCAAGTGTGATATGGAC
GGTGTTGGAAAGAATAATCTCCTGTCTCG
GTGGATCCATGGCCAAAGCCTACGACCA
GTGGATCCATGAGGAAGCCCGACAGCAA
GTGGATCCATGGCGCTGAGGGAGCTCAA
TCCCCCGGGb AATGTTGGAGGAAGATATGGA
GTGGATCCATGTCTGATGGAGATTATGA
GAATTCc ATGGCCCGGGACTACGACC

Rab9A
Rab10(S22N)
Rab10(Q68L)
Rab10N(N122I)
Rab11A(S25N)
Rab13
Rab20
Rab22A
Rab23
Rab27A
Rab35

30 )

N-terminal Primer (50

Rab GTPase

Table 1. Oligonucleotides used to amplify select Rab GTPases.

were first TA cloned into pGEM-T (Promega, Madison, WI) before digestion with either
BamHI or SmaI. BamHI- or SmaI-digested Rab DNA fragments were ligated in-frame
into BglII- or SmaI-linearized vector pTagRFP-TC (a gift from Bret Lindenbach, Yale
University, New Haven, CT), which was created by replacing EGFP in the Clontech vector
EGFPC3 with a photostable TagRFP-TC (179). The construction of pEGFP-Rab4A(S22N)
and pEGFP-Rab4A(Q67L) has been described (170). pEGFP-Rab10(T23N), pEGFPRab10(Q68L), pEGFP-Rab10(N122I), pEGFP-Rab11A(S25N), pEGFP-Rab1A(S25N) and
pEGFP-Rab1(AQ70L) were constructed using QuikChange (Stratagene, La Jolla, CA) using
each respective wild-type fusion as template with the mutagenic oligonucleotides listed in
Table 1. pEGFP-Rab11A(Q70L) was constructed by PCR amplification using a 50 genespecific primer designed with a 50 EcoRI site and a 30 gene-specific primer with a XhoI site
(Table 1). The PCR product was digested with EcoRI and XhoI and cloned into the EcoRI
and SalI sites of pEGFPC2.
Generation of maltose-binding protein (MBP)-APH_1387 and MBP-APH_0032.
The pMal-c2x vector (New England Biolabs, Ipswich, MA) was made into a Gateway
destination vector using the Gateway vector conversion system (Invitrogen) by following
the manufacturer’s protocol; this yielded pMal-c2x/DEST, which was transformed into One
Shot ccdB Survival competent E. coli cells (Invitrogen). pMal-c2x/DEST was isolated
from overnight cultures of transformants using a Qiaprep Spin miniprep kit (Qiagen, Valencia, CA). The aph_1387 and aph_0032 genes were amplified using Platinum Pfx DNA
polymerase (Invitrogen) and the primer sets listed in Table 2 for pENTR-aph_1387 and
pENTR-aph_0032, respectively. The underlined nucleotides correspond to nucleotides in a
Gateway-compatible sequence. After we confirmed that the amplicons were the expected
size by agarose gel electrophoresis, the amplicons were purified using a QIAquick PCR
purification column (Qiagen) and cloned without ligation into pENTR/D-Topo (Invitrogen)
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Underlined nucleotides correspond to a Gateway entry vector-compatible sequence.

CACCATGTATGGTATAGATATAGAGCTAAG
CACCTATGGTATAGATATAGAGCTAAGTGATTACAGAATTCC
CACCTATGGTATAGATATAGAGCTAAGTGATTACAGAATTCC
CACCTATGGTATAGATATAGAGCTAAGTGATTACAGAATTCC
CACCGGCAGAGCTGCTACTGCTGAAGGTGG
CACCGTGCAAGAGGAAGAGGGTACAGG
CACCTCGGGTGTAGATACGCAAGAAGAACAAG
CACCATGTTTGAACACAATATTCCTGATAC
CACCTTTGAACACAATATTCCTGATACATACACAGG
CACCTTTGAACACAATATTCCTGATACATACACAGG
CACCTTTGAACACAATATTCCTGATACATACACAGG
CACCGGCCGAGGAAGTAGCTCCTCAACC
CACCGACACTGCTGAAGACAGCAAGTGTAATAGTAG
CACCGACAATGTTCAGGAACTAGGTACATTGCC

pENTR-aph_1387
pENTR-aph_1387D 181-579
pENTR-aph_1387D 122-579
pENTR-aph_1387D 101-579
pENTR-aph_1387D 1-91
pENTR-aph_1387D 1-111
pENTR-aph_1387D 1-157
pENTR-aph_0032
pENTR-aph_0032D 313-620
pENTR-aph_0032D 175-620
pENTR-aph_0032D 143-620
pENTR-aph_0032D 1-134
pENTR-aph_0032D 1-162
pENTR-aph_0032D 1-301

30 )

N-terminal Primer (50

Designation

30 )

CTAATAACTTAGAACATCTTCATCG
CTAGTCTCAACTTCTTCAATTGCTGGTGCTTC
CTAGTACATACCTGTACCCTCTTCCTCTTGC
CTAACCACCTTCAGCAGTAGCAGC
CTAGTCTCAACTTCTTCAATTGCTGGTGCTTC
CTAATAACTTAGAACATCTTCATCGTCAGGATCCTTTAACG
CTAATAACTTAGAACATCTTCATCGTCAGGATCCTTTAACG
TCACAACGCGAGCACGTC
CTATAAAGGCAATGTACCTAGTTCCTGAACATTGTC
CTAAGTATCGCTACTATTACACTTGCTGTCTTCAGC
CCTACGGTTGAGGAGCTACTTCCTCG
TCACAACGCGAGCACGTCATC
CTCACAACGCGAGCACGTCATC
TCACAACGCGAGCACGTCATC

C-terminal Primer (50

Table 2. Oligonucleotides used to generate GFP-APH_1387 and -APH_0032 fusion constructs.

by following the manufacturer’s instructions, which yielded the entry plasmids pENTRaph_1387 and pENTR-aph_0032. The entry plasmids were transformed into chemically
competent E. coli One Shot cells (Invitrogen) and subsequently isolated from overnight
cultures. The insert sequence and cloning junctions were verified.
One hundred fifty nanograms of pENTR-aph_1387 and pENTR-aph_0032 were incubated with 150 ng of pMal-c2x/DEST and LR Clonase II (Invitrogen) at 25 C for 1
h to facilitate recombination of the aph_1387 and aph_0032 inserts downstream of the
gene encoding MBP of pMal-c2x/DEST, which yielded pMal-c2x-aph_1387 and pMalc2x-aph_0032. Proteinase K was added to a final concentration of 0.18 µg µl 1 , and then
the preparations were incubated at 37 C for 10 min, after which the LR recombination
reaction mixtures were transformed into E. coli DH5a cells (Novagen, Madison, WI).
Cultures of the transformants were grown in Luria-Bertani (LB) medium containing 100
µg ml

1

ampicillin at 37 C with shaking at 250 revolutions per minute (rpm). When the

cultures were in the mid-logarithmic phase of growth (optical density at 600 nm [OD600 ],
0.4), expression of MBP-APH_1387 and MBP-APH_0032 were induced at 37 C by adding
isopropyl-b -D-thiogalactopyranoside (IPTG) to a final concentration of 0.5 mM, and the
cultures were grown for another 3 h. Portions (80 ml) of the induced bacterial suspensions
were harvested by centrifugation at 4000 g for 10 min at 4 C. Each pellet was resuspended
in 5 ml column buffer (20 mM Tris-HCl [pH 7.4], 200 mM NaCl, 1 mM EDTA) and frozen
overnight at -20 C. Frozen pellets were thawed in cold water and placed in an ice-water
bath, in which they were sonicated. Soluble crude extracts were recovered by centrifugation
at 9000 g for 20 min at 4 C. The crude extracts were loaded onto columns containing
amylose resin (New England Biolabs) at a flow rate of 1 ml per min. The columns were
washed with 12 column volumes of column buffer. MBP-APH_1387 and MBP-APH_0032
were eluted in column buffer containing 10 mM maltose, and 3 ml MBP-APH_1387 and
MBP-APH_0032 fractions were collected and were visualized by Coomassie brilliant blue
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staining following resolution by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE). Desired fractions were pooled and concentrated by centrifugation through
an Amicon Ultra-4 centrifugal filter with a 50 kDa cutoff (Millipore, Bedford, MA) to
minimize the content of undesired breakdown products. Concentrated protein preparations
were quantified using the Bradford assay (96).
Generation of GFP tagged-APH_1387 and -APH_0032 constructs.
The full-length and truncated aph_1387 and aph_0032 genes were amplified using Platinum
Pfx DNA polymerase (Invitrogen) and the primers listed in Table 2. The underlined
nucleotides correspond to nucleotides in a Gateway-compatible sequence. The amplicons
were confirmed by agarose gel electrophoresis, purified using a QIAquick PCR purification
column (Qiagen) and cloned without ligation into pENTR/D-Topo (Invitrogen) using the
manufacturer’s instructions. The entry plasmids were transformed into chemically competent
E. coli One Shot cells (Invitrogen) and subsequently isolated from overnight cultures. The
insert sequence and cloning junctions were verified. One hundred fifty ng of each entry
plasmid was incubated with 150 ng of pDest53 and LR Clonase II (Invitrogen) at 25 C
for 1 h to facilitate recombination of the inserts downstream of the gene encoding GFP
(N-terminal fusion vector). Proteinase K was added to each reaction to a final concentration
of 0.18 µg µl

1

and incubated at 37 C for 10 min, after which the LR recombination

mixtures were transformed into E. coli One Shot ccdB Survival T1 Phage-Resistant Cells
(Invitrogen). Plasmid DNA was isolated from overnight cultures of the transformants grown
in LB medium containing 100 µg ml

1

ampicillin at 37 C with shaking at 250 rpm.

Generation of CyaA plasmid construction and clone verification.
The aph_0032 gene was amplified from A. phagocytophilum DNA using AccuPrime Pfx
polymerase (Invitrogen) and the primer set listed in Table 3 for pJB2581-aph_0032. Dif24

25

Underlined nucleotides correspond to pJB2581 compatible sequence

TTCCGGCTATGGATCCATGTTTGAACACAATATTCCTGATAC
TTCCGGCTATGGATCCGGAACTAGTAGCTCTTTTGCAGCT
TTCCGGCTATGGATCCGTGGTAGTTGCTCCAGAAGCGC

pJB2581-aph_0032
pJB2581-aph_0740
pJB2581-aph_1387

30 )

N-terminal Primer (50

Designation

30 )

ACAAGCTTGCATGCCTGCAGTCACAACGCGAGCACGTCA
ACAAGCTTGCATGCCTGCAGCTACCTACCGCGACCTCCTT
ACAAGCTTGCATGCCTGCAGCTAATAACTTAGAACATCTTCA

C-terminal Primer (50

Table 3. Oligonucleotides used to generate CyaA fusion constructs

ficulty in cloning and expressing the entire open reading frames of aph_0740 (ankA) and
aph_1387 necessitated cloning the C-terminal 100 residues of these proteins using the primer
sets listed in Table 3 for pJB2581-aph_0740 and pJB2581-aph_1387, respectively. It is
important to note that the translocation signal of T4SS substrates is located in the C-terminus
and the final 100 aa of T4SS substrates are sufficient for translocation (201). To allow
high-efficiency recombinational cloning, the 50 ends of forward and reverse primers contain
15 bases (denoted by the underline) that are homologous with the sequence at the ends of the
CyaA fusion vector pJB2581 linearized with BamHI and PstI. PCR products were cloned
into pJB2581 (170) linearized with BamHI/PstI using the In-fusion Advantage PCR Cloning
Kit (Clontech) to generate gene fusions encoding A. phagocytophilum proteins N-terminally
fused to the C-terminus of CyaA. L. pneumophila was transformed with plasmid constructs
by electroporation as previously described (203). Plasmids were isolated from colonies,
and BamHI/PstI restriction enzyme digests were performed to confirm the presence of the
expected restriction fragment. Expression of CyaA fusion proteins by wild type and DotA
L. pneumophila was verified by immunoblotting (203).
Transfections.
HL-60 Nucleofection. Uninfected or A. phagocytophilum infected HL-60 cells (2 ⇥ 106 )
were transiently transfected with 2 µg of endofree purified DNA (Qiagen) using the Nucleofector II device (Lonza, Cologne, Germany), Nucleofector solution V, and T-19 program,
according to the manufacturer’s protocol. Following nucleofection, the cells were transferred
into 12-well plates containing 1.5 mL IMDM Media (Invitrogen) supplemented with 10%
FBS and incubated at 37 C.
HeLa Transfection. HeLa cells were seeded onto coverslips and transfected with 0.4 µg
of plasmid using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s protocol.
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Twenty four hours post transfection cells were fixed in 4% paraformaldehyde (PFA) in
phosphate buffered saline (PBS) for 1 h and permeabilized with ice-cold methanol for 30 s.
RF/6A electroporation. RF/6A cells were electroporated using the Gene Pulser Xcell
System (Bio-Rad). RF/6A cells were resuspended in OPTI-MEM (Invitrogen) at a final
density of 106 cells ml

1

and mixed with 3 µg plasmid DNA. The cells were subjected

to a pulse in a 0.4 cm cuvette. The setting was 250 V, 1000 µF, with a 20 ms pulse
time. Following electroporation, cells were immediately transferred into pre-warmed media,
seeded onto coverslips and incubated at 37 C.
Immunofluorescence microscopy.
HL-60 and THP-1 cells. Asynchronous A. phagocytophilum-infected and uninfected
control HL-60 or THP-1 cells were washed twice with PBS, cytocentrifuged onto glass
slides using a 200 µl volume of 3 ⇥ 104 cells at 1000 g for 3 min in a Cytospin 4 centrifuge
(Thermo Electron), followed by fixation and permeabilization in methanol for 4 min. In
some cases, a synchronous A. phagocytophilum infection of HL-60 cells was established
as described (87), after which aliquots were removed at multiple time points over a 72 h
period. The nucleofected cells were incubated for 5 h at 37 C in 5% CO2 in a humidified
incubator. Cells were then washed twice with PBS, cytocentrifuged onto glass slides, fixed
in 2% PFA for 20 min and permeabilized in ice-cold methanol for 30 s.
To assess for fluorescently tagged-Rab GTPase recruitment to the ApV at 4, 6, 8, and
12 h post infection, uninfected HL-60 cells were first nucleofected with plasmids encoding
GFP- or red fluorescent protein (RFP)-tagged Rab GTPases. Five hours post-nucleofection,
the cells were incubated with host cell-free A. phagocytophilum organisms then washed
twice with PBS after 40 min and centrifuged at 300 g for 5 min to remove unbound bacteria.
At the appropriate time points, the cells were fixed and labeled with antibodies as described
above. Because we observed that GFP signal begins to fade in nucleofected cells between
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18 and 24 h, it was necessary to infect HL-60 cells for an appropriate time period prior
to nucleofection in order to more accurately assess GFP- or RFP-Rab recruitment to the
ApV at time points beyond 12 h. Accordingly, HL-60 cells were incubated first with host
cell-free A. phagocytophilum organisms then washed twice with PBS after 40 min to remove
unbound bacteria. Seven h post infection, the cells were nucleofected with GFP- or RFP-Rab
DNA, and then assessed at 5, 11, and 17 h post-nucleofection, which corresponded to 12,
18, and 24 h post infection, respectively. Cells that were nucleofected prior to infection
and cells that were infected prior to nucleofection exhibited nearly identical numbers of
bound A. phagocytophilum organisms at the beginning of each time course (data not shown),
which confirmed that the infection rates for each set proceeded comparably. Likewise,
examination of cells that were nucleofected prior to infection and cells that were infected
prior to nucleofection at 12 h post infection revealed highly similar rates of GFP- or RFP-Rab
GTPase recruitment to the ApV for all GFP- and RFP-Rabs examined.
HMEC-1, RF/6A and HeLa cells. HMEC-1, RF/6A or HeLa cells were grown on
glass coverslips in 24-well tissue culture plates. HMEC-1 or RF/6A cells were incubated
with host cell-free A. phagocytophilum organisms, centrifuged at 300 g for 5 min to facilitate
bacterial attachment, followed by a 1 h incubation at 37 C in 5% CO2 . Next, the cells were
washed twice with PBS to remove unbound bacteria. At appropriate time points cells were
fixed in 4% PFA for 1 h followed by permeabilization in ice-cold methanol for 30 s.
C3H/H2N severe combined immunodeficiency (scid) mice. C3H/HeN scid mice were
infected with NCH-1 exactly as previously described (28). On day 8 post infection, whole
blood was collected by cardiocentesis in EDTA and centrifuged, and the leukocyte-rich
buffy coat was removed and cytospun onto glass slides at 113 g for 5 min. The slides were
fixed in ice-cold methanol and stored at -20 C until they were used.
ISE6 cells. To facilitate A. phagocytophilum infection of ISE6 cells, the tick cells were
grown to confluence in 25 cm2 flasks, after which they were incubated with 1 ⇥ 107 A.
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phagocytophilum infected ( 90%) HL-60 cells in L15B300 medium at 34 C. After 3 days,
the culture medium was replaced to replenish nutrients and remove any unlysed HL-60
cells. Infected ISE6 cells were cytocentrifuged, followed by fixation and permeabilization
in methanol for 4 min. In some cases Ulrike Munderloh (University of Minnesota) kindly
provided slides of PFA-fixed A. phagocytophilum-infected ISE6 cells.
All slides were blocked with 5% BSA in PBS for 1 h. Primary antibodies were: mAb
FK2 (BIOMOL, UK), mAb FK1 (BIOMOL), rabbit polyclonal anti-APH_1387, rabbit
polyclonal anti-APH_0032, mouse mAb anti-Msp2 (P44) 20B4 (kindly provided by J.
Stephen Dumler of John Hopkins University, Baltimore, MD, USA), Rab14 (Aviva Systems
Biology LLB, San Diego, CA, USA), LAMP-1 specific mAb (clone H4A3; University of
Iowa Developmental Studies Hybridoma Bank, Iowa City), mouse GM130 (BD Transduction), mouse calnexin (BD Transduction). AlexaFluor fluorescent conjugated secondary
antibodies (Invitrogen) were used at 1:1000 dilutions and incubated for 30 min. Coverslips
were mounted with ProLong Gold Antifade with 4’-6’-diamidino-2-phenylindole (DAPI;
Invitrogen) and examined by confocal microscopy.
Slides were examined by confocal microscopy using a TCS-SP2 AOBS inverted confocal microscope (Leica Microsystems, Bannockburn, IL). Some images were acquired by
spinning disc confocal microscopy using a BX51 microscope (Olympus, Center Valley, PA)
affixed with an Olympus disk spinning unit and an Orca-R2 CCD camera (Hammamatsu,
Japan). Images were processed using the Slidebook software package (Intelligent Imaging
Innovations, Denver, CO). In experiments where the ApV was measured, analyses were
performed using ImageJ (National Institutes of Health, USA; rsb.info.nih.gov/ij).
BFA or tetracycline treatment of A. phagocytophilum infected HL-60 cells.
To determine whether continued association of GFP-Rab10 or GFP-Rab14 to the ApV is
dependent on an intact Golgi apparatus, A. phagocytophilum infected HL-60 cells were
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nucleofected to express GFP-Rab10 or GFP-Rab14. Two h post-nucleofection, BFA (EMD
Biosciences, San Diego, CA) in methanol was added to a final concentration of 1 µg ml

1

for 3 h. Methanol alone served as a vehicle control. To determine whether an intact Golgi
apparatus is required for initial GFP-Rab10 or GFP-Rab14 recruitment to the ApV, BFA
was added to uninfected HL-60 cells immediately following nucleofection. After 3 h, host
cell-free A. phagocytophilum organisms were added. After 2 h (5 h post nucleofection), the
cells were washed to remove unbound bacteria followed by 4 h continued incubation in the
presence of BFA. To determine whether selective Rab recruitment to the ApV is bacterial
protein synthesis-dependent, A. phagocytophilum infected HL-60 cells were nucleofected
to express GFP-Rab5, GFP-Rab7, GFP-Rab10, GFP-Rab11A, GFP-Rab14, RFP-Rab22A,
or GFP-Rab35. Five h post-nucleofection, tetracycline (Sigma) solubilized in 70% ethanol
was added to a final concentration of 10 µg ml

1

for 30 min. Ethanol alone served as a

vehicle control. In some experiments, to determine whether the localization of ubiquitinated
proteins to the AVM is bacterial protein synthesis-dependent, tetracycline was added to A.
phagocytophilum-infected HL-60 cells for 1 h. After the appropriate incubation periods in
the presence of BFA, tetracycline, or vehicle control, aliquots were removed, processed, and
examined by confocal microscopy. To determine if tetracycline treatment promotes ApVlysosomal fusion, A. phagocytophilum infected HL-60 cells expressing GFP-or RFP-Rabs
of interest were screened with a LAMP-1-specific mAb (clone H4A3; University of Iowa
Developmental Studies Hybridoma Bank) followed by anti-mouse IgG conjugated to Alexa
Fluor 594 and examined by confocal microscopy.
In silico sequence analyses of APH_1387 and APH_0032.
The entire APH_1387 and APH_0032 sequences were analyzed using several algorithms
in order to obtain clues that would help predict their secondary structure and their ability
to associate with the AVM. TMPred (www.ch.embnet.org/software/TMPRED_form.html)
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was used to determine if APH_1387 and/or APH_0032 has a transmembrane domain.
Protean, which is part of the Lasergene software package (version 8.02; DNASTAR, Madison, WI), was used to assess whether APH_1387 and/or APH_0032 has regions of alpha helices and beta strands, alpha amphipathic sequences, and hydrophobicity, using
the Garnier-Osguthorpe-Robson, Eisenberg, and Kyte-Doolittle algorithms, respectively
(190, 199, 204). BLASTP (blast.ncbi.nlm.nih.gov/Blast.cgi) was used to identify protein
sequences to which APH_1387 or APH_0032 exhibits homology. The SWISS-MODEL
(swissmodel.expasy.org), 3Djigsaw (bmm.cancerresearchuk.org/3djigsaw), ESyPred3D
(www.fundp.ac.be/sciences/biologie/urbm/bioinfo/esypred), and Geno3d
(geno3dpbil.ibcp.fr/cgibin/geno3d_automat.pl?page=/GENO3D/geno3d_home.html) algorithms were used in attempts to predict a tertiary structure for APH_1387 or APH_0032.
Generation of anti-APH_1387 and anti-APH_0032 polyclonal antiserum.
MBP-APH_1387 and MBP-APH_0032 were submitted to Animal Pharm Services (Healdsburg, CA) for production of rabbit polyclonal antiserum. Immunoreactivity against MBPAPH_1387 and native A. phagocytophilum APH_1387 was confirmed by Western blotting,
as was the lack of recognition of APH_1387 by preimmune serum. This was repeated to
confirm immunoreactivity against MBP-APH_0032. Anti-MBP-APH_1387 and anti-MBPAPH_0032 are referred to as anti-APH_1387 and anti-APH_0032, respectively.
Preparation of host cell-free A. phagocytophilum populations containing DC and RC
organisms or only DC organisms.
To isolate host cell-free A. phagocytophilum DC and RC organisms, infected (90%) HL-60
cells were mechanically disrupted by repeated passage through a 27-gauge needle. To isolate
DC organisms, infected HL-60 cells were subjected to eight 8-s bursts on ice interspersed
with 8-s rest periods using a Misonix S4000 ultrasonic processor (Farmingdale, NY) with
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an amplitude setting of 30, which destroyed host cells and fragile RC organisms but not
hardy DC organisms, as confirmed by transmission electron microscopy (data not shown).
Bacteria were separated from unbroken host cells and debris by differential centrifugation
as described previously (63).
Western blotting.
Whole-cell lysates were fractionated by SDS-PAGE, transferred to nitrocellulose, and
screened using primary antibodies followed by horseradish peroxidase (HRP)-conjugated
goat anti-rabbit IgG, as described previously (30). Actin was detected using anti-human actin
mAb (Sigma). Some blots were screened using HGA patient antiserum or normal human
serum (generously provided by Erol Fikrig of Yale University). Other primary antibodies
were anti-GFP (Clontech), anti-APH_1387, anti-APH_0032. Densitometric analyses were
performed using ImageJ (NIH) to quantitatively assess the relative amounts of APH_0032 in
whole cell lysates of DC organisms versus DC and RC organisms. Densitometric analyses
were also used to assess the increase in APH_1387 and APH_0032 band signal intensity over
the course of infection of HL-60 cells. The ratios of the densitometric values for APH_1387
or APH_0032 and actin at different time points were plotted.
Immunoelectron microscopy.
HL-60 cells were incubated with host cell-free A. phagocytophilum for 40 min at 37 C .
The cells were washed three times with PBS and centrifuged at 300 g for 5 min to remove
unbound bacteria. At appropriate time points 1 ⇥ 106 cells were washed with cacodylate
buffer and fixed in 1 ml of 3% PFA-0.05% glutaraldehyde in 0.1 M cacodylate buffer for 45
min at 4 C. The cells were washed four times by resuspending them in 1 ml cacodylate buffer
and incubating them at room temperature for 15 min. Next, the Virginia Commonwealth
University Department of Neurobiology and Anatomy Microscopy Core Facility transferred
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washed cells onto 200-mesh Formvar-coated nickel grids. The grids were washed twice
with PBS and blocked with 0.1% BSA/PBS for 1 h. Primary and secondary antibodies
were stained sequentially for 1 h. Primary antibodies were anti-APH_1387 (1:200) and
anti-APH_0032 (1:200). The secondary antibody was goat anti-rabbit IgG (1:10) conjugated
to 6-nm gold particles (Electron Microscopy Sciences). Grids were viewed and images
were recorded using a JEM-1230 transmission electron microscope (JOEL, Tokyo, Japan)
equipped with a Gatan Ultra Scan 4000SP 4K x 4K charge-coupled device camera.
RT-PCR.
Sukanya Narasimhan (Yale University) kindly provided total RNA isolated from A. phagocytophilum-infected I. scapularis nymph salivary glands. Total RNA isolated from neutrophils
(Gr-1-positive splenocytes) recovered from A. phagocytophilum-infected C3H/HeN mice on
day 8 post infection has been described previously (31). cDNA stocks and PCR amplicons
were generated as described (31) using primer 50 -ATGTTTGAACACAATATTCCTGATAC30 and 50 -TCACAACGCGAGCACGTC-30 to target aph_0032 transcript and primers 50 ATGTATGGTATAGATATAGAGCTAAG-30 and 50 -CCGTTGTGGAGGCATTATCGC-30 to
target aph_1387 transcript.
Legionella pneumophila.
L. pneumophila JR32 (wild type) and LELA3118 (DotA ) strains were generously provided
by Howard Shuman (Columbia University) and were cultured on charcoal yeast extract
(CYE) agar plates containing streptomycin (50 µg ml 1 ) and kanamycin (25 µg ml 1 ),
respectively. For plasmid selection, L. pneumophila transformants were additionally grown
in the presence of chloramphenicol (10 µg ml 1 ).
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Adenylate cyclase (CyaA) translocation assay.
L. pneumophila transformants were incubated overnight in AYE broth containing chloramphenicol (10 µg ml 1 ), diluted and then cultured until organisms displayed obvious motility
by phase-contrast light microscopy. Prior to infection, THP-1 cells were treated with 200
nM phorbol 12-myristate 13-acetate (PMA; EMD Biosciences) to promote differentiation
to an adherent, macrophage-like cell as previously described (204). Prior to infection,
IPTG was added to L. pneumophila cultures at a final concentration of 1 mM for 2 h to
induce expression of CyaA fusion proteins. PMA-differentiated THP-1 cells were plated
in 24-well plates (1 ⇥ 106 cells/well) and infected with L. pneumophila expressing CyaA
fusion proteins at a multiplicity of infection of approximately 20. Bacteria were added to
wells and the plate centrifuged for 5 min at 180 g to initiate contact between organisms and
THP-1 cells. After a 30 min incubation at 37 C in the presence of 1 mM IPTG, cells were
washed three times in PBS and lysed in 500 µl of a solution containing 50 mM HCl and
0.1% Triton X-100. Samples were boiled for 5 min followed by the addition of 30 µl of 0.5
M NaOH to neutralize the acid. One ml of 95% ethanol was added to samples, which were
incubated on ice for 5 min, dried under a vacuum, and resuspended in assay buffer [0.05
M sodium acetate (pH 5.8), 0.02% BSA]. The level of adenosine 3’, 5’-monophosphate
(cAMP) in dried samples was determined using the cAMP Enzyme immunoassay (GE
Healthcare, Piscataway, NJ) according to the manufacturer’s protocol. CyaA fusion proteins
were considered positive for translocation when the increase in cAMP over CyaA alone
(negative control) was at least 2.5-fold and this increase was abolished following expression
of fusion proteins in the L. pneumophila DotA mutant (LELA3118). A CyaA fusion to
RalF, a well-characterized L. pneumophila Dot/Icm effector (135) was used as a positive
control. cAMP levels resulting from translocation of CyaA-RalF were similar to those
reported by Bardill et al (17).
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Fluorescence-based assay to identify protein regions required for host membrane association.
To identify the region of APH_1387 that facilitates membrane association, HeLa cells
were grown on 12 mm glass coverslips and transfected with 0.4 µg of Endofree purified
DNA (Qiagen) using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
directions. Twenty four h following transfection, cells were washed three times with PBS
which does not permeabilize the cells, and fixed in 4% PFA in PBS for 1 h. Duplicate
cells were washed with digitonin buffer (125 mM NaC2 H3 O2 , 2.5 mM Mg(CH3 COO)2 ,
25 mM HEPES-KOH, 1 mg ml
ml

1

1

glucose, 1 mM DTT, pH 7.3), incubated with 30 µg

digitonin (Sigma) for 5 min to permeabilize the host cell plasma membrane, washed

twice more with digitonin buffer, so that any GFP fusion protein not specifically associating
with host-cell membranes was washed out, and fixed in 4% PFA for 1 h. Coverslips were
mounted with ProLong Gold Antifade with DAPI (Invitrogen) and the slides were examined
by immunofluorescence microscopy (28). Retention was calculated as the percentage of
cells that remained GFP-positive after digitonin permeabilization.
Differential permeabilization with digitonin to determine protein topology in the AVM.
To determine whether APH_1387 or APH_0032 are exposed on the cytoplasmic face of
the AVM, infected RF/6A cells were differentially permeabilized cells with digitonin or
saponin which allows the delivery of antibodies to the cytoplasm or to all the intracellular
compartments, respectively. Infected RF/6A cells were washed 2x with digitonin buffer and
the plasma membrane was permeabilized by incubation with 30 µg ml

1

digitonin for 5

min at room temperature. Cells were then immediately washed with digitonin buffer and
incubated with rabbit anti-APH_1387 or rabbit anti-APH_0032 at 37 C. After 20 min, the
cells were washed with PBS and fixed with 4% PFA for 1 h. Antibodies bound after digitonin
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permeabilization were detected with Alexa Fluor 594-conjugated anti-rabbit antibodies.
To confirm that digitonin did not permeabilize the AVM, cells were also incubated with
antibodies against Msp2 (P44), which is not expressed on the vacuolar membrane.
Statistical analysis.
The Student’s t-test (paired) performed using the Prism 4.0 software package (Graphpad; San
Diego, CA) was used to assess statistical significance. Statistical significance is indicated
in figure legends (*P < 0.05; **P < 0.01; ***P < 0.001). In some cases, an Analysis of
Variance (ANOVA) test was performed. If ANOVA indicated a group difference (p < 0.05)
then Tukey’s test was used to test for a significant difference among groups. Figures were
generated using Prism 4.0 and the ggplot2 (210) package for R (193).

36

The A. phagocytophilum-occupied vacuole (ApV)
selectively recruits Rab-GTPases that are predominantly
associated with recycling endosomes
3.1

Introduction

The Rab family (>60 members) is the largest member of the Ras superfamily of small
guanosine triphosphatases (GTPases) (24, 188). Rab GTPases localize to distinct organelles
and dictate organelle identity. Specific Rabs cycle on and off endosomes in a dynamic
process to control endosomal maturation, which ultimately results in lysosomal fusion. Each
of the four steps in membrane trafficking that Rabs regulate – vesicle budding, vesicle
delivery, vesicle tethering and fusion of the vesicle and target compartment membranes – are
carried out by a diverse collection of effector molecules that bind to specific Rabs in their
GTP-bound states. Rab GTPases are molecular switches that cycle between a cytoplasmic,
GDP-bound, inactive state and a membrane-associated GTP-bound, active state.
The switch of a GDP-bound Rab to a GTP-bound-Rab is controlled by guanine nucleotide
exchange factors (GEFs), which trigger the release of GDP, and GTPase-activating proteins
(GAPs), which accelerate hydrolysis of the bound GTP to GDP (24, 188). In their GDPbound state, Rabs are soluble and bound to guanine nucleotide dissociation inhibitor (GDI).
At the acceptor membrane, Rab-GDI interacts with GDI displacement factor (GDF), which
removes GDI to enable Rab membrane insertion. Next, a GEF catalyses the conversion of the
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membrane bound Rab to its GTP-bound state, which induces a conformational change that
allows it to interact with its effectors and initiate its downstream function. After inactivation
by their specific GAPs, the GDP-bound Rabs are extracted from the membrane by GDI and
returned to the cytosol.
Endosomal recycling pathways return much of the membrane proteins and lipids that
are internalized during endocytosis to the plasma membrane (76). Endocytic mechanisms
can be classified as either clathrin-dependent or clathrin-independent. TFR is an example
of a clathrin-dependent endocytic cargo. In contrast to clathrin-dependent endocytosis,
clathrin-independent endocytosis comes in many forms including macropinocytosis and
phagocytosis. Unrelated forms of clathrin-independent endocytosis require free cholesterol. Proteins and lipids that reside in sphingolipid-rich lipid rafts are prominent clathrinindependent endocytosis cargo (76, 126, 172). Endogenous proteins that enter cells via
clathrin-independent endocytosis include MHC class I proteins and proteins involved in
amino acid uptake (22, 58, 157). Clathrin-independent endocytosis- and clathrin-dependent
endocytosis-generated vesicles are delivered to the early endosome, which functions as a
sorting station. From there, cargo can be routed for degradation to late endosomes and lysosomes or recycled along rapid or slow recycling endosome pathways. Clathrin-dependent
endocytic cargo, such as TFR, can be returned to the plasma membrane via either rapid
recycling endosomes or slow recycling endosomes, while clathrin-independent endocytic
cargo is recycled exclusively by the slow recycling endosome pathway. In slow endocytic
recycling, cargo is sorted from the early endosome to an endocytic recycling compartment
from which recycling endosomes or tubular recycling endosomes emanate to return cargo to
the plasma membrane (76). Several Rab GTPases regulate traffic and confer vesicle identities along recycling endosome pathways (Table 4). Rab5 is found on the early endosomes.
Rab4 and Rab35 are on rapid recycling endosomes. Rab35 is also associated with tubular
recycling endosomes that return cargo to the plasma membrane in both clathrin-dependent
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Location(s)
ER exit sites, IC
IC
SV, SG
Rapid RE
EE, PM, caveosomes
Golgi
LE
ERC to tubular RE, TGN
LE
EE to ERC, tubular RE, TGN
ERC, RE, tubular RE
Tight junctions, EE
EE, ERC, TGN
ER, SG
Dense apical tubules
EE to ERC, tubular RE
PM, EE
SG, melanosomes, T-cell granules
Medial Golgi
Tubular RE, rapid RE

Transport function(s)
ER to Golgi, Golgi to ER, IC to PM
ER to Golgi, Golgi to ER
Regulated exocytosis
Endocytic recycling
Endocytosis, EE formation
Intra-Golgi, ER to Golgi, endosome to Golgi, Golgi to PM
EE to LE, lysosome biogenesis, phagosome maturation
ERC to tubular RE, TGN to PM
LE to TGN
Endocytic recycling, TGN to PM
Endocytic recycling
Biogenesis of tight junctions
Endocytic recycling, TGN to EE
ER to Golgi
Connexin-43 trafficking
Endocytic recycling, EE to TGN
Phagosome to lysosome fusion
Regulated secretion, Myosin Va recruitment
Golgi to ER, autophagy
Endocytic recycling

a. Data summarized from references by Grant and Donaldson (2009), Kelly et al. (2009) and Stenmark (2009).
b. ApV-associated Rab GTPases are denoted by bold text.
EE, early endosome; ER, endoplasmic reticulum; ERC, endocytic recycling center; IC, pre-Golgi intermediate compartment; LE,
late endosome; PM, plasma membrane; RE, recycling endosome; SG, secretory granule; SV, synaptic vesicle; TGN, trans-Golgi
network.

Rab GTPase
Rab1
Rab2A
Rab3A
Rab4A
Rab5
Rab6A
Rab7
Rab8A
Rab9A
Rab10
Rab11A
Rab13
Rab14
Rab18
Rab20
Rab22A
Rab23
Rab27A
Rab33A
Rab35

Table 4. Rab GTPases examined in this study

and -independent endocytosis (6). Rab10, Rab11, Rab14 and Rab22A are required for moving cargo from the early endosome to the endocytic recycling compartment (24, 99). The
endocytic recycling compartment is defined by the presence of Rab11 and Rab14. Rab11 is
also found on recycling endosomes, mediates delivery to the plasma membrane, is essential
for MHC class I cargo recycling, and is needed to transport vesicles that bud off from tubular
recycling endosomes to the plasma membrane (24). Rab14 is also found on early endosomes
and the trans-Golgi network and mediates vesicular transport from the trans-Golgi network
to the endocytic recycling compartment (99). Rab8 and Rab22A are required to transport
cargo from the endocytic recycling compartment to Rab10-/Rab22A-/Rab35-positive tubular
recycling endosomes (76, 188).
Selective retention of specific Rab proteins with the concomitant exclusion of others
has been shown to regulate the construction of vacuolar organelles inhabited by several
intracellular bacterial pathogens including Mycobacterium tuberculosis (98, 108, 202), C.
burnetii (77, 78, 168), Salmonella enterica serovar Typhimurium (131, 182, 183, 187),
Chlamydia species (42, 128, 170, 171) and L. pneumophila (49, 97, 120, 134). Here, we
examined a panel of fluorescent protein-tagged Rab GTPases that function in a variety of
membrane trafficking pathways and cellular processes (Table 4). We demonstrate that the
ApV selectively recruits a subset of fluorescently tagged Rabs that predominantly associate
with recycling endosomes in a tetracycline-sensitive manner. Endogenous Rab14 localizes to
a comparable percentage of ApVs as its GFP-tagged counterpart. Recruitment of GFP-Rab1,
GFP-Rab4A, GFP-Rab11A, GFP-Rab14 and GFP-Rab35 is guanine nucleotide-dependent,
while recruitment of GFP-Rab10 is strikingly guanine nucleotide-independent. These data
shed light on how A. phagocytophilum facilitates its intravacuolar survival and implicates
the requirement of bacterial-derived proteins for this strategy.
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3.2
3.2.1

Results
Fluorescent protein-tagged Rab1, Rab4A, Rab10, Rab11A, Rab14, Rab22A
and Rab35 localize to the ApV.

We reasoned if Rab GTPases are important for the formation, development, and/or altered
fusogenicity of the ApV, then specific Rab proteins would be recruited to the ApV while
others would be excluded. To investigate this, we transiently nucleofected A. phagocytophilum-infected HL-60 cells with plasmids encoding a representative panel of 20 Rab
GTPases N-terminally fused to GFP or RFP. The collection of Rabs examined, their organelle locales and functions are listed in Table 4. Fluorescently tagged Rabs used here
have been confirmed to localize to subcellular compartments similar to those of their endogenous counter parts (171). At 5 h post nucleofection, we analyzed the association of
GFP- or RFP-tagged Rabs, or GFP alone to the ApV by confocal microscopy. A. phagocytophilum inclusions were demarcated by labeling with a monoclonal antibody against
the major surface protein Msp2 (P44), which is present on the Anaplasma surface, but not
the AVM (91). A distinct subset of fluorescent protein tagged-Rab GTPases localizes to
the ApV (Figure 4 and Figure 5). GFP-Rab10, GFP-Rab11A, GFP-Rab14, RFP-Rab22A,
GFP-Rab35, GFP-Rab1 and GFP-Rab4A localize to 51.3 ± 9.5, 42.5 ± 15.5, 27.5 ± 7.8,
55.9 ± 2.9, 46.2 ± 3.5, 5.5 ± 3.5 and 4.7 ± 3.2% of inclusions respectively. For most
cells exhibiting Rab localization to the ApV, either all or none of the ApVs within a given
HL-60 cell was fluorescent protein-tagged Rab-positive. As an example of a GFP-Rab that
does not localize within a single infected cell, GFP-Rab11A associates with most but not
all of the bacterial inclusions in the cell presented in Figure 4D-F. The accumulations of
these fluorescent protein-Rabs at the ApV produce distinct aggregate signal that can be
seen as either rim-like or punctate at the periphery of the inclusion membrane. Rim-like
staining, which is typified by GFP-Rab10 (Figure 4A-C) and GFP-Rab35 (Figure 4M-O)
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Figure 4. Selective GFP- or RFP-Rab GTPase localization to the A. phagocytophilumoccupied vacuole (ApV).
A. phagocytophilum-infected (A-S) or uninfected control (T-V) HL-60 cells were transiently nucleofected with DNA constructs to express the indicated GFP- or RFP-tagged
Rab-GTPases or GFP alone. At 5 h post nucleofection, the cells were fixed and viewed by
indirect immunofluorescence. A-S. Representative confocal micrograph images depicting
localization of GFP-Rab10A (A-C), GFP-Rab11A (D-F), GFP-Rab14 (G-I), RFP-Rab22A
(J-L), GFP-Rab35 (M-O) or GFP-Rab4A (P) or lack of recruitment of GFP-Rab18 (Q),
GFP-Rab33A (R), or GFP alone (S) to the ApV are presented. Intravacuolar and HL-60
cell surface-associated A. phagocytophilum organisms were denoted by indirect immunofluorescence staining with mAb 20B4, which recognizes the A. phagocytophilum surface
protein, Msp2 (P44), but not the AVM, followed by anti-mouse IgG conjugated to Alexa
Fluor-594 (B, E, H, N, P, Q, R, S) or Alexa Fluor-488 (K). Panels A, B, D, E, G, H, J, K,
M and N present single channel GFP (A, D, G, M), RFP (J) or Msp2 (P44) (B, E, H, K,
N) fluorescence. Panels C, F, I, L, O, P, Q, R and S present merged fluorescent images.
T-V. In the absence of infection, GFP-Rabs exhibit diffuse and/or organelle-like patterns of
fluorescence. Asterisks demarcate HL-60 cell nuclei.
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Figure 4
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Figure 5. Percentages of ApVs exhibiting GFP- or RFP-Rab GTPase localization.
A. phagocytophilum inclusions as demarcated by anti-Msp2 (P44) staining of intravacuolar
bacteria were scored for GFP- or RFP-Rab GTPase localization as in Figure 4. The number
of GFP- or RFP-positive ApVs was divided by the total number of ApVs, which was
multiplied by 100 to determine the percentage of ApVs to which each GFP- or RFP-Rab
GTPase localized. Results are presented as the mean percentages (±SD) of ApVs exhibiting
GFP- or RFP-Rab GTPase and are derived from two to four separate experiments. Up to
972 bacterial inclusions were examined for localization of each GFP- or RFP-Rab GTPase.
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localization to the ApV, indicates that the GFP-Rab is uniformly distributed over the AVM’s
entirety. Punctate staining, as typified by GFP-Rab11A (Figure 4D-F), GFP-Rab14 (Figure
4G-I), RFP-Rab22A (Figure 4J-L) and GFP-Rab4A (Figure 4P), indicates recruitment
to microdomains on the AVM. GFP alone and all other fluorescently tagged Rabs fail to
associate specifically with the ApV and exhibit fluorescent signal that is diffuse throughout
the cell or that is vesicle- and/or Golgi apparatus-associated (Figure 4Q-S and data not
shown).
In the absence of infection, those fluorescent protein-tagged Rabs that otherwise localize
to the ApV demonstrate organelle-like localization and/or diffuse staining patterns (Figure
4T-V and data not shown). Since not all fluorescently tagged Rab proteins associate with the
ApV, GFP-Rab1, GFP-Rab4A, GFP-Rab10, GFP-Rab11A, GFP-Rab14, RFP-Rab22A and
GFP-Rab35 localization to the ApV is likely specific and not due to non-specific association
with GFP or RFP. The lack of detection of GFP-Rab5 recruitment to the ApV is consistent
with the inability to detect endogenous Rab5 on the AVM (129). From these data, it can be
concluded that the ApV primarily hijacks endocytic recycling traffic. The fluorescent proteintagged Rabs that exhibit the highest degrees of association with the ApV – Rab10, Rab11A,
Rab14, Rab22A and Rab35 – are specific to the endocytic recycling compartment, recycling
endosomes and tubular recycling endosomes associated with the slow clathrin-independent
endocytic recycling pathway (76). GFP-Rab4A, which is rapid recycling endosome-specific,
is only found on 4.7% of ApVs (Figure 5). Thus, the ApV predominantly hijacks the slow
clathrin-independent endocytic recycling pathway.
3.2.2

The ApV recruits Rabs upon formation and continues to do so throughout
infection.

Previous work determined that the A. phagocytophilum developmental cycle, which consists of four distinct phases – (i) entry of a surface bound infectious DC organism into a
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nascent ApV; (ii) conversion of the bacterium to a metabolically active RC organism; (iii)
intravacuolar bacterial replication of RC organisms; and (iv) condensation of RC bacteria
back to an inclusion full of DC organisms – takes approximately 24 h (199). Since the
recruitment of Rab GTPases to the ApV may be temporally regulated with respect to the
A. phagocytophilum developmental cycle and this, in turn, may influence the role that each
Rab plays during A. phagocytophilum infection, we examined the association of several
fluorescent protein-tagged Rabs to the ApV during the first 24 h of infection. At time 0,
Anaplasma organisms were added to synchronously infect HL-60 cells. Consistent with previous reports by our and other laboratories (20, 28, 96), it took approximately 4 h for bound
A. phagocytophilum bacteria to enter cells and form nascent vacuoles (data not shown).
Beginning at 4 h, all fluorescent protein-tagged Rabs examined can be detected at the ApV
(Figure 6). The percentages of ApVs positive for GFP-Rab4A, GFP-Rab10, GFP-Rab11A,
RFP-Rab22A and GFP-Rab35, each of which is involved in endocytic recycling, continually
increased throughout the course of infection. GFP-Rab14 localized to a considerably higher
percentage of inclusions at 4 h than any other recycling endosome-associated GFP-Rab. By
24 h, however, the number of GFP-Rab14-positive ApVs had waned. The percentages of
ApVs exhibiting association of endoplasmic reticulum/Golgi-specific GFP-Rab1 remained
consistently low at all time points.
3.2.3

Endogenous Rab14 localizes to the ApV.

We next examined whether endogenous Rab14 associates with the ApV. A. phagocytophiluminfected HL-60 cells were screened with antibodies against Msp2 (P44) and human Rab14
and examined by confocal microscopy. As previously reported, Rab14 localized to vesicular
structures that were ubiquitously distributed throughout the host cell cytoplasm (99). Examination of 1031 ApVs detected aggregate Rab14 staining on 37.9% of ApVs (Figure 7).
Attempts at detecting endogenous Rab11 at the ApV were unsuccessful (data not shown).
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Figure 6. Time-course analyses of GFP- or RFP-Rab GTPase recruitment to the ApV.
Percentages of ApVs to which GFP- or RFP-Rab GTPases associated are presented. Results
are the mean (±SD) of two to five experiments. Up to 575 bacterial inclusions were
examined for recruitment of each GFP- or RFP-Rab per time point. For assessment of GFPor RFP-Rab GTPase association with the ApV at 4, 6, 8 and 12 h post infection, HL-60 cells
were transiently nucleofected with DNA constructs encoding GFP- or RFP-Rab GTPases.
At 12 h post nucleofection, the cells were synchronously infected with A. phagocytophilum
for the time periods indicated and then fixed and examined by confocal microscopy. To
assess GFP- or RFP-Rab GTPase recruitment to the ApV at 12, 18 and 24 h, HL-60 cells
were synchronously infected with A. phagocytophilum. At 7 h post infection, the cells were
nucleofected to express GFP- or RFP-Rab GTPases and fixed and examined at 12, 18 and
24 h post infection.
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Figure 7. Endogenous Rab14 localizes to the ApV.
A. phagocytophilum-infected HL-60 cells were fixed and viewed by confocal microscopy.
Rab14 was detected using rabbit polyclonal antisera against Rab14 followed by anti-rabbit
IgG conjugated to Alexa Fluor-488. Intravacuolar and HL-60 cell surface-associated A.
phagocytophilum organisms were denoted by indirect immunofluorescence staining with
mAb 20B4, which recognizes the A. phagocytophilum surface protein, Msp2 (P44), but
not the AVM, followed by anti-mouse IgG conjugated to Alexa Fluor-594. Panels A, B
and C present single channel Rab14 detection, single channel Msp2 (P44) detection, and
merged fluorescent images respectively. Arrows denote ApVs that exhibit pronounced
Rab14 staining. Results are representative of a total of 1031 inclusions examined for two
separate experiments.
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3.2.4

GFP-Rab10 and GFP-Rab14 localization to the ApV is not dependent on an
intact Golgi apparatus.

In addition to mediating cargo transfer from the early endosome to the endocytic recycling
compartment, Rab10 is also found at the trans-Golgi network and directs transport of cargo
from the trans-Golgi network to the plasma membrane (Table 4) (76). Likewise, Rab14 is
not only found on early endosomes and the endocytic recycling compartment, but is also
found on the trans-Golgi network and mediates traffic from the trans-Golgi network to
the endocytic recycling compartment (Table 4) (94, 99). Therefore, Rab10 and/or Rab14
association with the ApV could be due to A. phagocytophilum hijacking endocytic recyclingand/or trans-Golgi network-derived traffic. To investigate the contribution of an intact
Golgi network to GFP-Rab10 and GFP-Rab14 delivery to the ApV, infected HL-60 cells
expressing GFP-Rab10 or GFP-Rab14 were treated with BFA. BFA treatment resulted
in Golgi fragmentation, as detected by staining for the Golgi marker, GM130 (Figure
8A-C). Vehicle control treated cells exhibited intact Golgi apparatuses (Figure 8D-F) and
GFP-Rab10 localization to the ApV (Figure 8J-M). GFP-Rab10 localization to the ApV in
BFA-treated cells exhibited no difference from that observed for control cells whether BFA
was added to cells with established A. phagocytophilum infections (Figure 8G-I and M) or
prior to infection (data not shown). Highly similar results were observed for GFP-Rab14
recruitment to the ApV in BFA- treated cells (Figure 8M).
3.2.5

GFP-Rab1, GFP-Rab4A, GFP-Rab11A, GFP-Rab14 and GFP-Rab35 associate
with the ApV in a guanine nucleotide-dependent manner, but GFP-Rab10 localizes to the ApV in a guanine nucleotide-independent manner.

Because Rab GTPases interact with their cognate effector proteins at target membranes
in a guanine nucleotide-dependent manner (188), we were interested in whether GFP49

Figure 8. GFP-Rab10 and GFP-Rab14 localization to the ApV is insensitive to BFA.
A. phagocytophilum-infected HL-60 cells expressing GFP-Rab10 or GFP-Rab14 were
treated with BFA or vehicle control (methanol) for 3 h, after which the cells were fixed,
processed for immunofluorescence microscopy and examined by confocal microscopy. A–L.
Confocal micrograph images depicting GFP-Rab10 and immunofluorescent staining for the
Golgi marker, GM130 or A. phagocytophilum Msp2 (P44). (A–C and G–I) BFA-treated
cells. (D–F and J–L) Vehicle control-treated cells. (A, D, G and J) GFP-Rab10. (B and
E) GM130. (H and K) Msp2 (P44). (C, F, I and L) merged images. M. Percentages of
ApVs to which GFP-Rab10 or GFP-Rab14 associates in the absence or presence of BFA.
Results are the mean (±SD) of two separate experiments. At least 361 ApVs inclusions
were examined for GFP-Rab GTPase localization.
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Figure 8
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Rab1, GFP-Rab4A, GFP-Rab10, GFP-Rab11A, GFP-Rab14 or GFP-Rab35 interacts with
the AVM in a similar manner. To investigate this, we assessed the intracellular locations
of constitutively active GTPase-deficient GFP-Rab1A(Q70L), GFP-Rab4A(Q67L), GFPRab10(Q68L), GFP-Rab11A(Q70L), GFP-Rab14(Q76L) and GFP-Rab35(Q70L) and dominant negative GDP-restricted GFP-Rab1A(S25N), GFP-Rab4A(S22N), GFP-Rab10(T23N),
GFP-Rab11A(S25N), GFP-Rab14(S25N) and GFP-Rab35(S22N) GFP-Rab proteins in
infected cells. Dominant negative Rab mutants act by establishing stable interactions with
GEFs, therefore they sequester available GEFs and prevent endogenous Rab GTPases from
being activated (170). A. phagocytophilum-infected HL-60 cells were nucleofected to express each GFP-Rab. Five hours post nucleofection, the cells were fixed, screened with
anti-Msp2 (P44) to denote Anaplasma inclusions, and examined for GFP-Rab recruitment to
the ApV. As shown in Figure 9A, the wild-type and GTPase-deficient forms of GFP-Rab1,
GFP-Rab4A, GFP-Rab11A, GFP-Rab14 and GFP-Rab35 localize to the ApV. Notably, considerably higher percentages of ApVs were positive for GFP-tagged, constitutively active
forms of Rab1 and Rab4 than their wild-type counterparts. In contrast, the GDP-restricted
forms of GFP-Rab1, GFP-Rab4A, GFP-Rab11A, GFP-Rab14 and GFP-Rab35 exhibited a
significant decrease to or did not localize to the AVM. Overexpression of GDP-restricted
Rab GTPases had no aberrant effects on the percentage of infected cells, numbers of ApVs
per cell, or ApV gross morphology (data not shown). In contrast to the guanine nucleotidedependent recruitment exhibited by GFP-Rab1, GFP-Rab4A, GFP-Rab11A, GFP-Rab14
and GFP-Rab35, GFP-Rab10 localization to the ApV is guanine nucleotide-independent.
The wild-type, constitutively active GTPase-deficient and dominant negative GDP-restricted
GFP-Rab10 fusions all localize to the ApV with comparable efficiencies (Figure 9A). Furthermore, the ability of GFP-Rab10(N122I), which is unable to bind guanine nucleotides, is
only modestly reduced (Figure 9B).
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Figure 9. Localization of GFP-Rab1, GFP-Rab4A, GFP-Rab11A, GFP-Rab14 and
GFP-Rab35 to the ApV is guanine nucleotide-dependent, while GFP-Rab10 association with the ApV is guanine nucleotide-independent.
(A) A. phagocytophilum-infected HL-60 cells expressing GFP fusions of wild-type (WT),
constitutively active GTPase-restricted (CA) and dominant negative GDP-restricted (DN)
forms of Rab1, Rab4A, Rab10 and Rab11A were assessed for GFP-Rab recruitment to
the ApV, which was demarcated by anti-Msp2 (P44) staining of intravacuolar bacteria.
The number of GFP-positive ApVs was divided by the total number of ApVs, which was
multiplied by 100 to determine the percentage of ApVs to which each GFP-Rab GTPase localized. Results are presented as the mean percentages (±SD) of ApVs exhibiting GFP-Rab
GTPase recruitment and are derived from at least three experiments. A total of at least 642
bacterial inclusions were examined for recruitment of each GFP-Rab. (B) Comparison of the
colocalization of GFP-Rab10 WT and GFP-Rab10N122I, which is a nucleotide-free mutant
that is incapable of binding GTP or GDP (no-nucleotide, NN), to the ApV. Results are
presented as the mean percentages (±SD) of ApVs exhibiting GFP-Rab GTPase recruitment
and are derived from two experiments. Totals of 363 and 332 inclusions were examined for
HL-60 cells expressing GFP-Rab10 and GFP-Rab10N122I respectively.
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Figure 9
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3.2.6

Selective recruitment of GFP- or RFP-Rab GTPases to the ApV is dependent
on A. phagocytophilum protein synthesis.

Because tetracycline treatment of A. phagocytophilum-infected host cells culminates in A.
phagocytophilum delivery to lysosomes (70), we reasoned that bacterial protein synthesis is critical for the ApV to selectively recruit recycling endosome-associated Rabs and
prevent maturation of the ApV along the endosomal-lysosomal pathway. Rab5 and Rab7
are found on endosomes and lysosomes, respectively (188), and do not normally associate
with the ApV (Table 4). To test our hypothesis, we treated A. phagocytophilum-infected
HL-60 cells expressing GFP-Rab5, GFP-Rab7, GFP-Rab10, GFP-Rab11A, GFP-Rab14,
RFP-Rab22A and GFP-Rab35 with tetracycline or vehicle control for 30 min. The cells
were fixed, screened with anti-Msp2 (P44) to denote bacterial inclusions, and examined
for GFP-Rab localization to the ApV. With the exception of GFP-Rab5 and GFP-Rab7, all
GFP-Rabs examined associated with the ApV in control cells (Figure 10A). GFP-Rab10,
GFP-Rab11A, GFP-Rab14, RFP-Rab22A and GFP-Rab35 localization to the ApV was
significantly reduced in tetracycline-treated cells. Concomitant with this phenomenon, the
ApV became positive for GFP-Rab5 and GFP-Rab7 following the addition of tetracycline,
which suggests that de novo bacterial protein synthesis is necessary for the ApV to intercept
recycling endosome traffic and to block recruitment of Rab GTPases that promote endosomal
maturation and lysosomal fusion. Indeed, 57.4 ± 3.8% of GFP-Rab7-positive ApVs were
also positive for the lysosomal marker, LAMP-1 (Figure 10B). As expected, LAMP-1 localizes only to Rab7-positive vacuoles (188). Even though the lumens of GFP-Rab7-positive
vacuoles were positive for Msp2 (P44) signal, intact organisms were rarely discernible (data
not shown).
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Figure 10. Selective recruitment of GFP- or RFP-Rab GTPases to the ApV is dependent on bacterial protein synthesis.
A. phagocytophilum-infected HL-60 cells were transiently nucleofected with DNA constructs
encoding the indicated GFP- or RFP-Rab GTPase. At 5 h post nucleofection, tetracycline
or vehicle control (70% ethanol) was added and incubation was continued. At 30 min, the
cells were fixed and examined for GFP- or RFP-Rab GTPase association with the ApV.
Intravacuolar A. phagocytophilum organisms were denoted by indirect immunofluorescence
staining of Msp2 (P44). (A) GFP- or RFP-Rab localization to the ApV in the absence (–Tet)
or 30 min post-addition of tetracycline (+Tet). Up to 817 bacterial inclusions were examined
for GFP-Rab GTPase association per condition. Results are the mean (±SD) of at least three
experiments. (B) GFP-Rab GTPase-positive A. phagocytophilum inclusions were examined
for lysosomal fusion 30 min following the addition of tetracycline or vehicle control using a
mAb directed against the lysosomal marker, LAMP-1. Up to 406 bacterial inclusions were
examined for the localization of each GFP-Rab GTPase. Results are the mean (±SD) of
at least three experiments. Statistically significant (*P < 0.05; **P < 0.01; ***P < 0.001)
values are indicated.
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3.3

Discussion

Our data demonstrate that the ApV predominantly hijacks Rab-GTPases that regulate the
slow clathrin-independent endocytic recycling pathway (summarized in Figure 11). The
high degrees of colocalization with the ApV exhibited by GFP-Rab10, GFP-Rab11A, GFPRab14, RFP-Rab22A and GFP-Rab35 and the absence of GFP-Rab8 association with
the ApV strongly suggest that the ApV hijacks the endocytic recycling compartment and
tubular recycling endosomes. Doing so conceivably provides A. phagocytophilum with
several intracellular survival advantages. A. phagocytophilum lacks genes necessary for
synthesizing 16 amino acids (57). Since endogenous host proteins that are critical for amino
acid uptake are brought into host cells via the slow clathrin-independent endocytic pathway
(58), intercepting this pathway is a possible means by which the bacterium acquires amino
acids. A. phagocytophilum incorporates cholesterol into its cell wall (112, 213), presumably
to compensate for its lack of peptidoglycan (57). Since cholesterol is highly abundant in
clathrin-independent endocytic recycling endosomes (126, 172), the bacterium may hijack
tubular recycling endosomes as a means for obtaining cholesterol. Continual delivery of
recycling endosomes to the ApV conceivably provides an unlimited supply of host membrane
material to allow for expansion of the AVM, which would be necessary to accommodate
growing intravacuolar bacterial populations. Lastly, by coating the AVM with recycling
endosome-associated Rab GTPases, the ApV camouflages itself as a recycling endosome,
which is key to preventing maturation along the endosomal pathway and avoiding fusion
with lysosomes. Support for this premise is evidenced by the lack of GFP-Rab7 association
with the ApV, which is in agreement with the report that the ApV avoids lysosomal fusion
(70). Additional support is provided by the observed rapid loss of GFP-tagged slow clathrinindependent endocytosis-associated Rabs from the ApV with concomitant acquisition of
GFP-Rab5, GFP-Rab7 and LAMP-1 upon the addition of tetracycline.
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Figure 11. Model indicating the Rab GTPases and host cell membrane traffic pathways that are hijacked by the ApV.
ER, endoplasmic reticulum; cG, cis-Golgi; ERC, endocytic recycling centre; IC, pre-Golgi
intermediate compartment; LE, late endosome; LYS, lysosome; mG, medial-Golgi; NUC,
nucleus; RE, recycling endosome; SG, secretory granule; SV, synaptic vesicle; tG, transGolgi. This figure is partially adapted from Figure 1 presented by (76, 85).
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The ApV’s hijacking of recycling endosome traffic is consistent with the observation
that that MHC class I and class II molecules, which are recycling endosome cargo, are found
on the AVM (8, 129, 136). Further evidence that the ApV primarily acquires recycling
endosome-derived traffic and does not acquire Golgi-derived vesicles comes from our
observation that an intact Golgi network is not required for GFP-Rab10 or GFP-Rab14 to
traffic to or maintain association with the ApV. This implies that GFP-Rab10 and GFP-Rab14
likely associate with the ApV by virtue of the ApV intercepting recycling endosome-derived
traffic. BFA does not inhibit ApV recruitment of GFP-Rab10 and GFP-Rab14. This is
consistent with a previous report that Golgi-derived markers are absent from the AVM and
BFA exerts no aberrant effect on A. phagocytophilum intracellular survival (129). However,
it cannot be completely ruled out that GFP-Rab10 and GFP-Rab14 are recruited to the ApV
from cytosolic pools.
The ApV rapidly recruits recycling endosome-associated Rab GTPases and Rab1 very
soon, if not immediately following bacterial entry and, with the exception of Rab14, which
begins to dissociate by 24 h, continually recruits recycling endosome-associated Rabs
throughout the duration of A. phagocytophilum intravacuolar development. At 4 h postbacterial addition, the percentage of ApVs that are positive for GFP-Rab14 greatly exceeds
those of all other ApV-associated GFP-Rabs, which indicates that Rab14 is the first Rab
recruited to and/or it more stably associates with the bacterial inclusion. Initial hijacking
of Rab14 may destine the ApV along the slow clathrin-independent endocytic recycling
pathway. The fact that the ApV is positive for GFP-Rab14, but is negative for GFP-Rab5
supports previous observations that the ApV does not resemble an early endosome (129, 209).
Perhaps the ApV hijacks Rab14 from a cytosolic pool or from an as yet defined Rab14positive vacuole that is intermediate between early endosome and the endocytic recycling
compartment. By 24 h, the number of GFP-Rab14-positive ApVs had declined, while the
numbers of ApVs positive for GFP-Rab10, GFP-Rab11A, RFP-Rab22A and GFP-Rab35
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had increased. Since the latter 4 Rabs are found on slow recycling endosomes and slow
tubular recycling endosomes, while Rab14 is found on early endosomes and the endocytic
recycling compartment, these data suggest that the ApV recruits traffic from the endocytic
recycling compartment, slow recycling endosomes and slow tubular recycling endosomes
through 18 h post infection, but draws less from the endocytic recycling compartment at
24 h post infection. How the ApV interacts with the recycling endosomes and membrane
trafficking pathways beyond 24 h of infection cannot be extrapolated from this study.
Endogenous Rab14 localizes to a similar percentage of ApVs as its GFP-tagged counterpart. Attempts to localize endogenous Rab11 to the ApV in infected HL-60 cells were
unsuccessful. Similarly, attempts to localize endogenous Rab4, Rab6 and Rab11 to the
chlaymdial inclusion were also not feasible, even though their GFP-tagged counterparts
localize to the chlaymdial inclusion (171). The inability to detect certain endogenous Rab
GTPases at pathogen-occupied vacuolar membranes may be due to the fact that the levels of endogenous Rabs that are recruited to inclusions are too low to detect by indirect
immunofluoresence microscopy or may simply reflect a limitation of available antibodies.
The ApV is fairly unique with respect to the composition of Rabs that it acquires
and/or the fact that most ApV-recruited Rabs are retained for the duration of the infection.
The ApV most closely resembles the Mycobacteria pathogen vacuole (MPV; occupied by
M. tuberculosis), which recruits Rab11, Rab14 and Rab22 to obtain nutrients from the
clathrin-independent recycling endosome pathway (24, 107, 108, 165). Unlike the MPV,
which also acquires Rab5 (98), the ApV actively blocks Rab5 localization (129). The
early and intermediate stages of the Salmonella-containing vacuole (SCV; occupied by S.
enterica serovar Typhimurium) hijacks Rab4 and Rab11, respectively, along with other Rabs
associated with early endosomes, late endosomes and pre-Golgi intermediate compartments
that do not associate with the ApV (182, 183, 187). In contrast to inclusions occupied by
Chlamydia spp., which recruit both recycling endosome- (Rab4, Rab11, Rab10, and Rab14)
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and secretory pathway (Rab1, Rab6 and Rab10)-associated Rabs, the ApV does not intercept
Golgi-derived traffic (27, 42, 170, 171). Furthermore, intercepting Golgi-derived traffic is
essential for chlamydial (83, 159), but not A. phagocytophilum intracellular survival (129).
Fluorescent protein-tagged Rab10, Rab11A, Rab14, Rab22A and Rab35 localize to no
more than 55.9 ± 2.9% of ApVs. Also, not all ApVs became positive for GFP-Rab5 or GFPRab7 upon the addition of tetracycline. Both phenomena are likely because endogenous Rabs
are recruited to those ApVs to which the fluorescent protein-tagged Rabs have not localized.
Also, because Rab GTPases dynamically cycle on and off target membranes, examining fixed
A. phagocytophilum-infected cells only provides a snapshot of the Rab GTPases associated
with the AVM at that instant. The presence of GFP-Rab4A on fewer ApVs than GFP-Rab10-,
GFP-Rab11A-, GFP-Rab14-, RFP-Rab22A- or GFP-Rab35-positive ApVs indicates that
the ApV intercepts rapid recycling endosomes but at a lower frequency than it intercepts
slow tubular recycling endosomes. GFP-Rab1, which is normally found on endoplasmic
reticulum exit sites and pre-Golgi intermediate compartments (153), localized to no more
than 6.8 ± 0.8% of bacterial inclusions at any examined time point. Moreover, GFP-Rab2,
which is found on pre-Golgi intermediate compartments (198), does not associate with the
ApV. Thus, we can infer that a small percentage of ApVs hijack vesicles that emanate from
endoplasmic reticulum exit sites. The low degree of GFP-Rab1 and GFP-Rab4A association
with the ApV indicates that acquiring endogenous Rab1-positive endoplasmic reticulumderived vesicles and/or Rab4A-positive rapid recycling endosomes either does not play a
major role in A. phagocytophilum intracellular survival or that Rab1 and Rab4A rapidly
cycle on and off the AVM and their transient associations cannot be accurately represented
by the snapshot analyses utilized in this study. Alternatively, Rab1- or Rab4A-positive ApVs
could have different complements of Rab GTPases and may have different intracellular
fates. Despite the low percentages of ApVs to which GFP-Rab1 and GFP-Rab4A localize,
these are likely real events since the GTPase-deficient versions of both GFP-Rab1 and
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GFP-Rab4A each localize to significantly greater percentages of ApVs than their wild-type
counterparts. This is presumably because the GTPase deficient Rabs are unable to cycle off
the AVM once associated.
All GFP-Rab GTPases examined in this study are found on the ApV shortly, if not
immediately following bacterial entry into HL-60 cells. Also, with the exception of GFPRab1, which localizes to very few inclusions throughout infection, and GFP-Rab14, which
initially associates to a much greater percentage of ApVs than any other GFP- or RFP-Rab
and begins to dissociate by 24 h, the GFP- and RFP-Rabs that are recruited to the ApV are
found on increasing numbers of inclusions throughout the course of infection. This is in
contrast to Rab GTPase recruitment to other pathogen-occupied vacuoles, such as those
occupied by Chlamydia spp. and S. Typhimurium, which differentially recruit Rab GTPases
over the duration of bacterial intravacuolar development (171, 183).
The observations that GTP-bound forms, but not GDP-bound forms of GFP-Rab1, GFPRab4A, GFP-Rab11A, GFP-Rab14 and GFP-Rab35 associate with the ApV indicate that
these Rabs localize to the ApV as they would to their normal host cell target organelles.
These GTP-bound Rabs may directly associate with the ApV by virtue of their interactions
with A. phagocytophilum-encoded proteins presented on the AVM that mimic effectors of
Rab1, Rab4, Rab11, Rab14 and/or Rab35. Alternatively, they may indirectly interact with
the ApV through host-derived Rab effectors that are presented by the AVM by virtue of their
interactions with Anaplasma-derived AVM proteins. Constitutively active GTPase-deficient
GFP-Rab11A localizes to significantly fewer ApVs than wild-type GFP-Rab11A. We
speculate that this is because a majority of GTP-locked GFP-Rab11A irreversibly associates
with the membranes of recycling endosomes and the endocytic recycling compartment,
which would effectively remove GTP-locked GFP-Rab11A from the cytosolic pool to be
hijacked by the ApV. This premise is supported by the presence of considerably larger
GFP-Rab11A-positive vacuoles in HL-60 cells expressing GTPase-deficient Rab11A as
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compared with HL-60 cells expressing wild-type Rab11A (data not shown). The dominant
negative GDP-locked Rab35 exhibited a decrease but not a complete loss of association to
the ApV. We speculate this is due to a polybasic motif in the C-terminus of Rab35 that has
been shown to be sufficient for targeting to the plasma membrane (81), which would explain
why a reduction but not complete loss in ApV association of the GDP-locked Rab35 was
observed. In addition, interference of Rab35 function has been shown to cause enlarged
early endosomes and inhibit MHC class I recycling (6), suggesting that normal recycling
and endocytic trafficking pathways are arrested. As a downstream effect, the activity of
GAPs to remove membrane bound Rab35 could be delayed, which would prolong Rab35
association with the ApV. Alternatively, it is plausible that Anaplasma encodes a protein
that has a functional role in Rab35 membrane cycling.
Our observations that the GDP-locked and nucleotide-free forms of GFP-Rab10 exhibit
no and minimal defects, respectively, in localization to the ApV are striking and strongly
suggest that A. phagocytophilum-derived proteins, presumably located on the AVM, mimic
host GEF, GDI and/or GAP activities by regulating guanine nucleotide exchange on Rab10
to directly control Rab10 membrane cycling on/off the AVM. The precedents for such a
remarkable phenomenon have been established by the identification of two L. pneumophila
inclusion membrane proteins, DrrA/SidM and LepB. DrrA/SidM exhibits dual functionality
as a GDF to displace Rab GDI such that Rab1 can be inserted into the Legionella containing
vacuole membrane (LCVM) and as a GEF to stimulate Rab1 activation (92, 120, 134).
LepB inactivates and removes Rab1 from the LCVM by functioning as a GAP to stimulate
GTP hydrolysis (92). High-affinity binding to the nucleotide-free or GDP-bound form of
a Rab GTPase is a characteristic feature of GDF/GEFs, while high-affinity binding to the
GTP bound form is a signature of GAPs (24, 188). Thus, the association of nucleotidefree and GDP-bound GFP-Rab10 suggests that one or more A. phagocytophilum-derived
proteins exhibit GDF/GEF activity. An alternative, albeit less likely, possibility is that the
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ApV indirectly mediates Rab10 membrane cycling by hijacking one or more host-derived
Rab10-specific GDIs, GEFs and/or GAPs. However, association of nucleotide-free and
GDP-bound GFP-Rab10 with the ApV, which is inconsistent with how Rabs associate with
eukaryotic target membranes, strongly argues in favor of these phenomena being dependent
on bacterial-encoded AVM proteins.
To determine if any A. phagocytophilum proteins exhibit primary amino acid sequence
homology to eukaryotic GAPs, GEFs and GDIs that interact with ApV-associated Rabs
or to known bacterial PVM and effector proteins, we searched each protein’s sequence
against the annotated A. phagocytophilum proteome (57). No A. phagocytophilum protein
exhibits primary sequence similarity to any known eukaryotic or bacterial pathogen Rab
ligand (data not shown). This is not surprising since Legionella- and Chlamydia-derived
Rab ligands and GEF/GDI/GAP mimics exhibit no primary amino acid sequence homology
to any mammalian Rab effector, GAP or GEF (42, 92, 120, 134, 170, 175). Indeed, most
bacterial effectors that mimic the activities of eukaryotic cellular proteins do so in the
absence of detectable amino acid similarity (64). Thus, the A. phagocytophilum proteins
that presumably regulate Rab10 membrane cycling are likely GEF/GDI/GAP homologues
in functionality, but not in primary amino acid sequence.
This work advances our understanding of a key strategy by which A. phagocytophilum
facilitates its survival within myeloid host cells. It actively controls the biogenesis of
the vacuole in which it resides by selectively hijacking Rab GTPases that predominantly
associate with recycling endosomes. In doing so, the ApV effectively disguises itself as a
recycling endosome, which is requisite for avoiding endosomal maturation and lysosomal
fusion. This strategy also likely contributes to the bacterium’s acquisition of host membrane
material, amino acids and cholesterol, each of which is important for bacterial growth and/or
cell wall stability. This premise warrants further investigation. It will also be critical to
identify and functionally assess the bacterial proteins that interact with each ApV-specific
65

Rab GTPase and those that regulate AVM cycling of Rab10. Further dissection of the
mechanism of selective recruitment of Rab GTPases to the ApV will continue to enhance
our understanding of how this unique pathogen survives within the primary effector cell of
microbial killing.
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A. phagocytophilum APH_1387 is expressed throughout
bacterial intracellular development and localizes to the
pathogen-occupied vacuolar membrane (PVM)
4.1

Introduction

Pathogen-encoded proteins that localize to the pathogen-occupied vacuolar membrane
(PVM) play critical pathobiological roles, which include providing structural integrity
to the PVM, hijacking vesicular traffic, and intercepting host signal transduction pathways. Because PVM alteration by pathogen-derived proteins is a paradigm of intracellular
pathogenesis and at the time of this study there had been no previous reports of A. phagocytophilum-encoded proteins that localize to the AVM, we sought to identify and characterize
such proteins. Since A. phagocytophilum is an obligate intracellular bacterium, we rationalized that bacterial proteins induced in host cells represent AVM candidate proteins. Storey
et al. identified 3 such A. phagocytophilum proteins, P100, P130, and P160, which had
apparent molecular masses of 100, 130, and 160 kDa, by screening an A. phagocytophilum
genomic expression library with convalescent dog serum (190). Recombinant forms of these
proteins were recognized by HGA patient antisera. P160, which has since been renamed
AnkA because it carries a series of ankyrin repeats (32), is the first A. phagocytophilum type
IV effector that was identified and does not localize to the AVM (95, 111, 161). P100 and
P130 correspond to APH_1387 and APH_0032, respectively, in the annotated A. phagocy67

tophilum proteome (57). Both of these proteins are acidic, carry tandem direct repeats, and
contain segments that putatively traverse the AVM. Because APH_1387 is induced upon
infection and because it shares secondary structure characteristics with chlamydial inclusion
membrane proteins (Inc), we performed detailed studies of APH_1387 and identified it as the
first A. phagocytophilum-encoded protein that localizes to the AVM. This chapter presents
the first direct evidence that A. phagocytophilum actively modifies the host cell-derived
organelle in which it resides.

4.2
4.2.1

Results
APH_1387 has limited homology to any previously described protein.

APH_1387 is an acidic protein (pI 3.67) that contains 578 amino acids and has a predicted
molecular mass of 61.4 kDa. It has 3 tandemly arranged direct repeats consisting of 93 amino
acids (amino acids 180 to 272), 122 amino acids (amino acids 304 to 425), and 130 amino
acids (amino acids 428 to 557) that together comprise 58% of the protein (Figure 12A).
BLASTP searches using the entire APH_1387 sequence, the tandem repeat region (amino
acids 180 to 557), or individual repeats identified no proteins that exhibited homology with
APH_1387. A BLASTP search using the amino-terminal non-repeat region (amino acids 1 to
179) identified a 93-amino-acid stretch exhibiting 32.3% identity to AM_924 and AMF_1226
of the A. marginale St. Maries and Florida strains, respectively (21, 44). APH_1387 is
predicted to consist largely of amphipathic alpha helices (Figure 12B). Chlamydial Inc
proteins possess transmembrane and/or hydrophobic domains that facilitate insertion into the
PVM (14, 15). Likewise, many PVM proteins possess hydrophilic domains that extend into
the host cytoplasm to interact with host proteins (167). Although APH_1387 lacks a typical
transmembrane domain, a 24-amino-acid sequence (AQVPVVAEAELPGVEAAEAIVPSL)
that is part of each of the 3 direct repeats constitutes a bilobed hydrophobic domain (amino
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Figure 12. Schematic diagram of A. phagocytophilum APH_1387 and its secondary
structure.
(A) The amino (N)-terminal region (amino acids [aa] 1 to 179) precedes the repeat region
(aa 180 to 549), which precedes a short carboxy (C)-terminal region (aa 550 to 578). The
repeat region consists of 3 tandem direct repeats (indicated by open arrows) consisting
of 93, 122, and 130 aa. Underlining indicates the locations of the bilobed hydrophobic
domains. (B) Diagram of the secondary structure of APH_1387. The scale indicates 50aa intervals. The open and filled boxes indicate alpha helical (Alpha regions) and beta
strand (Beta regions) regions, respectively, as determined using the Garnier-OsguthorpeRobson algorithm. In the Alpha amphipathic diagram, striped boxes indicate regions that
are predicted to form alpha helices and are comprised of amphipathic aa, as determined by
the Eisenberg algorithm. For the Hydrophobicity diagram, the Kyte-Doolittle algorithm was
used to determine hydrophobic (histogram above the x axis) and hydrophilic (histogram
below the axis) regions. The 24-aa sequence constituting a bilobed hydrophobic domain
occurs at aa 200 to 223, 324 to 347, and 448 to 471. All of the analyses were performed
using Protean, which is part of the Lasergene software package, as described in Materials
and Methods.
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acids 200 to 223, 324 to 347, and 448 to 471) (Figure 12B). Bilobed hydrophobic domains
are highly conserved among all chlamydial Inc proteins and are hypothesized to facilitate
insertion of these proteins into the chlamydial inclusion membrane (167). Between the 3
hydrophobic domains are alpha-helical stretches that are largely hydrophilic. This periodicity
of hydrophobic and hydrophilic domains could conceivably enable APH_1387 to traverse
the AVM multiple times. Attempts to predict a tertiary structure for APH_1387 using
SWISS-MODEL, ESyPred3D, 3Djigsaw, and GENO3D were unsuccessful because none of
these programs was able to identify similar sequences with known structures on which to
model the APH_1387 structure. Sequencing of the PCR products obtained for the entire
aph_1387 coding sequence of A. phagocytophilum strains NCH-1, HZ, and HGE-1 revealed
that this gene’s sequence is the same in these 3 strains and the USG3 strain, the strain in
which it was originally sequenced (190) (data not shown).
4.2.2

APH_1387 is more abundant in A. phagocytophilum RC organisms than in DC
organisms.

We initiated our characterization of APH_1387 by expressing it as a MBP fusion protein
in E. coli and using the recombinant protein to raise rabbit polyclonal antiserum. To
test the efficacy of anti-APH_1387 and to determine if APH_1387 is expressed during
A. phagocytophilum infection of promyelocytic HL-60 cells, we performed Western blot
analyses. Anti-APH_1387 recognized APH_1387 as a single band at ⇠115 kDa in an A.
phagocytophilum-infected cell lysate but not in an uninfected HL-60 cell lysate (Figure
13). A. phagocytophilum has a biphasic developmental cycle in which an infectious DC
organism binds, enters, and changes into a replicative RC organism that subsequently
divides by binary fission (199). The numerous RC organisms, which are noninfectious,
revert to DC organisms before they are released to infect naive host cells. We confirmed
that a host cell-free population of A. phagocytophilum DC and RC organisms can be
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Figure 13. Screening of A. phagocytophilum-infected HL-60 cells and host cell-free
bacterial populations with anti-APH_1387.
Western-blotted lysates of uninfected (lane U) and A. phagocytophilum-infected HL-60
cells (lane I), as well as host cell-free A. phagocytophilum populations consisting of RC
and DC organisms (lane RC + DC) or only DC organisms (lane DC), were screened with
anti-APH_1387. MBP-APH_1387 was used as a positive control. The blot was stripped
and screened with anti-Msp2 (P44) to confirm that equivalent amounts of lysates derived
from RC and DC organisms and from only DC organisms were used. The results are
representative of the results of two separate experiments.
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recovered following syringe lysis, which does not damage the fragile RC organisms, while
a pure DC organism population can be recovered following sonication, which destroys
the RC organisms (data not shown). To assess whether RC or DC organisms express
more APH_1387, we screened Western-blotted lysates of host cell-free A. phagocytophilum
organisms recovered following syringe lysis (DC and RC organisms) or sonication (only DC
organisms) that were normalized using the levels of Msp2 (P44), which is a constitutively
expressed outer membrane protein (71) (Figure 13). The intensity of the APH_1387 band
was considerably higher for the lysate derived from DC and RC organisms than for the
lysate generated from DC organisms. After longer exposures, additional anti-APH_1387
reactive bands at ⇠61 and 90 kDa were detected in lysates derived from the DC and RC
organisms, as well as infected HL-60 cells (data not shown).
4.2.3

APH_1387 is induced following bacterial entry into host cells and localizes to
the AVM.

We next screened A. phagocytophilum-infected HL-60 cells with anti-APH_1387 in conjunction with a mAb against Msp2 (P44) (149, 176) at 0.7, 8.5, and 24 h post infection
and visualized the cells by confocal microscopy. At 0.7 h post infection, very little or no
APH_1387 was detected on Msp2 (P44)-positive organisms that were bound to the HL-60
cell surface (Figure 14A to D). By 8.5 h, ApVs containing individual A. phagocytophilum
bacteria were detected. At this time point, the AVM was positive for APH_1387 (Figure
14E to H). At 24 h, the AVM was strikingly distinguished from enclosed bacteria by exclusive staining for APH_1387 (Figure 14I to L). A. phagocytophilum bacteria within
ApVs that were positive for both Msp2 (P44) and APH_1387 were green [corresponding
to Msp2 (P44) staining] spheroid organisms, each of which was surrounded by a red ring
(corresponding to APH_1387 staining) or a yellow ring [corresponding to APH_1387 and
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Figure 14. A. phagocytophilum APH_1387 is detectable on the surfaces of intravacuolar bacteria and localizes to the AVM in infected host cells.
(A–L) HL-60 cells were synchronously infected with A. phagocytophilum. At 0.7 h (A–D),
8.5 h (E–H), and 24 h (I–L) post infection, the cells were fixed and viewed by confocal
microscopy to determine immunoreactivity with antibodies against Msp2 (P44) (major
bacterial surface protein; used to identify bacteria in panels B, F, and J) and APH_1387 (C,
G, and K). Differential interfering contrast images are shown in panels A, E, and I. Merged
fluorescent images are shown in panels D, H, and L. (M–X) A. phagocytophilum-infected
THP-1 (M–P), HMEC-1 (Q–T), and ISE6 (U–X) cells were fixed and viewed by confocal
microscopy to determine immunoreactivity with antibodies against Msp2 (P44) (N, R, and
V) and APH_1387 (O, S, and W). Differential interfering contrast images are shown in
panels M, Q, and U. Merged fluorescent images are shown in panels P, T, and X. In panel
H the arrowheads indicate individual Msp2 (P44)-positive A. phagocytophilum organisms
enclosed in APH_1387-positive vacuoles. In panels L, P, T, and X the arrows indicate
representative AVMs or portions of AVMs that exhibit exclusive staining for APH_1387.
Intravacuolar bacteria are positive for Msp2 (P44) or both Msp2 (P44) and APH_1387. The
results are representative of the results of three separate experiments.
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Msp2 (P44) staining] (Figure 14J to L). At 24 h, 94.0 ± 3.5% of the ApVs were positive
for APH_1387. The AVM was negative for Msp2 (P44) at all time points.
4.2.4

APH_1387 localizes to the AVM during A. phagocytophilum infection of human
myeloid and endothelial cell lines and tick embryonic cell lines.

In addition to HL-60 cells, A. phagocytophilum infects and resides in ApVs in the human
monocytic cell line THP-1, the human microvascular endothelial cell line HMEC-1, and
the I. scapularis embryonic cell line ISE6 (65, 82, 133, 212). To determine if APH_1387 is
expressed and localizes to the AVM in each of these cell lines, A. phagocytophilum-infected
THP-1, HMEC-1, and ISE6 cells were examined by confocal microscopy at 24 h post
infection. As observed for HL-60 cells, virtually all ApVs in each cell line were positive for
APH_1387 (Figure 14M to X). Indeed, at 24 h post infection 93% of ApVs were positive
for APH_1387 in THP-1 cells (data not shown). Notably, the plasma membranes of heavily
infected THP-1 cells (Figure 14O and P), ISE6 cells (Figure 14W and X), and HL-60
cells (data not shown) and occasionally uninfected cells that were adjacent to the heavily
infected cells were also positive for APH_1387.
4.2.5

APH_1387 is expressed and localizes to the AVM throughout A. phagocytophilum
intracellular development in HL-60 cells.

We next assessed the temporal expression and AVM localization patterns of APH_1387 over
the course of a synchronous A. phagocytophilum infection of HL-60 cells. Host cell-free
bacteria were added to HL-60 cells and allowed to bind for 40 min, which was followed by
removal of unbound organisms. We and others have determined that it takes 4 h for bound A.
phagocytophilum DC organisms to internalize in nascent vacuoles (20, 28, 96). Beginning at
8 h after addition of bacteria, which corresponded to 4 h after entry, APH_1387 was weakly
detected as a 115-kDa band by immunoblot analysis (Figure 15A and B). The intensity of
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Figure 15. Kinetics of APH_1387 expression and AVM localization in A. phagocytophilum-infected cells.
HL-60 cells were synchronously infected with A. phagocytophilum. At the times post
infection indicated, aliquots were processed and analyzed using Western blotting and densitometric analysis (A–B) or immunofluorescence microscopy (C). (A) Western blots of
A. phagocytophilum-infected HL-60 whole-cell lysates screened with antibodies against
APH_1387, Msp2 (P44) (infection control), and actin (loading control). (B) Densitometry
to quantify the intensities of APH_1387 and actin bands. The ratio of the APH_1387 densitometric value to the actin densitometric value is shown for each time point. (C) Percentages
of ApVs [based on the presence of Msp2 (P44)-positive A. phagocytophilum bacteria] that
are positive for APH_1387 staining of intravacuolar bacteria and exclusive staining of the
AVM. The data are the means and standard deviations for 3 separate experiments. At least
948 Msp2 (P44)-positive ApVs were scored for APH_1387 for each time point.
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this band increased continually during the time course. Beginning at 18 h, several additional
bands were also detected, and the primary bands were at ⇠61 and 90 kDa. As we have
shown previously (31), the intensity of the Msp2 (P44) band, which is used as an infection
control, increases throughout the course of an infection. APH_1387 was detected on >80%
of the ApVs at 12 h and on >90% of the ApVs at all later time points by confocal microscopy
(Figure 15C).
To more closely examine when APH_1387 is expressed and associates with the AVM
during the course of infection, we screened synchronously infected HL-60 cells over a 48 h
period by using immunoelectron microscopy. APH_1387-negative spheroid DC organisms
were bound to the HL-60 cell surface at 0.7 h (Figure 16A), and some organisms had
internalized into nascent vacuoles by 4 h (Figure 16B). By 8 h, which corresponded to
⇠4 h after entry, the internalized bacteria had changed into elongated, pleomorphic RC
organisms and had begun to replicate. The surfaces of the replicating RC organisms were
positive for APH_1387, as were portions of the AVM (Figure 16C). More APH_1387 was
detected on the AVM and on intravacuolar A. phagocytophilum bacteria as the infection
progressed (Figure 16D to G). At 24 h, individual HL-60 cells contained numerous ApVs,
each of which harbored several DC organisms that had rough outer membranes or contained
multiple mature RC organisms that were changing into DC organisms (Figure 16F), which
is consistent with our previous report on the replication kinetics of A. phagocytophilum in
HL-60 cells (199). At this time point, APH_1387 heavily decorated the AVM, as well as the
surfaces of intravacuolar DC and RC organisms. APH_1387 labeling of the AVM was most
pronounced for mature ApVs that contained several A. phagocytophilum bacteria at 48 h
(Figure 16G and H).
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Figure 16. Assessment of A. phagocytophilum APH_1387 expression and localization
to the AVM by immunoelectron microscopy.
HL-60 cells were synchronously infected with A. phagocytophilum. At 0.7 h (A), 4 h (B), 8
h (C), 12 h (D), 18 h (E), 24 h (F), and 48 h (G and H) after addition of bacteria, samples
were fixed and screened with anti-APH_1387 followed by goat anti-rabbit IgG conjugated
to 6-nm gold particles and examined by electron microscopy. Representative results of two
separate experiments are shown. (A–B) Asterisks indicate bound or newly internalized A.
phagocytophilum DC organisms. (C–F) Arrows indicate representative portions of the AVM
that are labeled with gold particles. (H) Magnification of the region in panel G indicated by
a box. Scale bars, 0.5 µm.
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4.2.6

APH_1387 is expressed and localizes to the AVM in vivo.

Next, we investigated APH_1387 expression in vivo. MBP-APH_1387, but not MBP
alone, was recognized by antiserum from an HGA patient (Figure 17A), which confirmed
a previous report by Storey and colleagues (190). Likewise, Msp2 (P44)- and APH_1387positive ApVs were detected by confocal microscopy in murine buffy coats isolated from A.
phagocytophilum-infected mice at 8 days post infection (Figure 17B to E).

4.3

Discussion

APH_1387 is expressed and modifies the AVM in vivo in neutrophils during murine infection
and in vitro during intracellular residence in human HL-60, THP-1, HMEC-1, and tick
ISE6 cells, and it is expressed throughout the course of intracellular development. The
examination of A. phagocytophilum whole-genome transcription profile data that was performed by Nelson and colleagues for infected HL-60, HMEC-1, and ISE6 cells revealed that
aph_1387 is transcribed in each cell line (137), which corroborates the findings of our protein expression analyses. Thus, APH_1387 is conceivably important for A. phagocytophilum
survival in all eukaryotic host cells that this bacterium infects. This hypothesis is further
supported by the high degree of sequence conservation in at least 4 geographically diverse
A. phagocytophilum strains (190). Notably, anti-APH_1387 stains the plasma membranes
of heavily infected host cells and uninfected host cells that are adjacent to heavily infected
cells, which suggests that APH_1387 may associate with the host cell plasma membrane.
Tandem repeat proteins of pathogenic bacteria have been implicated in a wide range
of host-pathogen interactions (38, 63, 90, 95, 111, 205, 211, 219). A protein alignment of
APH_1387 and the E. chaffeensis tandem repeat protein P120 (encoded by ECH_0039 in
the annotated E. chaffeensis genome) (215) that was performed by Storey and colleagues
revealed that two short repeat segments that help comprise each APH_1387 tandem repeat
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Figure 17. A. phagocytophilum APH_1387 is expressed and associates with the AVM
during in vivo infection.
(A) Antiserum from an HGA patient recognized MBP-APH_1387 but not MBP alone.
(B–E) Buffy coats isolated from an A. phagocytophilum-infected mouse on day 8 post
infection were fixed and viewed by confocal microscopy to determine immunoreactivity
with antibodies against Msp2 (P44) (C) and APH_1387 (D). A differential interfering
contrast image is shown in panel B. A merged fluorescent image is shown in panel E. The
arrow indicates exclusive APH_1387 staining of the AVM. The results are representative of
the results of three separate experiments for each analysis.
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region share sequence similarity with portions of the tandem repeat region of P120 (190).
E. chaffeensis P47 is an acidic (pI 4.2) tandem repeat carrying protein that interacts with
host molecules involved in cell signaling, transcriptional regulation, and vesicle trafficking
(119, 205, 218). The target host molecules with which APH_1387 presumably interacts
and/or the pathobiological role of APH_1387 is likely unique to A. phagocytophilum
intracellular survival, as APH_1387 exhibits very little to no homology with any previously
described protein. Alternatively, APH_1387 may be important for adding structural integrity
to the AVM and may have no target ligand.
Upon electrophoresis APH_1387 migrates primarily as a 115 kDa band and also produces
less prominent bands; the primary less prominent bands are a 90 kDa band and a band at the
predicted molecular mass of 61.4 kDa. While other workers have attributed this aberrant
migration to glycosylation (47), our assessments of both native and recombinant APH_1387
indicate that neither protein is glycosylated (unpublished data). All Anaplasmataceae acidic
tandem repeat proteins analyzed to date migrate at molecular weights considerably higher
than their predicted molecular weights. Alternatively, the acidic nature of APH_1387 may
prevent it from amply binding SDS, which would retard proper SDS-PAGE resolution, as
has been observed for other acidic proteins and was reported for E. chaffeensis P47 by
Wakeel and colleagues (127).
Large amounts of APH_1387 associated with the surfaces of intravacuolar A. phagocytophilum RC and DC organisms are detected by indirect immunofluorescence and immunoelectron microscopy. Yet APH_1387 was not detected on the surfaces of glutaraldehyde-fixed
host cell-free A. phagocytophilum bacteria that were recovered following mechanical disruption of infected HL-60 cells, washed with PBS, and added to naive HL-60 cells, and it was
only weakly detected on methanol-permeabilized bacteria by immunofluorescence analysis.
Accordingly, we hypothesize that APH_1387 is not integrated into the A. phagocytophilum
outer membrane but instead is loosely associated with it and is easily washed away during
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the isolation procedure. We further hypothesize that this is because APH_1387 is transiently
associated with the surfaces of intravacuolar bacteria while it is being secreted and that it
subsequently integrates into the AVM.
Dissecting the role of APH_1387, confirming its route of delivery, and identifying its
eukaryotic host cell ligands are essential for fully comprehending the intracellular survival
strategies of this unusual bacterial pathogen.
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A. phagocytophilum APH_0032 is expressed late during
infection and localizes to the pathogen-occupied vacuolar
membrane
5.1

Introduction

Multiple pathogen-encoded PVM proteins have been found for a diverse array of obligate
vacuolar pathogens. Indeed,

45 and

65 Inc proteins have been confirmed and/or are

predicted for C. pneumoniae and C. trachomatis, respectively (167). Thus, APH_1387 is
likely one of a multitude of AVM proteins that are waiting to be identified and functionally
characterized. APH_0032 is another A. phagocytophilum acidic tandem repeat protein that,
along with APH_1387, is induced during A. phagocytophilum infection of dogs and humans
(190). In their abstract presented at the American Society for Rickettsiology-Bartonella as
an Emerging Pathogen Group 2001 Joint Conference, Nelson, Ahn, Herron, and Goodman
reported that antisera against APH_0032 recognized the AVM, which implicates APH_0032
as a bacterial-encoded AVM protein. Because of the relevance of bacterial PVM proteins to
intravacuolar pathogens and to gain further insight into how A. phagocytophilum modifies
its host cell-derived vacuole, we set out to confirm whether APH_0032 is a bona fide AVM
protein and characterize its expression pattern in a variety of host cells.
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5.2
5.2.1

Results
APH_0032 displays limited similarity to other known proteins but exhibits predicted secondary structural characteristics that are suggestive of AVM localization.

APH_0032 is a 619 aa acidic protein (pI = 3.6) with a predicted molecular weight of 66.1
kDa. Amino acids 313-597 (46.0% of the protein’s sequence) encode a tandem repeat region
(Figure 18A and C). Eight direct repeats, which are nearly identical and range from 33 to
35 amino acids long, are preceded by a truncated segment that is homologous to the last
10 amino acids of each repeat and followed by a truncated segment that is homologous
to the first 3 amino acids of each repeat (Figure 18A and C). BLASTP searches using
the entire APH_0032 sequence or the repeat-region revealed that amino acids 341-609
exhibit 30% identity to PY03917, which is a hypothetical protein of Plasmodium falciparum.
A BLASTP search using the N-terminal non-repeat region (amino acids 1-312) yielded
hits to hypothetical proteins of Microcoleus chthonoplastes and Entamoeba dispar and a
putative RNA methylase from Methanococcus voltae that ranged from 22 to 30% identity.
APH_0032 is predicted to be largely hydrophilic (Figure 18B). Chlamydial Inc proteins
possess transmembrane domains (TMD) that facilitate insertion into the PVM and often
carry hydrophilic domains that extend into the host cell cytoplasm to interact with host
proteins (14, 15). TMPred analysis predicts APH_0032 to carry a TMD that spans amino
acids 144-162 (Figure 18B) (47). Attempts to predict a tertiary structure for APH_0032
using SWISS-MODEL, ESyPred3D, 3Djigsaw, and GENO3D were unsuccessful because
none of these programs were able to identify similar sequences of known structure on
which to model APH_0032. Sequencing of PCR products of the aph_0032 coding sequence
amplified from A. phagocytophilum strains NCH-1, HZ, and HGE-1 revealed that this gene’s
sequence is identical among the 3 strains, as well as the USG3 strain for which it was
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Figure 18. Schematic representation of A. phagocytophilum APH_0032, sequence, and
secondary structure analyses.
(A) The amino (N)-terminal region (amino acids 1–312) precedes the repeat region (amino
acids 313–597), which precedes a short carboxy (C)-terminal region (amino acids 598–
619). The repeat region consists of 8 imperfect direct repeats (denoted by grey arrows)
of 34, 34, 34, 34, 33, 34, 34, and 35 amino acids that are arranged in tandem. The 8
direct repeats are preceded by a truncated segment that is homologous to the last 10 amino
acids of each repeat and followed by a truncated segment that is homologous to the first
3 amino acids of each repeat. The black bar and TMD designation denote the predicted
transmembrane domain encoded by amino acids 144–162, as determined by the TMPRED
algorithm. (B) Hydrophobicity analysis of APH_0032. The numerical scale demarcates
the protein sequence at 50-amino acid intervals. The Kyte-Doolittle algorithm was used
to denote hydrophobic (black filled histogram above the x-axis) and hydrophilic (black
filled histogram below the axis) regions. (C) APH_0032 tandem repeat sequence alignment.
The amino acid (aa) positions and sequence of each repeat are provided. Dashes denote
gaps in the alignment. Grey highlighting denotes identical amino acids. Bolded amino acid
segments are those that are homologous to a segment that occurs 4 times in the E. chaffeensis
ECH0039 (P120) tandem repeat region (57, 190).
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originally sequenced (190) (data not shown).
5.2.2

APH_0032 is present in higher abundance in A. phagocytophilum RC organisms than in DC organisms.

We performed Western blot analysis to determine if APH_0032 is expressed during A.
phagocytophilum infection of promyelocytic HL-60 cells. Anti-APH_0032 recognized
APH_0032 as a single band of ⇠130 kDa in an A. phagocytophilum-infected, but not an
uninfected HL-60 cell lysate (Figure 19A). APH_0032’s apparent MW is considerably
larger than its predicted size of 66.1 kDa. Likewise, MBP-APH_0032 (pI = 4.1) migrates
with an apparent MW of 160 kDa, which is larger than its predicted MW of 109.3 kDa.
A. phagocytophilum undergoes a biphasic developmental cycle in which an infectious
DC organism binds, invades, and develops into a replicative RC organism that divides
by binary fission (199). The numerous RC bacteria, which are non-infectious, revert to
DC organisms before being released to infect naive host cells. We have determined that a
host cell-free population of A. phagocytophilum DC and RC organisms can be recovered
following syringe lysis, which does not damage the fragile RC, while a pure DC population
can be recovered following sonication, which destroys the RC (data not shown). To assess
whether DC or RC organisms express more APH_0032, we screened Western-blotted lysates
of host cell-free A. phagocytophilum organisms recovered following syringe lysis (RC and
DC) or sonication (DC only) that were normalized according to the levels of Msp2 (P44),
which is a constitutively expressed outer membrane protein (71). APH_0032 was detected
in lysates derived from RC and DC organisms and from DC organisms alone (Figure 19A).
Densitometric analyses of two separate experiments revealed that there is 2.37-2.74 times
more APH_0032 in lysates derived from RC and DC organisms as compared to lysates
derived from DC organisms (Figure 19B).
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Figure 19. APH_0032 is present in greater abundance in lysates of A. phagocytophilum
RC organisms compared to DC organisms.
(A) Western-blotted lysates of uninfected (U) and A. phagocytophilum-infected HL-60
cells (I) as well as host cell-free A. phagocytophilum populations consisting of RC and
DC organisms (RC + DC) or only DC organisms (DC) was screened with anti-APH_0032.
MBP-APH_0032 served as a positive control. The blot was stripped and screened with
anti-Msp2 (P44) to confirm that equivalent amounts of lysates derived from RC and DC
organisms and only DC organisms were used. The results are representative of two separate
experiments. (B) Densitometry to quantify the intensities of APH_0032 and Msp2 (P44)
bands. The ratio of the APH_0032 densitometric value to the Msp2 (P44) densitometric
value is shown for RC + DC and DC lysates for two separate experiments.
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5.2.3

APH_0032 is not detected until 24 h post infection and localizes to the AVM.

Next, we screened A. phagocytophilum-infected HL-60 cells with anti-APH_0032 in conjunction with a mAb against Msp2 (P44) (149, 176) and at 0.7, 8.5, and 24 h post infection
and examined the cells by confocal microscopy. At 0.7 h post infection, essentially no
APH_0032 was detected on Msp2 (P44)-positive organisms that were bound to the HL-60
cell surface (Figure 20A-D). By 8.5 h, some A. phagocytophilum organisms that were
positive for both Msp2 (P44) and APH_0032 were detectable (Figure 20E-H). At 24 h,
the AVM was strikingly distinguishable from enclosed bacteria by exclusive staining for
APH_0032 (Figure 20I-L). A. phagocytophilum organisms within inclusions that were positive for both Msp2 (P44) and APH_0032 appeared as green (corresponding to Msp2 [P44]
staining) spheroid organisms, each of which was surrounded by a red ring (corresponding
to APH_0032 staining; Figure 20J-L) or as yellow organisms. At 24 h, 56.6 ± 3.1% of
A. phagocytophilum inclusions were positive for APH_0032 (Figure 20L). The AVM was
negative for Msp2 (P44) at all time points.
5.2.4

APH_0032 localizes to the AVM during A. phagocytophilum infection of human
myeloid and endothelial cell lines and tick embryonic cell lines.

In addition to HL-60 cells, A. phagocytophilum infects and resides within host cell-derived
inclusion in the human monocytic cell line, THP-1, the human microvascular endothelial
cell line, HMEC-1, and the I. scapularis embryonic cell line, ISE6. To confirm whether
APH_0032 is expressed and localizes to the AVM within each of these cell lines, A. phagocytophilum-infected THP-1, HMEC-1, and ISE6 cells were examined by confocal microscopy
at 24 h post infection. APH_0032-positive inclusions were detected within each cell line
(Figure 20M-X). As observed for HL-60 cells, a notable number of ApVs were negative
for APH_0032 staining (Figure 20P, T, and X). Indeed, at 24 h post infection only 54% of
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Figure 20. A. phagocytophilum APH_0032 is detectable on the surfaces of intravacuolar bacteria and localizes to the AVM in infected host cells.
(A–L) HL-60 cells were synchronously infected with A. phagocytophilum. At 0.7 (A–D),
8.5 h (E–H), and 24 h post infection (I–L), the cells were fixed and viewed by confocal microscopy for immunoreactivity with antibodies against Msp2 (P44) (major bacterial surface
protein; used to denote bacteria in B, F, and J) and APH_0032 (C, G, and K). DIC images
are presented in panels A, E, and I. Merged fluorescent images are presented in D, H, and
L. (M–X) A. phagocytophilum-infected THP-1 (M–P), HMEC-1 (Q–T), and ISE6 (U–X)
cells were fixed and viewed by confocal microscopy for immunoreactivity with antibodies
against Msp2 (P44) (N, R, and V) and APH_0032 (O, S, and W). DIC images are presented
in panels M, Q, and U. Merged fluorescent images are presented in panels P, T, and X.
(L, P, T, and X) Arrows denote representative AVMs that exhibit exclusive staining for
APH_0032 surrounding Msp2 (P44)-positive or Msp2 (P44)- and APH_0032-dual-positive
intravacuolar bacteria. The results are representative of three separate experiments.
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Figure 20
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ApVs were positive for APH_0032 in THP-1 cells (data not shown).
5.2.5

APH_0032 is not amply expressed by A. phagocytophilum and does not localize
to the AVM until 24 h post infection of HL-60 cells.

We next monitored the temporal expression and AVM localization kinetics of APH_0032
over the course of a synchronous A. phagocytophilum infection of HL-60 cells. Host cell-free
organisms were added to HL-60 cells and allowed to bind for 40 min after which unbound
bacteria were removed. Our and other laboratories have shown that it takes approximately 4
h for bound A. phagocytophilum DC organisms to enter into nascent vacuoles (20, 28, 96).
APH_0032 is not detectable by Western blot analysis until 24 h post-bacterial addition,
which corresponds to ⇠20 h post entry (Figure 21A). At 48 h, the intensity of the APH_0032
130 kDa band is considerably stronger and additional less intense bands of higher and lower
apparent molecular weights are also detected. One of the lower molecular weight bands is
⇠66 kDa, which is in agreement with the predicted size for APH_0032. Consistent with
what we have shown previously (31), the intensity of the Msp2 (P44) band, which serves as
an infection control, increases throughout the course of infection. APH_0032 is detectable
on 9.8 ± 4.3% and 15.5 ± 2.0% of ApVs at 12 and 18 h, respectively (Figure 21B). By 24
h, the number of APH_0032-positive ApVs had increased to 56.6 ± 3.1%. The percentage
of APH_0032-positive ApVs fluctuated between 41.4 ± 16.2% and 61.1 ± 1.4% for the
remainder of the time course. The decrease in the percentage of APH_0032-positive ApVs
that occurs at 42 h is likely due to reinfection, which we have shown occurs by or shortly
after 36 h (199).
We utilized immunoelectron microscopy to screen synchronously infected HL-60 cells
over a 48 h period to further examine when APH_0032 is expressed and when it localizes to
the AVM during A. phagocytophilum infection. APH_0032-negative DC organisms were
bound to the HL-60 cell surface at 0.7 h (Figure 22A) and had internalized into nascent
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Figure 21. Kinetics of APH_0032 expression and AVM localization in A. phagocytophilum-infected HL-60 cells.
HL-60 cells were synchronously infected with A. phagocytophilum. At the indicated post
infection time points, aliquots were processed and analyzed by Western blot analysis (A) or
immunofluorescence microscopy (B). (A) Western blots of A. phagocytophilum-infected
HL-60 whole cell lysates were screened with antibodies against APH_0032, Msp2 (P44)
(infection control), and actin (loading control). (B) Percentages of ApVs [based on the
presence of Msp2 (P44)-positive A. phagocytophilum organisms] that are also positive
for APH_0032 exclusive staining of the AVM. Results are the mean (±SD) of 3 separate
experiments. 828–1471 Msp2 (P44)-positive inclusions were scored for APH_0032 staining
per time point.
94

Figure 22. Assessment of A. phagocytophilum APH_0032 expression and localization
to the AVM by immunoelectron microscopy.
HL-60 cells were synchronously infected with A. phagocytophilum. At 0.7 (A), 4 (B), 8
(C), 12 (D), 18 (E), 24 (F), and 48 h (G) post-bacterial addition, samples were fixed and
screened with anti-APH_0032 followed by goat anti-rabbit IgG conjugated to 6 nm gold
particles and examined by transmission electron microscopy. Representative results of two
separate experiments are shown. (A–B) Asterisks denote bound or newly internalized A.
phagocytophilum DC organisms. (F–H) Arrowheads denote representative portions of the
AVM that are labeled with gold particles. (H) Magnified view of the region in panel G that
is demarcated by a hatched box. Scale bars, 0.5 µm.
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Figure 22
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vacuoles by 4 h (Figure 22B). By 8 h, which corresponds to 4 h post entry, internalized
bacteria had transitioned into elongated, pleomorphic RC and initiated replication (Figure
22C). Consistent with our observations obtained using Western blot analysis and confocal
microscopy, A. phagocytophilum organisms exhibited little anti-APH_0032 reactivity and
the AVM was negative for APH_0032 at 8, 12, and 18 h (Figure 22C-E). APH_0032 was
not convincingly detected at the AVM of any inclusion through 18 h. At 24 h, individual
HL-60 cells contained numerous ApVs that harbored several APH_0032-positive A. phagocytophilum organisms; and the AVM was heavily decorated by APH_0032 (Figure 22F).
We have previously demonstrated that an A. phagocytophilum infection of HL-60 cells that
was synchronously initiated becomes asynchronous after 24 h due to reinfection by DC organisms (199). Figure 22G presents a representative example of an asynchronously infected
HL-60 cell at 48 h that harbors numerous ApVs differing in their maturities. Immature
inclusions are those that contain either an individual DC organism or those that contain few
RC organisms. A mature inclusion containing several DC organisms having rough outer
membranes is also present. APH_0032 heavily labels the AVM of the mature ApV, while
little to no APH_0032 is detected on the AVMs of less mature inclusions (Figure 22G and
H).
5.2.6

APH_0032 is expressed and localizes to the AVM during in vivo A. phagocytophilum infection and aph_0032 and aph_1387 are transcribed during A.
phagocytophilum residence in tick salivary glands.

APH_0032 is expressed and elicits a humoral immune response during HGA as MBPAPH_0032, but not MBP alone is recognized by antiserum from an HGA patient (Figure
23A). This is in agreement with our results obtained using another HGA patient’s antiserum
(data not shown) and with a report by Storey and colleagues (190). Seronegative normal
human serum recognizes neither MBP-APH_0032 nor MBP alone (data not shown). We
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Figure 23. A. phagocytophilum APH_0032 is expressed and modifies the AVM during
in vivo infection.
(A) Antiserum from an HGA patient recognizes MBP-APH_0032, but not MBP alone.
(B) RT-PCR utilizing primers targeting aph_1387 (1387), aph_0032 (0032), murine hprt
(loading control), and the A. phagocytophilum 16S rRNA gene (infection control) and total
RNA isolated from neutrophils recovered from A. phagocytophilum-infected mice on day
8 was performed in the presence (+RT) and absence (–RT) of reverse transcriptase. A.
phagocytophilum DNA and water served as positive and negative controls, respectively. (C–
F) Buffy coats isolated from an A. phagocytophilum-infected mouse on day 8 post infection
were fixed and viewed by confocal microscopy for immunoreactivity with antibodies against
Msp2 (P44) (D) and APH_0032 (E). DIC images are presented in panel C. A merged
fluorescent image is presented in F. The arrow denotes exclusive APH_0032 staining of
the AVM. (G) RT-PCR targeting aph_1387, aph_0032, msp2 (p44) (infection control),
and human actin (loading control) was performed on total RNA isolated from uninfected
(U) and A. phagocytophilum-infected (I) I. scapularis nymph salivary glands. Reactions
performed in the absence of reverse transcriptase (–) served as negative controls. The results
are representative of two to three separate experiments for each analysis.
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next investigated transcription of aph_0032 and aph_1387, which encodes another bacterial
AVM protein (87), during murine infection. Both transcripts are detected in total RNA
recovered from GR-1-positive neutrophils isolated from A. phagocytophilum-infected mice
on day 8 post infection (31) (Figure 23B). Moreover, Msp2 (P44)- and APH_0032-positive
inclusions are detectable by confocal microscopy in murine buffy coats obtained from A.
phagocytophilum-infected mice at 8 days post infection (Figure 23C-F). Consistent with
our observations of A. phagocytophilum-infected mammalian cell lines, multiple APH_0032negative inclusions are also present within murine buffy coat cells (Figure 23F). Because
APH_0032 (Figure 20) and APH_1387 (87) are expressed in ISE6 cells, we investigated
whether aph_0032 and aph_1387 are transcribed by A. phagocytophilum during its residence
in I. scapularis nymphal salivary glands. RT-PCR analysis revealed that both genes are
expressed in tick salivary glands (Figure 23G).

5.3

Discussion

We have confirmed APH_0032 as an A. phagocytophilum-derived protein that localizes to the
AVM during infection of human myeloid, human microvascular endothelial and I. scapularis
embryonic cell lines and murine neutrophils. A recent whole genome transcription profiling
study that demonstrated aph_0032 transcription in HL-60, HMEC-1, and ISE6 cells (137)
corroborates these results. aph_0032, along with aph_1387, is transcribed in I. scapularis
salivary glands. aph_0032 exhibits a high degree of nucleotide sequence conservation
among at least 4 geographically diverse A. phagocytophilum strains (190). APH_0032 may
exert a function that is unique to A. phagocytophilum, as it exhibits very little to no sequence
similarity to any other known protein. APH_0032 is expressed in high abundance beginning
⇠20 h post invasion and is retained on the AVM for the remainder of the infection. A
plausible speculation is that it may play an important role during late-stage infection of
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mammalian and tick host cells, such as preparing the ApV for eventual release of infectious
DC organisms, and is less likely important for preventing early host cell-mediated killing.
APH_0032 can serve as a marker for distinguishing more mature ApVs that contain DC
organisms and/or RC organisms that are transitioning to DC organisms (APH_0032-positive)
from less mature ApVs that contain RC organisms (APH_0032-negative). It is important to
note that not all AVMs are positive for APH_0032 at any given time point, which may be
directly related to the maturity of the ApVs. For instance, the majority of the APH_0032negative ApVs in Figure 20L are smaller and presumably contain fewer and less mature
organisms than those ApVs that are APH_0032-positive. Likewise, the AVM that is heavily
decorated by APH_0032 in Figure 22G encloses the most bacteria of any ApV in that
cell. The bacteria within that strongly APH_0032-positive vacuole display ruffled outer
membranes and are ⇠0.5 µm in diameter, both characteristics of which are consistent
with DC organisms and late-stage RC organisms (199). An alternative explanation is that
APH_0032 may be dispensable for A. phagocytophilum intracellular survival, perhaps
because it shares a redundant function with another Anaplasma AVM protein.
Acidic tandem repeat proteins are emerging as key effectors and AVM proteins of
Anaplasmataceae pathogens. A protein alignment of APH_0032 and the E. chaffeensis
tandem repeat protein P120 (ECH_0039 in the annotated E. chaffeensis genome) (215)
revealed that a short amino acid segment that occurs in each of the full-length tandem
repeats of APH_0032 (Figure 18C) shares sequence similarity to a segment that occurs 4
times in the tandem repeat region of P120 (190). E. chaffeensis P47 is another acidic (pI 4.2)
tandem repeat carrying protein that interacts with host molecules involved in cell signaling,
transcriptional regulation, and vesicle trafficking (119, 205, 218).
APH_0032 migrates predominantly as a 130 kDa band in SDS-polyacrylamide gels,
which is considerably larger than its predicted MW of 66.1 kDa. Others have proposed
that this phenomenon is due to APH_0032 being a glycoprotein (47). However, we find
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no evidence of glycosylation of APH_0032 (data not shown). The anomalous migration
of APH_0032 is likely due to its acidic nature, which conceivably prevents SDS from
amply coating the protein and thereby inhibits its proper electrophoretic mobility. This
phenomenon has been demonstrated for other acidic proteins in SDS-polyacrylamide gels,
including E. chaffeensis P47 (206). Indeed, Wakeel and colleagues showed that recombinant
forms of the full-length and C-terminal region of P47, both of which have overall acidic pIs,
but not the N-terminal region, which has a near neutral pI, exhibit slower than predicted
electrophoretic mobilities upon SDS-PAGE (206).
Even though APH_0032 is detected on the surfaces of intravacuolar A. phagocytophilum
organisms and is detected in great abundance at the AVM, it is not detected on bacteria that
were bound at the HL-60 cell surface by immunofluorescence microscopy. A similar trend
was observed for APH_1387 (87). Because these bacteria had been recovered following
disruption of infected HL-60 cells, washed with PBS, and added to naive HL-60 cells, we
propose that APH_0032 and APH_1387 are not integral membrane proteins, but are instead
loosely associated with the Anaplasma outer membrane while being secreted and are easily
washed away during bacterial isolation. APH_0032 is more abundantly detected in an A.
phagocytophilum lysate of RC and DC organisms as compared to a lysate derived from
only DC organisms. RC organisms are metabolically active and therefore actively express
APH_0032, while metabolically inert DC will presumably have less APH_0032 protein.
APH_0032 is the second confirmed AVM protein. APH_1387 is the first (87). Their
differential expression patterns during the course of infection suggest that they play distinct pathobiological roles. Elucidating the host cell ligands and/or signaling pathways
with which APH_0032 and APH_1387 interact and confirming the mechanism by which
they are delivered to the AVM, as well as identifying additional bacterial-derived AVM
proteins represent ongoing efforts in our laboratory. Achieving these goals will be critical to
understanding how A. phagocytophilum facilitates its intracellular survival.
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A. phagocytophilum proteins APH_1387 and APH_0032
are expressed on the cytoplasmic face of the AVM and are
critical for ApV development.
6.1

Introduction

A. phagocytophilum-encoded proteins actively modify the vacuole in which it resides. As a
result, the ApV becomes a unique compartment by which A. phagocytophilum can acquire
nutrients, replicate, and interact with multiple host vesicular pathways. The bacterial and
corresponding host cell factors that mediate the intracellular trafficking and fusogenicity
of the ApV are not fully understood. However, pathogen-derived proteins that localize to
the PVM likely contribute to the molecular mechanisms that underlie the establishment of
a protective niche. We identified the first two A. phagocytophilum-encoded proteins that
localize to the AVM, APH_1387 and APH_0032 (86, 87). APH_0032 presumably traverses
the AVM by means of its predicted N-terminal TMD. The region of the protein that is Cterminal to the TMD likely projects into the host cell cytoplasm since it is highly hydrophilic
and lacks additional TMDs or hydrophobic stretches that are of requisite length ( 20 aa)
to traverse the AVM (152). This is in agreement with a theme among bacterial-encoded
PVM proteins; the cytoplasmic domains interact with host cell signaling cascades and
vesicular traffic. In contrast, APH_1387 does not carry a traditional TMD, but it contains a
stretch of amino acids in the N-terminal non-repeat region that form a hydrophobic b -sheet
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and 3 additional bilobed hydrophobic domains that could conceivably facilitate insertion
into the AVM. In addition, APH_1387 carries predicted “surface exposed” regions that are
presumably exposed on the cytoplasmic face.
The functional roles of APH_1387 and APH_0032 remain largely unknown, in part
because both proteins exhibit limited to no homology with any previously described protein.
However, many bacterial effectors have been shown to mimic the activities of cellular
proteins without detectable amino acid sequence similarity (186). While targeted gene
deletion would be the most direct way to decipher their respective functions, the lack
of genetic techniques for knock-out, complementation or site directed mutagenesis of
Anaplasma requires the use of alternative and less direct approaches. In this chapter we
identify the regions of APH_1387 and APH_0032 that facilitate membrane association and
determine that the proteins are exposed on the cytoplasmic face of the AVM. In addition, we
demonstrate that ectopic expression of the GFP-tagged repeat regions of APH_1387 and
APH_0032 interfere with the intracellular development of A. phagocytophilum containing
vacuoles.

6.2
6.2.1

Results
GFP tagged APH_1387 and APH_0032 constructs used in this study.

In this study we generated a series of GFP-tagged APH_0032 and APH_1387 truncations
(Figure 24A and Figure 25A). To confirm expression and test the immunoreactivity of
anti-APH_0032 and anti-APH_1387 against selected fusion proteins, HeLa cells were
transfected, lysates were resolved by SDS-PAGE, and immunoblots were probed with
anti-APH_0032 or anti-APH_1387. Robust expression of full-length GFP-APH_0032, GFPAPH_0032D 313

620 ,

and GFP-APH_0032D 1

301

were detected with APH_0032 antisera

(Figure 24B). In contrast, APH_1387 antisera failed to recognize expression of the N103

Figure 24. Schematic representation of APH_0032 gene constructs used in this study.
(A) Diagram of APH_0032 deletion constructs N-terminally fused to GFP. Amino acids
144-162 represent the predicted transmembrane domain, denoted by the yellow bar.The
C-terminal region consists of 8 imperfect tandem direct repeats (denoted by grey arrows).
(B) HeLa cells transfected with plasmids encoding GFP fusions to full length APH_0032,
APH_0032D 313 620 , and APH_0032D 1 301 . Lysates were resolved by SDS-PAGE and the
immunoblot was probed with anti-APH_0032.

104

Figure 25. Schematic representation of APH_1387 gene constructs used in this study.
(A) Diagram of APH_1387 deletion constructs N-terminally fused to GFP. Amino acids
101-112 form a hydrophobic b -pleated sheet, indicated by the yellow bar. The C-terminal
repeat region consists of 3 tandem direct repeats (denoted by grey arrows) consisting of 93,
122, and 130 amino acids. (B) HeLa cells were transfected with plasmids encoding GFP
fusions to full length APH_1387, APH_1387D 181 579 , and APH_1387D 1 157 . Lysates were
resolved by SDS-PAGE and the immunoblot was probed with anti-APH_1387. (C) The blot
was stripped and screened with anti-GFP to confirm the expression of all fusion proteins in
HeLa cells. The results are representative of 3 separate experiments.
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terminal non-repeat portion of APH_1387, GFP-APH_1387D 181

579

(Figure 25B). Only

when the immunoblot was stripped and re-probed with an anti-GFP antibody was GFPAPH_1387D 181

579

detected, indicating it is the C-terminal repeat region of APH_1387 that

is immunoreactive (Figure 25C).
6.2.2 A. phagocytophilum AnkA, but not APH_0032 or APH_1387 can be heterologously secreted by the L. pneumophila Dot/Icm T4SS secretion system.
The presence of APH_0032 (86) and APH_1387 (87) at the AVM indicates that the proteins
are secreted. A. phagocytophilum encodes a VirB/D T4SS that is similar to that of A. tumefaciens (140). Indeed, a GFP-tagged version of the A. phagocytophilum T4SS effector, AnkA
(APH_0470), can be secreted by A. tumefaciens (111). To determine whether APH_0032
or APH_1387 are T4SS substrates, each was N-terminally fused to the enzymatic reporter,
Bordetella pertussis CyaA, and expressed in the surrogate host, L. pneumophila, which
utilizes its Dot/Icm secretory apparatus to export T4SS substrates (180). The ability of a
surrogate host that uses the Dot/Icm system to secrete VirB/D substrates has been previously
reported (46). THP-1 cells were infected with L. pneumophila transformants expressing
CyaA-fusions of APH_0032, APH_1387, A. phagocytophilum AnkA, RalF (L. pneumophila
Dot/Icm effector; positive control), or CyaA alone (negative control) and changes in host
cAMP levels were measured. Expression of each CyaA-tagged protein in infected THP-1
cells was confirmed by Western blot analysis (data not shown). As presented in Figure 26,
cAMP levels were substantially elevated relative to that in L. pneumophila expressing CyaA
alone (negative control) when cells were infected with bacteria producing CyaA-RalF or
CyaA-AnkA, but not CyaA-APH_0032 or CyaA-APH_1387. As anticipated, cAMP levels
were low for host cells infected with transformants of a L. pneumophila DotA mutant.
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Figure 26. A. phagocytophilum AnkA, but not APH_0032 or APH_1387 can be secreted by the Legionella pneumophila Dot/Icm secretion system.
PMA-stimulated THP-1 cells were infected with L. pneumophila transformants expressing
CyaA-tagged RalF, APH_0032, or N-terminally truncated APH_1387 (APH_1387-T), and
N-terminally truncated AnkA (AnkA-T). Black bars present the fold change in intracellular
[cAMP] for THP-1 cells infected with wild type L. pneumophila transformants expressing
CyaA-fusions relative to control cells infected with transformants expressing CyaA alone.
Grey bars correspond to the fold change in intracellular [cAMP] measured for THP-1 cells
infected with T4SS-defective L. pneumophila DotA– transformants. Results are representative of three independent experiments. Statistically significant (*P < 0.05; ***P < 0.001)
values are indicated.
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6.2.3

The N-terminal non-repeat regions of APH_0032 and APH_1387 possess domains that facilitate association with host cell membranes.

We identified the residues required for membrane localization of APH_0032 and APH_1387
by deletion analysis and use of a fluorescence-based technique. The TMPred algorithm
predicts a putative transmembrane domain for APH_0032 that spans amino acids 144162. To investigate the potential contribution of this region for membrane association, we
constructed GFP-tagged APH_0032 constructs (Figure 24A) and ectopically expressed them
in HeLa cells (Figure 27B). The cells were washed with PBS to confirm expression, which
does not permeabilize the cells so that transfected cells retained the GFP proteins. Duplicate
samples were digitonin permeabilized prior to fixation so that any GFP protein not associated
with host membranes was washed out. Digitonin is a cholesterol binding drug that targets
and perforates the plasma membrane. The selectivity is due to the plasma membrane having
the highest concentration of cholesterol, containing approximately 65-80% of free cellular
cholesterol (115). Following digitonin permeabilization, loss of intracellular GFP signal
from the cells indicated that the fusion protein was not membrane associated. By contrast,
GFP signals that were retained upon cell permeabilization indicated the fusion protein
was membrane bound. Retention was determined as the percentage of cells that remained
GFP-positive after digitonin permeabilization. Deletion of the C-terminal repeat region,
GFP-APH_0032D 313

620 ,

did not impact retention relative to full-length GFP-APH_0032.

In contrast, upon digitonin permeabilization, deletion of the N-terminal non-repeat region,
GFP-APH_0032D 1

301 ,

resulted in almost complete loss of GFP signal, indicating that

region of APH_0032 was not membrane associated (Figure 27A). Further analysis revealed
that in cells producing GFP-APH_0032D 1

162

or GFP-APH_0032D 143

620 ,

both of which

lack the putative transmembrane domain, there was a pronounced decrease in retention
compared to full-length GFP-APH_0032. However, retention was partially restored in
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Figure 27. Deletion analysis of APH_0032 reveals a N-terminal domain necessary for
host cell membrane association.
(A) HeLa cells were transiently transfected to ectopically express GFP alone, GFPAPH_0032 or GFP-APH_0032 deletion constructs. To confirm expression the cells were
washed with PBS, which does not permeabilize the host cell membrane so that the GFP
proteins were retained. Duplicate samples were digitonin permeabilized prior to fixation
so that any GFP proteins not specifically associated with host organelle membranes were
washed out. Retention was calculated as the percentage of cells that remained GFP-positive
after digitonin permeabilization and PBS washing. The data are representative of 3 separate
experiments. A schematic diagram of the APH_0032 protein sequence shows the different
deletion constructs with the predicted transmembrane domain indicated by the yellow bar.
The predicted N-terminal transmembrane domain was found to be critical for membrane
association of ectopically expressed APH_0032. (B) Representative images of HeLa cells
ectopically expressing GFP-APH_0032 constructs. DAPI stained host and bacterial are blue
and are present in all panels.
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Figure 27
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cells producing the transmembrane containing constructs, GFP-APH_0032D 1
APH_0032D 175

620 ,

134

and GFP-

indicating that region is necessary for the association of APH_0032

with host cell membranes (Figure 27A).
Although APH_1387 lacks a predicted transmembrane domain, it contains a stretch
of amino acids, 101-112, in the N-terminal non-repeat region that form a hydrophobic
b -pleated sheet and 3 bilobed hydrophobic domains that could conceivably facilitate insertion into the AVM. To investigate the potential contribution of either region to membrane
localization of APH_1387, GFP-tagged APH_1387 constructs (Figure 25A) were ectopically expressed in HeLa cells (Figure 28B) and washed with either PBS or permeabilized
with digitonin. Similar to APH_0032, deletion of the C-terminal repeat region, GFPAPH_1387D 181

579 , did not impact retention relative to full-length GFP-APH_1387 (Figure

28A). However, upon digitonin permeabilization, deletion of the N-terminal non-repeat region, GFP-APH_1387D 1

157 , resulted in almost complete loss of GFP protein (Figure 28A).

These results indicate the 3 bilobed hydrophobic domains are not critical for membrane
association. Further analysis to confirm the involvement of the hydrophobic b -pleated sheet
revealed that in cells producing GFP-APH_1387D 1

111

or GFP-APH_1387D 101

579 ,

both

of which lack the putative membrane associating domain, there was a pronounced decrease
in retention compared to full-length GFP-APH_1387. However, retention was partially
restored in cells producing GFP-APH_1387D 1

91

or GFP-APH_1387D 122

579 ,

indicating

that the hydrophobic b -pleated sheet domain is essential for the localization of APH_1387
to host cell membranes (Figure 28A).
6.2.4

APH_1387 and APH_0032 are exposed on the cytoplasmic face of the AVM.

Because vesicular trafficking is regulated by protein-protein interactions at the surface of
transport vesicles and their appropriate target membrane, we investigated whether APH_1387
and/or APH_0032 are exposed on the cytoplasmic face of the AVM. A. phagocytophilum
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Figure 28. Deletion analysis of APH_1387 identifies a N-terminal domain, residues
101-112, necessary for host cell membrane association.
(A) HeLa cells were transiently transfected to ectopically express GFP alone, GFPAPH_1387 or GFP-APH_1387 deletion constructs. To confirm expression the cells were
washed with PBS, which does not permeabilize the host cell membrane so that the GFPproteins were retained. Duplicate samples were digitonin permeabilized prior to fixation
so that any GFP proteins not specifically associated with host organelle membranes were
washed out. Retention was calculated as the percentage of cells that remained GFP-positive
after digitonin permeabilization and PBS washing. The data are representative of 3 separate
experiments. A schematic diagram of the APH_1387 protein sequence shows the different
deletion constructs with the stretch of amino acids that form a hydrophobic b -sheet denoted
by the yellow bar. The region containing amino acids 101-112 was found to be critical
for membrane association of ectopically expressed APH_1387. (B) Representative images
of HeLa cells ectopically expressing GFP-APH_1387 constructs. DAPI stained host and
bacterial nuclei are blue and are present in all panels.
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infected RF/6A cells were differentially permeabilized with digitonin and saponin to distinguish between proteins exposed to the cytoplasm and proteins enclosed within membrane
bound vacuoles or organelles. Digitonin perforates the plasma membrane and allows antibodies to diffuse into the host cell while organelle membranes remain intact (34). To determine
whether APH_1387 and/or APH_0032 are exposed to the host cell cytosol, anti-APH_1387
and anti-APH_0032 antibodies were introduced into A. phagocytophilum infected RF/6A
cells following digitonin permeabilization. Next, the cells were fixed and bound intracellular
antibodies were detected with an Alexa Fluor conjugated secondary antibody. The positive
APH_1387 and APH_0032 signals detected at the periphery of the ApV indicated that the
anti-APH_1387 and -APH_0032 antibodies recognized portions of their respective proteins
that were accessible in the host cell cytoplasm (Figure 29M-R). To confirm that digitonin
did not compromise the integrity of the AVM, an antibody against the A. phagocytophilum
major outer surface protein Msp2 (P44) was used. Msp2 (P44) is only expressed on bacterial
membranes and not the vacuolar membrane. The lack of staining with anti-Msp2 (P44) in
digitonin permeabilized cells demonstrated the AVM was intact (Figure 29J-L). To confirm
that the antibodies were immunoreactive with their appropriate targets, A. phagocytophilum
infected RF/6A cells were permeabilized with saponin, which permeabilizes all membranes,
and stained with each antibody. Consistent with previous studies (86, 87), vacuolar-enclosed
bacteria were positive for P44, APH_1387 and APH_0032, while the AVM was also positive for APH_1387 and APH_0032 (Figure 29A-I). Thus, positive staining after digitonin
permeabilization indicates APH_1387 and APH_0032 are present on the cytoplasmic face
of the AVM.
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Figure 29. APH_1387 and APH_0032 contain portions exposed on the cytoplasmic
face of the AVM.
A. phagocytophilum infected RF/6A cells were permeabilized with digitonin (J-R) or
saponin (A-I) as described in the Materials and Methods and viewed by confocal microscopy.
DAPI stained host and bacterial nuclei blue and was used to delineate A. phagocytophilum
inclusions. Merged fluorescent images are presented in panels C, F, I, L, O, and R. To
determine whether APH_1387 and APH_0032 are exposed on the cytoplasmic face of
the AVM, cells were permeabilized with digitonin (J-R) and subsequently incubated with
APH_1387 (N) or APH_0032 (Q) antibodies. Bound antibodies were detected with an
Alexa fluor 594 conjugated secondary antibody (red). In O and R, punctate staining around
the periphery of the ApV represent positive APH_1387 and APH_0032 detection. The
integrity of the AVM was confirmed after digitonin permeabilization by the lack of ApV
staining with the Msp2 (P44) antibody. To confirm that the antibodies were immunoreactive,
A. phagocytophilum infected RF/6A cells were fixed and permeabilized with saponin (A-I).
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6.2.5

Ectopic expression of GFP-tagged APH_1387 and APH_0032 interferes with
A. phagocytophilum development in RF/6A cells.

Because APH_1387 and APH_0032 are on the cytoplasmic face of the AVM, we assessed
the abilities of ectopically expressed proteins to competitively inhibit A. phagocytophilum
infection. We rationalized that if APH_1387 or APH_0032 established interactions with host
proteins critical for ApV development then ectopic expression of APH_1387 or APH_0032
might competitively inhibit infection. To test this, GFP fusions of APH_1387 or APH_0032
were transfected into RF/6A cells and then infected with A. phagocytophilum. Twenty
four h post infection, the number of ApVs and the ApV morphology were assessed by
confocal microscopy. Expression of GFP-APH_1387 led to an observable decrease in
ApV size relative to ApVs in untransfected cells or cells expressing GFP-APH_0032 or
GFP. These data were quantified by measuring the diameter of ApVs in transfected cells
(Figure 30). In cells expressing GFP-APH_1387, ApV diameters were 2.3 ± 0.9 µm
compared with 3.5 ± 1.2 µm and 4.3 ± 1.2 µm in cells expressing GFP-APH_0032 and
GFP alone, respectively. Next, we wanted to identify regions of APH_1387 that might be
important in facilitating the developmental block. To do this, we assessed ApV morphology
in A. phagocytophilum infected cells expressing amino- and carboxy-terminal deletions
of APH_1387. In cells expressing the C-terminal repeat region, GFP-APH_1387D 1

157 ,

the average ApV was 2.4 ± 1.1 µm, similar to what was observed in cells expressing
full-length GFP-APH_1387 (Figure 30). In contrast, when the N-terminal non-repeat region
of APH_1387 was expressed, GFP-APH_1387D 181

579 ,

the average ApV size was 4.2 ±

1.4 µm, similar to that observed in GFP expressing cells, indicating ApV development
was not blocked. These results suggest that the C-terminal repeat region of APH_1387
is interacting with host proteins and consequently interfering with A. phagocytophilum
infection. It should be noted that although ectopic expression of vacuolar membrane proteins
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Figure 30. Ectopically expressed GFP-APH_1387 interferes with ApV development
at 24 h post infection.
RF/6A cells transiently expressing the indicated APH_0032 or APH_1387 constructs Nterminally fused to GFP were infected with A. phagocytophilum. At 24 h post infection cells
were fixed and the ApVs from transfected cells were measured. A schematic representation
of the APH_1387 and APH_0032 protein sequences illustrate the different truncation
constructs. The C-terminal region of APH_1387 was found to be involved in the ApV
developmental block. NR: non-repeat region; TR: tandem repeat region.
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from other pathogens have been shown to localize to the PVM, we were unable to detect
GFP-APH_1387 or GFP-APH_0032 at the AVM in A. phagocytophilum infected RF-6A
cells (138).
Because APH_0032 is not expressed in high abundance until 24 h post infection, we speculated that a block in A. phagocytophilum development would not be detectable until time
points beyond 24 h. To investigate this, we infected RF/6A cells with A. phagocytophilum for
24 h, then transfected the cells. At forty-eight h post infection the resulting effects on infection and ApV morphology were examined by confocal microscopy (Figure 31B-H). Similar
to the results observed at 24 h post infection, cells expressing GFP-APH_1387 yielded
atypical ApVs that were smaller than those in GFP expressing cells (Figure 31A-E). In cells
expressing GFP-APH_1387 the average ApV was 1.9 ± 0.7 µm, compared with 4.0 ± 1.4
µm in cells expressing GFP (Figure 31A-C). Furthermore, the developmental block was
only seen in cells expressing full-length APH_1387 or the C-terminal repeat region. Notably,
at 48 h post infection the ApVs in GFP-APH_0032 expressing cells were also significantly
smaller in size, with the average ApV 1.9 ± 0.5 µm (Figure 31A and F-H). To identify the
region of APH_0032 responsible for the atypical ApV morphology we used GFP-fusions
expressing the N-terminal non-repeat and C-terminal repeat regions of APH_0032. In cell
expressing the APH_0032 repeat region, GFP-APH_0032D 1

301 ,

the ApVs were 2.1 ± 0.6

µm (Figure 31A and G). In contrast, the atypical ApV phenotype was less pronounced
in cells expressing the APH_0032 non-repeat region, GFP-APH_0032D 313

620 ,

with the

average ApV 2.7 ± 0.9 µm (Figure 31A and H). Therefore, the C-terminal repeat regions
of APH_1387 and APH_0032 are important for competitively inhibiting A. phagocytophilum
infection.
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Figure 31. Ectopically expressed GFP-APH_1387 and GFP-APH_0032 competitively
inhibit ApV development at 48 h post infection.
RF/6A cells were infected with A. phagocytophilum. At 24 h post infection, cells were
transiently transfected to express the indicated APH_0032 or APH_1387 constructs Nterminally fused to GFP. At 48 h post infection the cells were fixed, stained with antibodies
against Msp2 (P44) (major A. phagocytophilum outer membrane protein) to identify bacteria,
and viewed by confocal microscopy. (A) To assess the block in ApV development, the
ApV in transfected cells was measured. A schematic representation of the APH_1387 and
APH_0032 protein sequences illustrate the different truncation constructs. The C-terminal
regions of APH_1387 and APH_0032 were found to be involved in the ApV developmental
block at 48 h post infection. (B-H) Representative confocal micrographs depicting transiently transfected RF/6A cells infected with A. phagocytophilum. A. phagocytophilum
organisms were delineated by staining with Msp2 (P44), which recognizes the A. phagocytophilum surface protein. NR: non-repeat region; TR: tandem repeat region. The scale bar
represents 4 µm.
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6.3

Discussion

To date, three A. phagocytophilum AVM proteins, APH_1387, APH_0032 and AptA (A.
phagocytophilum toxin A), have been identified (86, 87, 192). The study of these proteins
is hindered by the overall lack of sequence identity with proteins of known function. In
addition, the obligate intracellular nature of Anaplasma limits the ability to perform targeted
gene deletion or site directed mutagenesis for functional analyses. In this study, we extend
our understanding of APH_1387 and APH_0032 to show they are present on the cytoplasmic
face of the AVM and contribute to the proper maturation of the ApV. Similar approaches
have been used to investigate secreted vacuolar membrane proteins by other pathogens
(15, 42, 166).
Upon translocation from the bacteria, APH_1387 and APH_0032 localize to the AVM.
It is unlikely that APH_0032 and APH_1387 are T4SS substrates. Indeed, the C-termini
of both proteins are negatively charged, which is in conflict with T4SS substrates having
positively charged C-termini (201). Also, most intravacuolar A. phagocytophilum organisms
are not intimately associated with the inner face of the AVM, which goes against the fact
that type IV secretion is contact dependent (7, 201). Lastly, the L. pneumophila Dot/Icm
system failed to translocate CyaA-tagged versions of APH_0032 and APH_1387. One could
argue that this is attributable to the Dot/Icm system being unable to secrete heterologous
VirB/D effectors. However, Dot/Icm-mediated delivery of other VirB/D substrates has been
reported (46). Moreover, L. pneumophila could translocate CyaA-AnkA, which is the first
demonstration that the Dot/Icm system can secrete a heterologous A. phagocytophilum
VirB/D effector. These results warrant cautiously accepting the hypothesis that APH_0032
and APH_1387 are not T4SS effectors.
We speculate that A. phagocytophilum delivers APH_0032 and APH_1387 to the intravacuolar space via type I, or ATP-binding cassette-dependent secretion and that the
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substrates subsequently localize to the AVM. T1SSs recognize a C-terminal uncleaved
secretion signal that is rich in certain amino acids (LDAVTSIF) and poor in others (KHPMWC) (48). 72.7% of the APH_0032 C-terminal amino acids (APSTGVEIRFMDRDS
DDDVLAL) are found in type I secretion signals. 71.4% of the APH_1387 C-terminal
amino acids (LVDVPTALPLKDPDDEDVLSY) are found in type I secretion signals. T1SS
effectors are acidic (pI ⇠4) and contain very few or no cysteines (48). Only 5 of the 619
and 4 of the 578 amino acids that compose APH_0032 and APH_1387, respectively, are
cysteines. Accordingly, we propose that APH_0032 and APH_1387 are delivered to the
intravacuolar space via type I secretion and subsequently localize to/integrate into the AVM.
We identified the regions of APH_1387 and APH_0032 necessary for host cell membrane
association. GFP-tagged APH_0032 deletion constructs revealed that APH_0032 requires a
N-terminal TMPred predicted transmembrane domain for associating with host cell membranes. GFP-APH_0032 fusion proteins that lacked the transmembrane domain were poorly
retained following digitonin permeabilization, indicating they were not specifically interacting with the host cell membrane. Moreover, in non permeabilized cells, the same constructs
exhibited a diffuse cytoplasmic distribution similar to that observed for GFP alone. However,
amino acids flanking the transmembrane domain are likely important for host membrane
association since retention was only partially restored when GFP-APH_0032D 1
GFP-APH_0032D 175

620

134

and

were expressed. It is possible that other A. phagocytophilum pro-

teins are involved in APH_0032 insertion into the membrane. Alternatively, APH_0032 may
require additional amino acids flanking the transmembrane domain for proper membrane association. APH_1387 does not have a predicted transmembrane domain. However, analysis
of GFP-APH_1387 deletion constructs identified a stretch of amino acids in the N-terminal
region that encode a hydrophobic beta pleated sheet necessary for membrane association.
Similar to APH_1387 and APH_0032, it has been reported that AptA also requires an
N-terminal domain for subcellular localization (139). As such, all A. phagocytophilum
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AVM proteins identified to date require discrete hydrophobic N-terminal domains for host
cell membrane association. Continued identification of AVM proteins may help to reveal
common secondary structures or primary sequence identity that will aid in the identification
of additional candidate A. phagocytophilum vacuolar membrane proteins. This approach has
been used to identify a unique bilobed hydrophobic secondary structural for chlamydial Inc
proteins and the subsequent identification of over 40 Inc orthologs (14, 167).
The topology of a vacuolar membrane protein dictates its accessibility to interacting
partners and provides functional clues. The results from the differential permeabilization
studies with digitonin and saponin indicate that APH_1387 and APH_0032 are present on
the cytoplasmic face of the AVM. Cells permeabilized with digitonin and incubated with
anti-APH_1387 or anti-APH_0032 antibodies specifically labeled the periphery of the AVM,
but did not label intravacuolar bacteria. For APH_1387 we hypothesize the C-terminal
domain is projected into the host cell cytosol. Support for this premise is the immunoblots
of lysates from HeLa cells expressing GFP fusions to full-length, non-repeat and tandem
repeat regions of APH_1387. When the immunoblot was probed with an antibody against
APH_1387 only the full length and C-terminal tandem repeat region were detectable (Figure
25B). However, when the blot was stripped and re-probed with an antibody against GFP
a prominent band was detected for all three constructs, including the non-repeat region of
APH_1387 (Figure 25C). This indicates the antibody against APH_1387 is immunoreactive
against the C-terminal portion of the protein. Thus, positive detection of APH_1387 on the
AVM suggests the C-terminal portion is exposed to the host cytosol. It has been shown that
the C-terminal portions of inclusion membrane proteins from C. trachomatis and C. psittaci
are exposed to the host cytosol, presumably to allow interaction with host cytoplasmic
proteins (42, 166). Specifically the C-terminal of the C. pneumoniae Inc protein, Cpn0585,
faces the cytosol and interacts with multiple Rab GTPases (42).
Vesicular trafficking is mediated by protein-protein interaction at the surfaces of transport
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vesicles and target membranes. The presence of APH_1387 and APH_0032 on the cytoplasmic face of the AVM makes them likely candidates for interacting with host proteins. Here,
we expressed GFP fusion of APH_1387 and APH_0032 in A. phagocytophilum infected
RF/6A cells and examined the resulting phenotypes by confocal microscopy. There was no
observable reduction in the number of ApVs when the cells were transfected prior to infection, suggesting that neither APH_1387 nor APH_0032 are essential for A. phagocytophilum
replication. However, we found that ectopic expression of APH_1387 competitively inhibits
proper A. phagocytophilum development and yields atypical ApVs at 24 h. Similar experiments have shown that ectopic expression of the C. pneumoniae Inc protein Cpn0585 results
in atypical inclusions that are smaller in size and contain larger reticulate bodies (RBs),
the metabolically active chlamydial form (42). The exact mechanism for the chlamydial
developmental block is unknown. Cpn0585 recruits multiple Rabs – Rab1, Rab10 and
Rab11 – to the C. pneumoniae inclusion (42); therefore, it is possible that overexpression
of GFP-Cpn0585 may compete with endogenous Cpn0585 for Rabs and consequently disrupt development. Indeed, since APH_1387 is expressed early in infection (87), ectopic
expression of GFP-APH_1387 may also compete with endogenous APH_1387 for a specific
host protein that is important for ApV maturation. As a result, by 24 h A. phagocytophilum
development is blocked and atypical ApVs are formed. On the other hand, APH_0032
is not expressed in high abundance until 24 h post infection. The expression kinetics is
consistent with the detection of atypical ApVs at 48 h post infection in cells expressing
GFP-APH_0032, and explains why the ApVs appeared normal at 24 h. Further analyses
revealed the C-terminal repeat regions of APH_1387 and APH_0032 are responsible for the
aberrant development of ApVs. The mechanism by which ectopic expression of APH_1387
and APH_0032 blocks A. phagocytophilum development is unclear. We hypothesize that the
transfected fusion protein acts as a competitive inhibitor for host proteins that are important
for A. phagocytophilum development. Therefore, future studies to identify the interacting
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partners of APH_1387 and APH_0032 will be critical to understanding their functional roles
in ApV intracellular development and survival.
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Monoubiquitinated proteins decorate the A.
phagocytophilum-occupied vacuolar membrane (AVM)
7.1

Introduction

Post-translational modification by ubiquitin is a highly conserved eukaryotic cell-specific
process. Ubiquitin is a 76 amino acid protein that is covalently attached to lysine residues of
target proteins. Attachment of ubiquitin to a protein substrate occurs in three successive steps
that are mediated by the activating enzyme E1, the conjugating enzyme E2, and the ubiquitin
ligase E3. Protein modification by ubiquitin can be classified as poly- or monoubiquitination
(62, 155). Polyubiquitination occurs when a chain of four or more covalently linked
ubiquitin moieties is added to a single lysine of a target protein. In monoubiquitination, a
single ubiquitin molecule is conjugated to one or several (multi-monoubiquitination) lysines
(79, 116). Poly- and monoubiquitination differentially dictate the localization and/or activity
of the modified protein. Polyubiquitination has long been known to destine proteins for 26S
proteasome-mediated destruction, but can also direct proteins to lysosomes for degradation,
activate protein kinases, and contribute to DNA repair (36, 197). Monoubiquitination does
not target proteins for degradation, but rather occurs after ligand binding to a variety of
cell surface receptors and can act as an internalization signal, thereby directing plasma
membrane-associated proteins to endosomes (40, 84, 151). Monoubiquitination of the
peroxisome membrane targets the organelle for autophagosome-mediated destruction (101).
Additionally, monoubiquitination is involved in transcriptional regulation and DNA repair
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(84, 117). Lastly, ubiquitination of a variety of human pathogens in the host cell cytosol
targets them to autophagosomes (37, 40). While this process is emerging as an infection
control against intracellular pathogens, evidence also hints that intracellular bacteria can
subvert it, as S. Typhimurium, after being mono- and polyubiquitinated in the cytosol,
survives to occupy a damaged membranous compartment (19).
Given the importance of ubiquitination in modulating numerous eukaryotic cell processes, it is not surprising that many vacuole-adapted pathogens have evolved mechanisms
to exploit the ubiquitin conjugation pathway. For example, the L. pneumophila-containing
vacuole (LCV) recruits polyubiquitinated proteins by virtue of the actions of translocated
bacterial effector proteins (51, 106, 154). S. Typhimurium manipulates the ubiquitin pathway to ensure proper trafficking of its effector, SopB to the SCV (104, 151). Given that
A. phagocytophilum hijacks an array of intracellular trafficking pathways, we set out to
test the hypothesis that the ApV co-opts ubiquitin. In this chapter, we demonstrate that
ubiquitinated proteins accumulate on the AVM during infection of mammalian myeloid
and endothelial cells and, to a lesser extent, tick cells. The AVM becomes ubiquitinated
early following entry of HL-60 cells and continues to do so throughout infection. Notably,
the AVM is decorated by mono-, not polyubiquitinated proteins in an A. phagocytophilum
protein synthesis-dependent manner. Collectively, these data identify a novel means by
which the AVM is remodeled during the course of infection and provide the first evidence of
a Rickettsiales pathogen co-opting ubiquitin during intracellular residence. Monoubiquitinating the AVM is presumably part of the multifaceted approach by which A. phagocytophilum
ensures its survival within eukaryotic host cells.
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7.2
7.2.1

Results
Ubiquitinated proteins accumulate on the AVM.

To assess whether ubiquitinated proteins decorate the AVM, we screened A. phagocytophilum
infected HL-60 cells with mAb FK2, which recognizes mono- and polyubiquitinated conjugates (61), in conjunction with antisera against APH_1387 or APH_0032, both of which are
A. phagocytophilum effectors that are associated with the bacterial surface and localize to the
AVM (86, 87). The cells were visualized by confocal microscopy. Anti-APH_1387 (Figure
32B and H) and anti-APH_0032 (Figure 32E) detected A. phagocytophilum organisms
within the ApV and the target antigens on the AVM. FK2 staining exhibited punctate distribution throughout infected and uninfected control cells (Figure 32A, D and J). FK2 also
yielded intense ring-like staining patterns that surrounded intravacuolar A. phagocytophilum
bacteria and colocalized with APH_1387 or APH_0032 signal on the AVM (Figure 32C
and F). FK2 labeled the AVMs of 51.0 ± 2.0% ApVs in infected HL-60 cells (Figure 33G).
In addition to human promyelocytic HL-60 cells, A. phagocytophilum also infects and
resides in ApVs in the monkey choroidal endothelial cell line RF/6A and the I. scapularis
embryonic cell line ISE6 (82, 132, 133). To determine if the AVM is ubiquitinated in
each of these cell lines, A. phagocytophilum infected RF/6A and ISE6 cells were screened
with FK2 in conjunction with antibody against Msp2 (P44), which is the most abundant A.
phagocytophilum surface protein (163), and examined by confocal microscopy. Comparable
to observations of infected HL-60 cells, 61.0 ± 6.2% AVMs in RF/6A cells were FK2positive (Figure 33A-C and G). Notably fewer AVMs exhibited detectable ubiquitination
in ISE6 cells, as only 13.8 ± 0.4% were FK2-positive (Figure 33D-G).
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Figure 32. Monoubiquitinated proteins decorate the AVM in HL-60 cells.
A. phagocytophilum infected (A–I) or uninfected (J–K) HL-60 cells were fixed, screened
with mAb FK2 (A, D, and J), which recognizes poly- and monoubiquitinated proteins, or
mAb FK1 (G and K), which recognizes only polyubiquitinated conjugates, in conjunction
with antisera against A. phagocytophilum-derived APH_1387 (B and H) or APH_0032
(E), both of which present at the bacterial surface and on the AVM. Merged fluorescent
images are shown in panels C, F, and I. DAPI stained host and bacterial nuclei are blue
and are present in all panels. In panel C, an arrow denotes intense FK2 staining that
surrounds intravacuolar A. phagocytophilum organisms. In panels C and F, arrowheads
denote examples of colocalization of FK2 and APH_1387 (C) or APH_0032 (F) signals at
the AVM. Images are representative of at least three separate experiments.
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Figure 33. Ubiquitinated proteins localize to the AVM in infected host cells.
(A–F) A. phagocytophilum infected RF/6A (A–C) or ISE6 cells (D–F) were fixed and
viewed by confocal microscopy to determine immunoreactivity with antibodies against
Msp2 (P44) (A and D) and FK2 (B and E). Merged fluorescent images are shown in panels
C and F. The insets demarcated by a solid box in the lower right corners of panels A, B, and
C are magnified versions of the regions in the respective panels denoted by hatched boxes,
each of which demarcate an AVM that is intensely labeled with FK2 and that surrounds
Msp2 (P44)-positive bacteria. DAPI stained host and bacterial nuclei are blue and are
present in all panels. (G) Percentages of FK2-positive ApVs [based on the presence of Msp2
(P44)-positive A. phagocytophilum bacteria] in infected HL-60, RF/6A, and ISE6 cells.
Results are the means (±SD) for two or three separate experiments in which a minimum of
700 bacterial inclusions was examined.
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7.2.2

The AVM accumulates ubiquitinated proteins over the course of A. phagocytophilum infection in HL-60 cells.

After binding to the HL-60 cell surface, most A. phagocytophilum organisms enter to reside
in ApVs within 4 h (20, 28, 96), after which they replicate by binary fission for approximately
24 h and subsequently exit the host cell (199). Reinfection occurs between 24 and 36 h
following a synchronous infection (199). To assess the temporal association of ubiquitinated
conjugates with the AVM over the course of infection, A. phagocytophilum organisms were
added to HL-60 cells and allowed to bind for 40 min followed by the removal of unbound
bacteria. At various post infection time points over a 48 h period, aliquots were screened
with FK2 and anti-Msp2 (P44) and examined by confocal microscopy (Figure 34). At 4
and 6 h, a time period during which nascent ApVs form, ubiquitin association with 22.1 ±
0.8% and 27.1 ± 0.4% AVMs was detected as aggregative and/or punctate staining patterns
surrounding intravacuolar A. phagocytophilum organisms (Figure 34A-F and Figure 35).
AVM ubiquitination consistently increased over the next 12 h, as 35.2 ± 6.7%, 41.3 ± 5.7%,
and 52.6 ± 4.2% exhibited FK2 staining at 8, 12, and 18 h (Figure 35). The aggregative FK2
staining pattern on most of the AVMs continually increased over infection (Figure 34). By
and after 12 h, many AVMs were decorated such that a ring-like staining pattern surrounding
the bacteria resulted (Figure 34J-d). By 24 h, AVM ubiquitination began to decline, as
46.2 ± 5.0% and 38.9 ± 10.1% of AVMs were FK2 positive at 24 and 30 h (Figure 35).
Beginning at 36 h, the percentages of ubiquitinated AVMs began to increase once again. At
30 and 36 h, in addition to large ApVs full of A. phagocytophilum bacteria, many HL-60
cells also harbored small ApVs that contained one to a few organisms (Figure 34S-X). The
small ApVs exhibited punctate FK2 staining reminiscent of the staining patterns observed at
4 and 6 h (Figure 34A-F), thereby indicating that reinfection had occurred between 24 h
and 36 h and that the infection had become asynchronous.
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Figure 34. Ubiquitinated proteins are detectable on the AVM following A. phagocytophilum entry into nascent vacuoles and continue to accumulate on the AVM throughout infection.
HL-60 cells were synchronously infected with A. phagocytophilum. At 4 h (A-C), 6 h (D-F),
8 h (G-I), 12 h (J-L), 18 h (M-O), 24 h (P-R), 30 h (S-U), 36 h (V-X), 42 h (Y-a) and 48
h (b-d) post infection, the cells were stained with antibodies against Msp2 (P44) (A, D,
G, J, M, P, S, V, Y, and b) and FK2 (B, E, H, K, N, Q, T, W, Z, and c) and viewed by
confocal microscopy. Merged fluorescent images are presented in panels C, F, I, L, O, R,
U, X, a and d. DAPI stained host and bacterial nuclei are blue and are present in all panels.
In panels C and F, arrows indicate portions of AVMs that exhibit intense punctate and/or
ring-like FK2 staining surrounding intravacuolar A. phagocytophilum bacteria. The images
are representative of results from three separate experiments.
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Figure 34
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Figure 34
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Figure 35. Percentages of AVMs exhibiting ubiquitinated protein association over the
course of A. phagocytophilum infection of HL-60 cells.
ApVs, as demarcated by anti-Msp2 (P44) staining of intravacuolar bacteria, were scored
for FK2 staining of the AVM. The number of FK2-positive ApVs was divided by the total
number of ApVs, which was multiplied by 100 to determine the percentage of FK2-positive
ApVs. Data are the mean percentages (±SD) of ApVs exhibiting FK2 staining and are
derived from three separate experiments. A minimum of 600 ApVs was examined per time
point per experiment.
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7.2.3

The AVM is monoubiquitinated.

Because mono- and polyubiquitination differentially dictate the subcellular trafficking of
downstream processes in which protein substrates participate (36, 50, 156), we next determined whether mono- or polyubiquitinated proteins accumulate on the AVM. Accordingly,
we stained A. phagocytophilum infected HL-60 cells with mAb FK1, which detects only
polyubiquitinated proteins and does not detect monoubiquitinated substrates or free ubiquitin
(61) in conjunction with anti-APH_1387 and examined the cells using confocal microscopy.
By comparing the staining patterns obtained with FK1 and FK2, we can infer whether the
AVM is mono- or polyubiquitinated (41, 80, 93). AVM staining by both FK2 and FK1
would indicate that the AVM is polyubiquitinated or poly- and monoubiquitinated, whereas
staining with FK2 but not FK1 would suggest that the AVM is only monoubiquitinated. FK1
staining yielded punctate patterns throughout infected and uninfected control cells (Figure
32G and K) similar to those obtained using FK2 (Figure 32A, D and J). However, in
contrast to that observed for FK2, neither an intense ring-like nor an aggregate FK1 staining
pattern surrounding APH_1387- or APH_0032-positive A. phagocytophilum organisms was
observed (Figure 32I and data not shown). Moreover, FK1 staining did not colocalize
with AVM-associated APH_1387 or APH_0032 signal. Similar results were obtained for A.
phagocytophilum infected RF/6A cells (data not shown).
7.2.4

de novo bacterial protein synthesis is important for continued association of
ubiquitinated proteins at the AVM.

Because tetracycline treatment of A. phagocytophilum infected host cells results in dissociation of Rab GTPases from the AVM and delivery of the bacterium to lysosomes (70, 85), we
rationalized that bacterial protein synthesis is critical for the AVM to accumulate ubiquitinated conjugates. To test our hypothesis, we treated A. phagocytophilum infected HL-60
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cells with tetracycline or vehicle control for 1 h. The cells were screened with anti-Msp2
(P44) and FK2 and analyzed by confocal microscopy. Whereas 39.9 ± 9.4% of AVMs in
control cells were FK2-positive, tetracycline treated cells exhibited a significant reduction
in ubiquitination, as only 16.0 ± 3.7% of AVMs were stained with FK2 (Figure 36). This
effect was reversible, as removed of the antibiotic restored AVM ubiquitination by 4 h.
Thus, de novo bacterial protein synthesis is requisite for maintaining the association of
ubiquitinated proteins with the AVM.

7.3

Discussion

These data demonstrate that A. phagocytophilum co-opts monoubiquitin conjugation machinery in a bacterial protein synthesis-dependent manner. Monoubiquitination of the AVM
is important early during A. phagocytophilum development, as monoubiquitinated proteins
rapidly associate with the ApV upon bacterial entry to produce a sparse punctate distribution
pattern on the membranes of nascent ApVs. Monoubiquitination of the AVM is coincident
with bacterial replication, as monoubiquitinated proteins continually accumulate on the
AVM until 24 h, a time point at which we have documented that A. phagocytophilum begins
to transition from the replicative and metabolically active RC form to the infectious DC
cell form (199). Beginning at 24 h, the percentages of ubiquitin-positive AVMs declines
until the second round of infection is initiated. Overall, our results hint at the importance
of monoubiquitination of AVM associated proteins throughout the A. phagocytophilum
infection cycle in promyelocytic HL-60 cells as well as endothelial cells, since a comparable
degree of ubiquitination of the AVM was observed for infected RF/6A cells. Considerably
fewer ApVs of infected ISE6 cells exhibited ubiquitination than infected mammalian cells.
Either AVM ubiquitination does not play a prominent role in A. phagocytophilum infection
of ISE6 cells or association of ubiquitinated proteins with the AVM may be temporally
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Figure 36. Ubiquitin association with the AVM is dependent on bacterial protein synthesis.
An A. phagocytophilum infected HL-60 cell culture was split into two cultures, one of
which was incubated with tetracycline (+Tet) and the other was incubated with vehicle
control (ethanol; -Tet) for 1 h (Treatment). Drug- and control-treated cells were washed with
PBS and returned to cultivation conditions for 1 or 4 h (Post-treatment). At the indicated
time point, the cells were fixed, screened with FK2 and anti-Msp2 (P44), and examined
by confocal microscopy. ApVs were scored as being FK2-positive if an intense ring-like
FK2 staining pattern was observed surrounding Msp2 (P44)-positive A. phagocytophilum
organisms. Results are the mean (±SD) of at least two experiments in which at least 1,000
ApVs were examined per condition. Statistically significant (**P<0.01) values are indicated.
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regulated during infection of ISE6 cells.
By accruing monoubiquitinated proteins that localize and direct traffic to endocytic
compartments, A. phagocytophilum conceivably camouflages its vacuolar membrane as
a means for avoiding lysosomal targeting. Support for this possibility comes from the
precedent that the ApV selectively recruits Rab GTPases that are predominantly associated
with recycling endosomes while concomitantly blocking recruitment of Rabs that are
important for lysosomal delivery. Tetracycline treatment of infected cells culminates in the
dissociation of recycling endosome-associated Rabs with the concomitant association of
the lysosomal markers Rab7 and LAMP-1 (85). Confocal microscopic analysis of fixed
cells reveals that no more than 52.6 ± 4.2% or 61.0 ± 6.2% ApVs in HL-60 cells or
RF/6A cells, respectively, are positive for ubiquitin at any time point examined. A highly
similar trend occurs when one examines the percentages of ApVs to which GFP-tagged
recycling endosome-associated Rab GTPases localize (85). Ubiquitin machinery, like Rab
GTPases, dynamically cycles on and off target organelle membranes (74, 177). Thus,
examining fixed A. phagocytophilum infected cells provides a snapshot of the AVMs that
are monoubiquitinated or have associated Rab GTPases at the instant at which preservative
was added.
Several bacterial effectors have been shown to exploit the host cell’s ubiquitination
system to diversify or regulate their biological functions. Several effectors secreted by
intracellular bacterial pathogens mimic the activities of E3 ubiquitin ligases to spatially or
temporally regulate host or bacterial proteins (105, 106). Alternatively, the ubiquitination of
other bacterial effectors regulates their activities and subcellular localization rather than serve
as a signal for their proteasomal degradation (104, 122, 151). As AVM monoubiquitination
is bacterial protein synthesis-dependent, it is plausible that A. phagocytophilum encodes one
or more effectors that either may recruit monoubiquitinated host proteins to the AVM or
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may be monoubiquitinated themselves.
To date, only three A. phagocytophilum-encoded AVM proteins – APH_1387, APH_0032
and AptA – have been identified (86, 87, 192). Whether any of these proteins are involved
in recruiting ubiquitinated proteins to the AVM or are ubiquitinated themselves remains
to be determined. A. phagocytophilum may encodes effectors that mimic the activities of
endogenous ubiquitin enzymes. A challenge to elucidating whether A. phagocytophilum
proteins are involved in monoubiquitinating the AVM is that, while some bacterial effectors
share primary amino acid sequence similarity with their eukaryotic counterparts, many have
evolved to functionally mimic the biochemical activities of eukaryotic proteins without
obvious sequence or structural homology. For instance, members of a family of type III
secretion system effector proteins functionally mimic eukaryotic HECT E3 ligase activity,
but lack structural similarity to known eukaryotic or bacterial E3 ligases (181, 220).
Rickettsia conorii internalization into host cells correlates with host cell-mediated ubiquitination of the rickettsial receptor, Ku70 (125). This chapter marks the first example of a
Rickettsiales member that co-opts ubiquitin during its residence within host cells. Thus, rickettsial pathogens diversely exploit ubiquitin machinery to promote infection and presumably
to facilitate intracellular survival. This chapter also adds to the growing body of evidence that
intercepting ubiquitination pathways is a common theme among vacuole-adapted bacterial
pathogens.
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Conclusions
A distinguishing feature of A. phagocytophilum is its unusual capacity to establish a protective niche in the hostile environment of the neutrophil. It replicates within a host cell
derived vacuole that successfully avoids fusion with lysosomes and subverts antimicrobial
defenses. Because A. phagocytophilum protein synthesis is requisite for the establishment
of a protective niche, we focused on the characterization of host and bacterial factors that
localize to the AVM. Based on previous work and the work presented here, it is clear that A.
phagocytophilum has evolved the ability to exploit a broad repertoire of host processes and
pathways to facilitate its survival (Figure 37).
Given the role of Rab GTPases in directing vesicular trafficking, it is not surprising that
A. phagocytophilum selectively recruits a subset of Rabs to its vacuolar membrane. GFPRab4A, GFP-Rab10, GFP-Rab11A, GFP-Rab14, RFP-Rab22A and GFP-Rab35, which
mediates endocytic recycling, and GFP-Rab1, which regulates endoplasmic reticulum to
Golgi trafficking, localize to the ApV. Fluorescently tagged Rabs are recruited to the ApV
upon its formation and remain associated throughout infection. Tetracycline treatment
concomitantly promotes loss of recycling endosome-associated GFP-Rabs and acquisition
of GFP-Rab5, GFP-Rab7, and the lysosomal marker, LAMP-1 (Figure 37). Thus, the
selective recruitment of Rab GTPases and the altered fusogenicity of the ApV are dependent
upon A. phagocytophilum encoded proteins. In addition, GFP-Rab10 associates with
the ApV in a guanine nucleotide independent manner. This strongly suggests that A.
phagocytophilum encode proteins that can regulate Rab10 cycling. This work highlights
142

Figure 37. The A. phagocytophilum-occupied vacuole interacts with a broad repertoire of host pathways to facilitate its intracellular survival strategy in host cells.
(A) The ApV associates with multiple eukaryotic pathways. During A. phagocytophilum
inclusion biogenesis it acquires markers for: recycling endosomes (accumulates Rab GTPases that are associated with the endocytic recycline pathway), autophagosomes (LC3 and
Beclin 1), and monoubiquitin pathways (accumulates monoubiquitinated proteins to the
AVM). (B) The altered fusogenicity of the ApV is presumably due to the active modification
of the vacuolar membrane by bacterial encoded proteins. To date, 3 A. phagocytophilum
proteins have been identified: APH_1387, APH_0032 and AptA. Others have determined
that AptA interacts with host vimentin, likely as a means to modulate interactions with host
cytoskeleton components and maintain structural stability. (C) Upon inhibition of bacterial
protein synthesis, the ApV no longer accumulates recycling endosome associated Rab
GTPases or monoubiquitinated proteins, but instead matures along the normal endosomal
pathway and fuses with lysosomes.
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a key strategy by which A. phagocytophilum facilitates its survival within myeloid host
cells. It actively controls the biogenesis of the vacuole in which it resides by selectively
hijacking Rab GTPases that predominantly associate with recycling endosomes. In doing so,
the ApV effectively disguises itself as a recycling endosome, which is requisite for avoiding
endosomal maturation and lysosomal fusion. This strategy also likely contributes to the
bacterium’s acquisition of host membrane material, amino acids and cholesterol, each of
which is important for bacterial growth and/or cell wall stability.
Another host pathway A. phagocytophilum exploits is the ubiquitin machinery. A theme
emerging among vacuole-adapted bacterial pathogens is their ability to hijack the ubiquitin
machinery to manipulate host processes and diversify the function of their effectors. Ubiquitination is an attractive target for pathogenic bacteria because it regulates many pathways in
eukaryotic cells. Mono- and polyubiquitination differentially dictate the subcellular localization, activity, and fate of protein substrates. Monoubiquitination directs membrane traffic
from the plasma membrane to the endosome and has been shown to promote autophagy.
Work presented in this dissertation show that monoubiquitinated proteins are present on the
AVM upon its formation and continue to accumulate throughout infection. Monoubiquitinated proteins decorate the AVM during infection of promyelocytic HL-60 cells, endothelial
RF/6A cells, and to a lesser extent, embryonic tick ISE6 cells. Although it is unclear whether
the ubiquitinated conjugates on the AVM are host or bacterial proteins, we speculate that
ubiquitination is important for the ApV’s altered fusogenicity (Figure 37A). Support for
this premise is the loss of ubiquitinated proteins on the AVM upon tetracycline treatment.
An intriguing alternative is that A. phagocytophilum may exploit the ubiquitin machinery to
regulate the localization of it’s secreted effectors. This phenomena has been reported for
the S. Typhimurium effector, SopB, that utilizes host ubiquitin to traffic to different cellular
compartments and diversify it’s function (151). Association of SopB with the SCV is dependent on it being ubiquitinated when it is tethered to the plasma membrane (151). Therefore
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it is possible that following secretion, APH_1387 or APH_0032 is ubiquitinated as a means
to target it to the AVM. Studies to define the bacterial effectors and/or host proteins involved
will be important for understanding the role of monoubiquitination to A. phagocytophilum
survival. These results identify a novel mechanism by which A. phagocytophilum modifies
its vacuolar membrane and present the first example of a Rickettsiales pathogen co-opting
ubiquitin during intracellular survival.
PVs are composed of host-derived membranes that are modified by pathogen-encoded
proteins and lipids. As a result, PVs become unique compartments that exhibit an altered
fusogenicity. Therefore, we reasoned that bacterial-derived AVM proteins are central to the
pathogenesis of A. phagocytophilum . We identified the first two A. phagocytophilum-derived
proteins that associate with the AVM, APH_1387 and APH_0032 (Figure 37B). The study
of these proteins is complicated by both their lack of sequence identity with proteins in
the sequence databases and the absence of a system for targeted gene deletion. However,
APH_1387 and APH_0032 exhibit differential expression patterns, which suggests that
they have distinct pathobiological roles. Upon A. phagocytophilum entry into the host cell,
APH_1387 is expressed early and associates with greater than 90% of ApVs by 12 h post
infection. In contrast, APH_0032 is not expressed in high abundance until 24 h, at which
time only about 60% of ApVs are APH_0032 positive. APH_1387 and APH_0032 are
present on the cytoplasmic face of the AVM and competitively inhibit ApV development
when ectopically expressed in host cells. Although we have not identified the corresponding
host factors, the results presented in this dissertation strongly suggest that APH_1387 and
APH_0032 mediate interactions with the host cell that are important for ApV survival.
The work here highlights the repertoire of bacterial adaptations that have evolved to
hijack host pathways and secure the pathogen’s survival. Further, it emphasizes the AVM as
a crucial interface for deciphering host-pathogen interactions. Despite the progress made in
characterizing Rab GTPases that are selectively recruited to the ApV and identifying two
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bacterial encoded AVM proteins, many important questions remain unanswered. Current
efforts are underway to identify A. phagocytophilum-encoded ligands that interact with
the ApV associating Rab GTPases, specifically the bacterial protein(s) that regulate Rab10
cycling on the AVM. Further dissection of the mechanism of selective recruitment of Rab
GTPases to the ApV will continue to enhance our understanding of how this unique pathogen
survives within the primary effector cell of microbial killing. Of equal importance will be
the identification of host proteins that interact with APH_1387 and APH_0032.
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